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ABSTRACT 
Myostatin, or GDF8, regulates skeletal muscle growth and adipose development in 
mice, cattle and humans. Individuals with non-functional myostatin mutation exhibit 
excessive muscle growth, decrease fat mass and huge body size. Previous studies indicated 
that epistatic interaction might play an important role in the myostatin pathway. However, 
only several loci that have a significant interaction with myostatin genotype have been 
identified in mice and cattle. 
In this dissertation work, we performed a QTL mapping study in F2 mice derived from 
a C57BL/6 myostatin-null mouse line and the M16i obese mouse line. A large number of 
traits were collected, which included 14 body weight traits, 10 obesity-related traits, 11 body 
composition traits, three bone strength traits and eight eQTL traits from 1000 F2. A total of 
242 SNPs across the genome were genotyped for each mouse by Sequenom. A linkage map 
was constructed using the marker and pedigree information. Interval mapping was applied to 
identify main effect QTL for these traits. In addition, additive, dominance and imprinting 
effects were evaluated for each QTL position. The corresponding variation accounted for by 
the QTL was computed as well. Comparing different QTL models with QTL effect, 
myostatin genotype effect and the interaction between QTL and myostatin genotype, 
comparison-wise P-values were obtained to identify possible epistatic loci that interact with 
myostatin genotype. A similar approach was utilized to search for loci that have significant 
interactions with sex or reciprocal cross. 
viii 
We identified a total of 115 main effect QTL. Among them, 10 QTL exhibited a 
significant imprinting pattern. In addition, 38 QTL were detected for their interaction with 
myostatin genotype with comparison-wise P-values less than 0.05. Most of them were 
associated with body weight and obesity-related traits. A total of 44 sex-specific and 41 
cross-specific loci were discovered as well. Some of these QTL regions overlapped and this 
indicates possible pleiotropic effects. These QTL explained a large amount of phenotypic 
variation. 
To the best of our knowledge, a large proportion of these QTL have not been identified 
in previous studies. This work is the first research to investigate epistatic interaction between 
genetic variation and myostatin genotype for bone strength and organ weight traits. The 
outcome of this work elucidates that epistatic interacting patterns widely exist between 
genetic loci that regulate muscle mass and fat accumulation. Moreover, the results from this 
dissertation work provide a foundation for future fine mapping work. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
 Double muscling phenotype was first documented in cattle (CULLEY 1807). Common 
double muscled cattle breeds include Belgian blue and Piedmontese (MASOERO and 
POUJARDIEU 1982). The most significant phenotype of these cattle is a huge muscle mass and 
body size. While this increased muscle mass results in  increased meat yield, which is a 
benefit to the producer, it also causes some problems, such as increased incidence of dystocia. 
People were curious about the genetic mechanisms underlying the double muscling 
phenotype. At the beginning of 90’s, the only genetic knowledge about double muscled cattle 
was a possible mutation on chromosome 2 (CHARLIER et al. 1995). With the discovery of a 
similar phenotype in myostatin-null mice, researchers quickly identified the double muscle 
phenotype in cattle is also caused by a mutation in myostatin gene. Myostatin was a new 
member of the transforming growth factor beta superfamily (MCPHERRON et al. 1997). 
Myostatin-null mice exhibited a heavily muscling phenotype that was similar to double 
muscled cattle. Following that observation, mutations in myostatin gene were successfully 
found in several cattle breeds (MCPHERRON and LEE 1997).   
 Myostatin is not the only gene that regulates skeletal muscle growth.  Skeltal muscle 
mass, which is a complex trait, is controlled by a number of quantitative trait loci (QTL) that 
have small individual effects. Interestingly, the double muscling phenotype is influenced by 
both breed and sex of the animal. These results indicate the possibility that other genes or 
factors may interact with myostatin genotype to impact skeletal muscle mass. However, no 
genes have been shown to epistatically interact with myostatin and only several genome 
regions have been identified for their ability to interact with myostatin to affect carcass traits 
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in cattle (CASAS et al. 2000; CASAS et al. 2001). A potential way to increase the QTL 
mapping power is to conduct a large-sample size study, but this is a costly and time 
consuming effort in cattle.  In contract, a mouse based study is another option that is less 
costive and feasible considering the presence of the myostatin-null mouse line.  
 In addition to its role in skeletal muscle growth, myostatin also affects adipose growth. 
For example, myostatin-null mice have less fat accumulation than wild-type mice 
(MCPHERRON and LEE 2002). Considering that fat content is a key point in meat production, 
the myostatin-null mice also provide an opportunity to investigate the molecular details of 
adipose regulation. The approach we propose in this dissertation project is to utilize the 
myostatin-null C57BL/6 mouse line and the polygeneic obese mouse line, M16i, to identify 
QTL that interact with myostatin in an epistatic manner.  The M16i line was developed from 
the outbred ICR line after continuous selection for high weight gain (HANRAHAN et al. 1973). 
In contrast to myostatin-null mice, M16i mice exhibit extensive adipose accumulation and a 
few obesity-related phenotypes. We hypothesized that loci that interact with myostatin to 
impact skeletal muscle and fat growth would segregate in the F2 mice derived from the 
crossing of these two lines. These loci could be identified with current QTL mapping 
methodology. 
 Myostatin has also been shown to affect organ weights, such as heart and liver 
weights (BUNGER et al. 2004), although myostatin gene expression is only detected in muscle 
and adipose tissue. Since there is a close correlation between body weights and individual 
organ weights, we performed a QTL mapping of body composition traits in our study to 
identify main effect QTL that impacted these traits. In addition, we analyzed the interaction 
effect between QTL and the myostatin genotype to detect potential epistatic loci that interact 
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with myostatin gene. Moreover, myostatin might regulate bone strength either directly or 
indirectly due to an increased skeletal muscle mass. Therefore, the bone breaking strength 
and bone stiffness were measured for femurs and used as traits for QTL mapping.  
 We recently completed a microarray experiment in myostatin-null and myostatin 
wild-type mice. The gene expression profiles were obtained from the pectoralis muscle tissue 
of mouse embryo. More than 2100 genes were differentially expressed in the muscle tissue 
while only 73 genes were differentially expressed in the embryos. In this dissertation work, 
we performed a eQTL mapping for nine genes selected from these 2100 genes. These nine 
genes were selected for their important effects on cellular signaling, muscle and adipose 
development, and fiber type alternation. The gene expression levels were obtatined by a 
multiplex real time PCR experiment and then used for eQTL identification. 
 In summary, the goal of this dissertation work was to identify QTL that interacted 
with myostatin genotype to affect body weight, muscle and fat weight, body composition, 
and bone strength traits. eQTL mapping of important genes was performed as well. More 
importantly, the interaction effects between QTL and myostatin gene, QTL and sex, QTL and 
reciprocal cross were evaluated. It was expected that the results from this study would 
provide numerous QTL regions that interacted with myostatin genotype. It would also give a 
general idea how much of the phenotypic variation seen in these traits were contributed from 
QTL by myostatin interaction effects.  
Thesis organization 
 This dissertation presents the author’s research in a journal format. The first chapter 
contains a general introduction and a literature review as background information for the 
dissertation work.  
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 Chapter 2 through Chapter 5 are papers in preparation for four journals. Chapter 2 is a 
manuscript submitted to the Heredity Journal. It describes the QTL mapping work of body 
weights in F2 mice derived from myostatin-null C57BL/6 mouse line and M16i obese mouse 
line. The statistical methods for QTL mapping and interaction analysis of this project were 
described in most detail in Chapter 2. Chapter 3 continues Chapter 2’s QTL mapping work 
for muscle weight, fat weight and eQTL traits with an additional statistical analysis of 
imprinting effect and will be submitted to PLoS Genetics. Chapter 4 and Chapter 5 consist of 
QTL mapping of body composition and bone strength traits and they will be submitted to 
Mammalian Genome and Genetics Notes respectively. Chapter 6 is a general conclusion of 
the research presented in this dissertation. In Chapter 2, 3, 4 and 5, the contributions of the 
authors were as follows: Ye Cheng was the primary researcher and author of all chapters, 
under the direction of James Reecy. The work described in Chapter 2 to 5 was assisted by 
collaborative work from Satyanarayana Rachigani (mouse raising, DNA isolation and 
phenotype collection), Jack C M Dekkers (direction of statistical analysis), Mary Sue Mayes 
(coordination of phenotype collection) and Richard Tait (bone strength data collection). RNA 
isolation and real time PCR work described in Chapter 3 was assisted by Angela Cánovas 
Tienda.  
Literature review 
Myostatin 
1) Introduction 
It has always been fascinating how tissue growth is regulated. Animals stop their 
growth when they reach their normal body mass. Cells maintain a perfect balance between 
amplification and apoptosis when they are healthy. Liver has the ability to regenerate even 
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after severe trauma. One of the most studied tissues in this area is skeletal muscle. Research 
in skeletal muscle is mostly focused on the development, maintenance, and regeneration of 
muscle cells (BRYSON-RICHARDSON and CURRIE 2008; PARKER et al. 2003; PEAULT et al. 
2007). Many internal signal pathways have been identified for their regulation on muscle 
growth (CLEMMONS 2009; ZHAO and HOFFMAN 2004). Both promotion and inhibition of 
growth have been observed in these signal pathways (PAMPUSCH et al. 2003; SACHECK et al. 
2004; XI et al. 2004). Over 40 years ago, Bullough came up with the chalone hypothesis 
(BULLOUGH 1962; BULLOUGH 1965). He proposed that there might be some molecules 
secreted by certain tissues to circulate in the body and inhibit tissue growth. He named these 
molecules chalones. There may be some chalones that specially reuglate muscle tissue. 
Therefore, this hypothesis provides a way to explain why muscle stops growing when it 
reaches the size limitation. The first known evidence to support the chalone hypothesis is the 
discovery of the myostatin gene.  
2) Discovery of myostatin gene 
Myostatin, or GDF-8, was first discovered during a screen for new a TGF-ß 
superfamily member using degenerative PCR primers (MCPHERRON et al. 1997). Following 
this, the entire myostatin cDNA sequence was obtained from the cDNA library. They 
discovered that the myostatin gene carried all of the hallmarks of members of the TGF-ß 
superfamily. For example, it has a secretion signal sequence, a proteolytic processing site and 
conserved cysteine residues in its carboxy-termainal region. Myostatin was given its name 
based on its function.  
In mouse, myostatin mutant mice that lost normal myostatin gene function, by gene 
targeting approach, exhibited a significant increase in both body weight and muscle weight 
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(MCPHERRON et al. 1997). Even heterozygous myostatin mice showed some muscle gain and 
this indicated that the myostatin gene might be dose dependent.  
In agriculture, modification of the myostatin gene might help improve meat 
production yield. Therefore, the myostatin gene has been widely analyzed in many species in 
addition to the mouse, e.g cattle (GROBET et al. 1997; MCPHERRON and LEE 1997), pigs 
(SONSTEGARD et al. 1998), chicken (MCFARLAND et al. 2007), turkeys (MCFARLAND et al. 
2006), sheep (CLOP et al. 2006) and humans (WILLIAMS 2004).  
The most interesting example here is cattle. Double-muscling, which is a phenotype 
of growing extremely large skeletal muscle, was documented in cattle quite early (CULLEY 
1807). Afterwards, this phenotype was mapped to a chromosomal region on bovine 
chromosome 2 (CHARLIER et al. 1995). After the discovery of the myostatin gene in mouse, 
the double muscling cattle were re-analyzed to search for possible mutations in the myostatin 
gene. Not surprisingly, double muscle cattle breeds, e.g Belgian blue and Piedmontese, carry 
a mutation in their myostatin gene, which resulted in a truncated non-functional myostatin 
protein (MCPHERRON and LEE 1997). These cattle breeds have been selected for significant 
muscle growth historically (MASOERO and POUJARDIEU 1982).  
On the other hand, the identification of myostatin mutations in the human genome 
may provide some ideas to develop new therapies for muscle diseases. In humans, this 
mutation was firstly identified in a German boy whose mother was an athlete (WILLIAMS 
2004). The mother’s genome carried a mutated copy of the myostatin gene which contributed 
to this double muscled phenotype in the boy. This super boy was able to carry two 3-kg 
dumbbells in his arms when he was about half years old. This is the first report of human 
muscle hypertrophy caused by myostatin gene mutation. In addition, alterations of the 
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myostatin expression level were also found to be associated with some muscle diseases in 
clinic researches, e.g muscle atrophy (MA et al. 2003) and muscle hypertrophy (ZHU et al. 
2000). 
Despite the relative conservation of the myostatin gene in the species mentioned 
above, fish appear to be an exception. Studies have found that the predicted myostatin protein 
sequence in fish is more closely related to GDF-11 (OSTBYE et al. 2001; ROBERTS and 
GOETZ 2001). This phenomenon suggests that more complicated events might have happened 
during the evolution of the fish genome and the myostatin gene.  
3) Expression pattern of myostatin gene 
Myostatin expression is initiated as early as embryonic day 9.5 (MCPHERRON et al. 
1997). This expression continues in the myotome afterwards. In adult mouse, myostatin gene 
expression is mainly detected in skeletal muscle with a wide range of different expression 
levels. The knock-out experiment of myostatin gene supports the fact that the major function 
of myostatin is to control muscle mass. 
 In addition, a detectable myostatin RNA level is present in adult fat tissue 
(MCPHERRON et al. 1997), which suggests some possible function of myostatin gene in 
adipose accumulation. Further study showed that myostatin mutation could cause significant 
lose in fat accumulation and this evidence makes myostatin one of the possible genes related 
to obesity (MCPHERRON and LEE 2002). 
4) Biosynthesis and activity regulation of myostatin 
Myostatin pathway research began with looking into its biosynthesis and activity 
regulation. Myostatin is synthesized in a precursor form (MCPHERRON et al. 1997). Two 
proteolytic processing events occur after that (LEE and MCPHERRON 2001). The first event 
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removes 24 amino acids from the N-terminal. The second event removes another 240-243 
amino acids from the first cutting site. This results in a latent complex of myostatin protein. 
However, the full activity of myostatin can only be gained after removal of the propeptide 
which is noncovalently linked to the C-terminal (LEE and MCPHERRON 2001; THIES et al. 
2001; WOLFMAN et al. 2003). The propeptide has two important functions. First, it ensures 
the proper folding of the precursor protein. Evidence supports this function in that only a 
small proportion of myostatin product was correctly folded to gain their biological activity 
from bacteria without the presence of the propepetide (TAYLOR et al. 2001; THOMAS et al. 
2000). Secondly, the propeptide might also participate in the regulation of myostatin activity, 
since experimental results indicated that over-expression of the propeptide leaded to a similar 
phenotype as seen in a myostatin-null mouse (LEE and MCPHERRON 2001; YANG et al. 2001). 
Additional evidence clearly shows that the propeptide can block the binding of myostatin to 
the receptor (LEE and MCPHERRON 2001; THIES et al. 2001). 
5) Myostatin pathway 
TGF-beta family members bind to two types of serine/threonine kinase receptor (type 
I receptor and type II receptor) to active the downstream signals. Myostatin is known to bind 
the activin type II receptor (ActRIIB and ActRII) first. These activated receptors then 
phosphorylate SMAD proteins. After phosphorylation, the SMAD protein functions as 
intracellular mediators that enter the nucleus and activate downstream target genes. The 
downstream genes that are regulated by the myostatin gene include some myogenic 
regulators, such as MyoD, myogenin, or Myf5 (JOULIA et al. 2003; LANGLEY et al. 2002; 
RIOS et al. 2002). The target genes impact myogenic differentiation.  
6) Control the specificity of myostatin 
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As long as myostatin is activated, it follows the usual TGF-beta signaling pathway. 
The most important question is how myostatin to reaches its specificity using this common 
pathway at specific times and in different tissues.  
The first level of specificity can be controlled at the protein level, which is the 
transition from a latent complex to an active myostatin protein. Researchers found that this 
level can only be reached by the specific expression of metalloproteinase, e.g. BMP-1/ tolloid 
(WOLFMAN et al. 2003). The second level of specificity comes from the existence of a special 
co-receptor. Although no evidence have shown that a co-receptor is needed to myostatin to 
bind the ActRIIA and ActRIIB, other studies found that a co-receptor or protein was required 
for other TGF-beta members to bind to the receptor (CHENG et al. 2003; LEWIS et al. 2000; 
SCHIER and SHEN 2000). In addition to a co-receptor, a type I receptor might also be required 
to combine with a type II receptor to gain specificity, e.g. ALK4 and ALK5 are two 
candidates for this because of their ability to bind myostatin (REBBAPRAGADA et al. 2003). 
Further evidence is needed to prove that these two type I receptors can promote the binding 
of myostatin to type II receptors.   
Certain important signaling pathway, e.g. SMAD protein, also participate in the 
specificity of myostatin signaling. For example, myostatin may promote the phosphorylation 
of SMAD2 and SMAD3 to active the downstream genes (LANGLEY et al. 2002; 
REBBAPRAGADA et al. 2003; THIES et al. 2001). The result is that nuclear protein c-ski was 
shown to block the activity of SMAD makes c-ski a candidate for controlling muscle growth 
(AKIYOSHI et al. 1999; SUN et al. 1999a; SUN et al. 1999b). In fact, experiments showing that 
over-expression of c-ski in mouse have lead to mice with muscle hypertrophy gave further 
support for this conclusion (SUTRAVE et al. 1990). 
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7) Proteins that interact with myostatin 
Except for the propeptide, other proteins are able to interact with myostatin. The most 
important one is follistatin. Follistatin expression happens at approximately the same 
development stage as myostatin gene expression (AMTHOR et al. 2002a; AMTHOR et al. 1996; 
AMTHOR et al. 2002b). Experiments using receptor binding assays show that follistatin can 
inhibit myostatin function (ZIMMERS et al. 2002). In addition, mice that over-express 
follistatin have the same amount of muscle mass increase as myostatin knockout mice (LEE 
and MCPHERRON 2001).  Besides follistatin, FLRG and GASP-1 are two other important 
proteins that interact with myostatin (HILL et al. 2002; HILL et al. 2003). They both bind to 
the c-terminal of myostatin.  This blocks the active site of myostatin protein. All these 
proteins join together and regulate myostatin activity in order for it to remain at a normal 
level. More details need to be clarified for this complicated regulation mechanism to be 
understood. 
8) Myostatin and satellite cell 
Satellite cells are a mononucleated myogenic cells which stops in the middle of the 
cell cycle (CAMPION 1984; SCHULTZ and MCCORMICK 1994). After birth, they can re-enter 
the mitotic cycle and differentiate into new muscle cells while stimulated by other signals 
(BISCHOFF 1994). Several evidences supported that myostatin could inhibit the proliferation 
of satellite cells. For example, myostatin-null mice have more satellite cells than wild-type 
mice (MCCROSKERY et al. 2003). p21 gene is one of the downstream genes that interact with 
myostatin gene to impact satellite cell activity. It has been shown that myostatin raises p21 
expression, and this lowes cdk2 expression than in turn inhibits cell proliferation and 
differentiation (MCCROSKERY et al. 2003; RIOS et al. 2001). Therefore in myostatin-null 
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individuals, this inhibition affect is removed, and the satellite cell becomes active again. Rb 
might also be a mediator for myostatin might affect cell proliferation through p21. 
Researches found that increasing the expression level of the p21 gene resulted in a 
suppression of cdk2 expression, which further caused less phosporylation of Rb2 protein 
(RIOS et al. 2001). The final consequence of this regulation is lower myogenic regulator 
expression, which in turn leads to the inhibition of differentiation in the myoblast. 
9) Myostatin and muscle diseases 
Some severe muscle atrophy diseases are caused by different reasons. For example, 
muscular dystrophy in mdx mice is caused by a mutation in dystrophin gene (SICINSKI et al. 
1989). Muscle degeneration has also been reported in some HIV patients (GONZALEZ-
CADAVID et al. 1998). In these cases, patients have significant muscle mass loss although this 
is via different mechanisms. Therefore, modifying myostatin gene expression levels has been 
suggested to be a potential direction for developing new therapies. Experiments in cachexia 
mouse showed that the suppression myostatin by RNA in vivo lead to a significant increases 
in skeletal muscle and improvement of muscle fiber (LIU et al. 2008). This might be the 
consequence of satellite cell reactivation. This raises concerns that this kind of treatment 
might cause this tissue to run out of the storage of satellite cells and put patients in an even 
more dangerous situation.  
QTL mapping 
1) Introduction 
A large number of traits show a continuous distribution, e.g. body weight, height and 
disease susceptibility. These traits are often defined as quantitative traits or complex traits 
(FALCONER and MACKAY 1996). Some other traits, which fall into discrete phenotype 
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variation, can also be treated as quantitative traits, e.g. number of tumors in the mouse 
intestine that carries cancer. Quantitative traits have a close relationship with agriculture, 
medicine, evolutionary theory etc. Quantitative traits are controlled by numerous genes 
simultaneously and are often influenced by both genetic and environmental factors. The term 
Quantitative Trait Locus (QTL) was suggested in quantitative marker analysis 
(GELDERMANN 1975). It is used to refer to the multiple genetic loci (more than one) that 
cause the phenotypic variation in quantitative traits. In some articles, QTL can also be used 
to stand for a single quantitative trait locus. The first definition is used throughout this thesis. 
Modifiers are described as QTL as well (GLAZIER et al. 2002; KORSTANJE and PAIGEN 2002). 
Modifiers are genes that alther the phenotypic effect of other genes. 
Usually, QTLs possess several or all of the following characteristics (TANKSLEY 
1993). Quantitative traits are controlled by a large number of genes with a small individual 
gene effect. Each QTL follows Mendelian rules and their effect can be dominant or co-
dominant. Gene by gene interaction, or epistasis, and gene by environment interaction often 
exist.   
It is known that each of the QTL might only contribute to a very small proportion of 
the variation observed. Mapping QTL that lie underneath complex traits provides an efficient 
way to search for candidate regions that can be used in the next step for candidate gene 
identification. There is growing evidence which suggests that many phenotypic traits are 
controlled by QTL (Complex Trait Consortium, 2003). Studies also demonstrate that obesity 
and other human diseases are associated with QTL (BOUCHARD 1997; RANKINEN et al. 2006). 
Mapping QTL related to human disease is helpful in order to discover the genetic 
components and the molecular mechanism underlying the disease. Moreover, considering the 
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other issues involved in QTL mapping, such as pleiotropy, pair-wise and high-order gene 
interactions and gene by environmental interaction, it helps to explore the genetic 
mechanisms behind quantitative traits. This perspective of integration is very important in 
this post-genome era.  
With the knowledge of statistics, many methods have been developed to identify QTL 
(DA 2003; KENDZIORSKI and WANG 2006). In addition, total phenotypic variance can be 
partitioned into polygenic (fixed effect), additive, dominance and epistatic genetic variation. 
Putting all these pieces of information together, help establish a better model of how each 
quantitative trait is controlled by genetic and environmental factors.  
2) QTL mapping stages and methods used in each stage 
The principle of QTL mapping is quite straightforward. It is a statistical test of 
association between a particular phenotype and polymorphic marker genotype (FLINT and 
MOTT 2001). If a significant association is there, this implies a trait QTL is linked to the 
marker. The first markers that were used in a QTL mapping study are allelic forms of 
enzymes. Different forms have different amino acid structures that can be separated on 
electrophoretic gels. Therefore, genes coding for these enzymes can be used as polymorphic 
markers for a mapping study.  As time passed, a larger number of DNA makers have been 
discovered and widely used. The most commonly used molecular markers include SNP 
(single nucleotide polymorphism), microsatellites and RFLP. The phenotype to be tested can 
be any quantitative phenotypic or gene expression profile (see eQTL section).  
(1) Stages of QTL mapping 
According to a review given by members of the Complex Trait Consortium (ABIOLA 
et al. 2003), there are generally three stages of any QTL mapping project, which includes 
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coarse mapping, fine mapping and identification of candidate genes. The difference between 
these three mapping stages is the resolution that can be reached in position of the QTL on the 
genome. Many factors affect the ability to detect a QTL and the resolution that can be 
reached. For example, how tightly the QTL is linked to the flanking markers. In addition, 
QTL having larger effect or higher heritability is easier to be identified. The size of the 
mapping population is also closely related to the mapping result. The most important factor 
that affects mapping resolution is the number of recombination events that occurred in the 
mapping population. A successful mapping strategy increases the recombination frequency in 
the mapping population, and consequently achieves a better mapping resolution.  
Usually, coarse mapping gives the QTL location within a range of 10-30 cM. The 
second fine mapping step further shrinks this range to about 1-5 cM. Some important factors 
for fine mapping QTLs include: marker density, crossover density and molecular architecture 
of the QTL. Increasing marker density and crossover density solve the resolution problem 
(DARVASI 1998).  In addition, some specially constructed mice populations have been 
utilized for QTL fine mapping, e.g. recombinant inbred lines (BAILEY 1971; SILVER 1995), 
recombinant congenic lines (STASSEN et al. 1996), recombinant intercross lines (VADASZ et 
al. 2000) and chromosomal substitution lines (HUNTER and WILLIAMS 2002).   
After the fine mapping stage, the region that might contain the QTL is significantly 
smaller and therefore only a few genes fall into this QTL range. These genes become the 
candidate genes that can be examined for polymorphism in the third mapping stage. Many 
methods are used in this stage to identify the causal mutation and clone the gene (GLAZIER et 
al. 2002; KORSTANJE and PAIGEN 2002). The first criterion is to select candidates that have a 
strong effect on the given phenotype. The hypothetical function of these candidate genes can 
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be verified by molecular biology methods. For example, knockout and transgenic animals are 
often used to confirm the true function of the gene. Then, protein analysis can be used to give 
some proof of this gene function on a protein level. 
(2) Statistical methods for QTL mapping 
Many statistical approaches have been developed for QTL mapping. The three most 
important mapping methods are single marker analysis, interval mapping, and composite 
interval mapping.  
i. Single marker analysis 
In the single marker analysis, a statistical test is used to determine if there is a 
significant association between genotype at a single marker and phenotype. For example, in 
the backcross mapping population, there are two different genotypes, marker Aa and AA. If 
AA individuals have a phenotypic value significantly different from Aa individuals, this 
suggests a QTL might link to this AA marker, which in turn affects the phenotype. A simple 
t-test (SOKAL and ROHLF 1981) can be used here if there are only two different genotypes at 
the marker position. In addition, linear regression (LONG et al. 1995; LYNCH and WALSH 
1998) and ANOVA (LYNCH and WALSH 1998) methods can also be applied here if there are 
more than two genotypes at the marker position. Linear regression provides a method to 
evaluate not only the QTL effect (additive and dominance effect) but also gene by gene and 
gene by environment interactions. The likelihood approach is also used for single marker 
analysis (LUCIEN 1990). In practice, the maximum likelihood estimates of the QTL genotypic 
values are obtained by an iterative approach.  
ii. Interval mapping method 
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In the interval mapping method, a chromosomal region between two flanking genetic 
markers is analyzed for the existence of QTL. Maximum likelihood (LANDER and BOTSTEIN 
1989; LYNCH and WALSH 1998) and Haley Knott regression (HALEY and KNOTT 1992; 
MARTINEZ and CURNOW 1992) are two common techniques used here. In maximum 
likelihood, the observed phenotype data is used to obtain the likelihood of a QTL within 
flanking markers. The likelihood of odds (LOD) score is calculated by taking the minus log 
of the likelihood-ratio test statistics (maximum likelihood of no segregating QTL versus 
maximum likelihood of segregating QTL). For each trait, the LOD score is mapped along 
each chromosome. Positions where the LOD score is above a significance threshold might 
harbor potential QTL. One important issue for this technique is to set the proper threshold to 
maintain a relatively low false positive rate. Another problem for the maximum likelihood 
method is the high computational demand. One new improvement of maximum likelihood is 
called order-restricted interval mapping (NETTLETON and PRAESTGAARD 1998). This method 
orders the genotype effects and then use it to calculate LOD scores based on restricted 
likelihood ratio test statistics. They suggest that this change in testing hypothesis can improve 
the QTL detection capability. Haley Knott regression method uses an approximate likelihood 
ratio test to test a full QTL and a reduced QTL model. This QTL model is a regression  
model that includes both additive and dominance QTL effect. It also includes the 
probabilities of QTL genotypes conditioning on the corresponding flanking markers. 
iii. Composite interval mapping and multiple interval mapping method 
Composite interval mapping method (ZENG 1994) is a multipoint QTL mapping 
method based on the interval mapping method. Composite interval method makes 
improvements on the efficiency and precision of QTL mapping by incorporating other 
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marker information into the analysis. In this analysis, additional markers outside the mapping 
region are used as cofactors in the regression, which will partly explain the phenotypic 
variation. In addition, multiple interval mapping (KAO et al. 1999) can also be applied to map 
multiple QTL simultaneously. Different from composite interval mapping method, multiple 
interval mapping methods simultaneously consider multiple interval regions instead of 
additional markers. The basic method of multiple interval mapping is still maximum 
likelihood, which takes into account a mix of several normal distributions. A potential 
problem of this method is an increase in parameters to estimate with the increase of QTL 
numbers.  
iv. Bayesian QTL mapping method 
Besides the traditional methods discussed above, Bayesian methods have been 
applied to QTL mapping (SATAGOPAN et al. 1996; SILLANPAA and ARJAS 1999; UIMARI et al. 
1996). In the Bayesian analysis, QTL number, QTL genotypes and QTL effects are treated as 
unknown. The observed data, including phenotypic values, marker genotypes and linkage 
map are treated as known. The Bayesian approach accounts for all the uncertainties in the 
system conditional on the observed data. From the observed data, Bayesian theory is used to 
sample from the posterior and update the prior statistical model. Most of the sampling 
procedure is done with Metropolis-Hastings or Gibbs sampling. Some software has been 
developed to implement the Bayesian approach in QTL mapping (MARTINEZ et al. 2005; 
SILLANPAA and ARJAS 1998; YANDELL et al. 2007). 
3) Experimental cross and population used in mouse QTL mapping 
QTL mapping in mouse models is favored over human or other animal populations. 
Besides the lower cost and less time consumption, the primary reason to use mouse models is 
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to control environment exposure (HUNTER and CRAWFORD 2008). The ability to account for 
environment variation can increase the power of QTL analysis. The second reason to use 
mouse models is to tap into the power of using a known population structure and the 
corresponding breeding scheme. Adding more complete pedigree information to the analysis 
can reduce false negative and false positive rates (SERRE et al. 2008). In mouse QTL 
mapping, backcross (BC) and F2 populations are commonly used. In addition, other existing 
mapping populations are also good candidates for QTL mapping.  
(1) Recombinant inbred lines 
Recombinant inbred strains were originally proposed by Bailey (BAILEY 1971) and 
developed by Taylor (TAYLOR 1978). Recombinant inbred (RI) lines are constructed by 
inbreeding an F2 generation from two genetically distinct strains. A large number of RI lines 
have been developed, genotyped, and are commercially available, refer to www.jax.org.  
(2) Advanced intercross lines 
Advanced intercross lines (AI) are produced by semi-random intercrossing within 
each generation after a standard F2 cross. It  has been proven that AI lines can systematically 
increase the accumulation of recombination events (DARVASI and SOLLER 1995). Therefore, 
AI lines are useful for the fine mapping stage.  
(3) Chromosome substitution strains (CSS) 
Chromosome substitution strains (CSS) are mice strains with one single chromosome 
replaced by the corresponding chromosome from a donor strain (HILL et al. 2006). CCS are 
developed by recurrent backcrossing progeny to one parent strain. They can provide QTL 
location to a chromsome in the first coarse mapping stage.  
(4) Congenic strains 
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Congenic strains are another way to construct QTL mapping populations using 
repeated backcrossing (HILL 1998). Different from CCS, congenic strains keep one 
chromosome segment from the donor strain instead of a whole chromosome. Many congenic 
strains have been developed and genotyped. They are an ideal source for QTL fine mapping.  
(5) Collaborative Cross 
The concept of the Collaborative Cross was first brought up by members of the 
Complex Trait Consortium at the Edinburgh meeting of the International Mouse Genome 
Conference in October of 2001 (THREADGILL et al. 2002).  The Collaborative Cross was 
started with eight commercial inbred mouse lines (A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, 
NZO, CAST/Ei, PWK/Ph and WSB/Ei) (CHESLER et al. 2008). They were mated pair wise to 
get the first generation (G1). From all 56 possible combinations of G0, G1 lines were crossed 
to obtain two four-way G2 progeny. Afterwards, G2 lines were crossed to yield 8-way 
hybrids (G2:F1). Lines were propagated by sib mating until they were inbred (THREADGILL 
et al. 2002). It is estimated that the collaborative cross can shrink the QTL interval  to only 1 
to 5 candidate genes (WILLIAM et al. 2002). SNP information, population structure 
recombination rate and other genome information will be available for each line (CHESLER et 
al. 2008). The current status of this project is continually updated online 
(http://mouse.ornl.gov/projects/cc_breeding_progress.html). 
eQTL (expression QTL) Mapping 
1) Introduction 
Microarray techniques for analysis of gene expression were first brought up and 
applied to molecular genetics in 2000. These experiments have been widely used to discover  
gene expression differences between two different biological conditions, e.g. cross 
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differences, healthy versus diseased individuals (PRIMIG et al. 2000; SANDBERG et al. 2000). 
Compared to traditional methods, microarrays provide an efficient way to obtain a large 
number of gene expressions simultaneously. With this advanced high-throughput technique, 
it has become possible to study the global gene expression profiles in parallel. In the mean 
time, statistical and bioinformatic tools make it possible to begin to look at and analyze this 
high dimensional data.  
Combining traditional quantitative genetic approaches, Jansen and Nap proposed 
genetic mapping of genome-wide gene expression data, which  treats gene expression level 
as a quantitative trait and follows this with quantitative genetic analysis (JANSEN and NAP 
2001). They termed this strategy ‘genetical genomics’. The first study that successfully 
realized this was a global gene expression mapping study performed in yeast (BREM et al. 
2002). Following this study, the QTL that are associated with expression variation of genes 
are named expression QTL (eQTL). Many eQTL have been mapped in more than a dozen 
species, e.g. mice, maize, human, rats, eucalyptus and Arabidopsis thaliana (BREM et al. 
2002; BYSTRYKH et al. 2005; CHESLER et al. 2005; CHEUNG et al. 2005; DECOOK et al. 2006; 
HUBNER et al. 2005; KIRST et al. 2004; MEHRABIAN et al. 2005; MONKS et al. 2004; 
MORLEY et al. 2004; SCHADT et al. 2003; STRANGER et al. 2005; YVERT et al. 2003).  
One reason to study gene expression as quantitative traits is that many gene 
expressions have a high heritability. Obtaining more details about these genetic factors is 
needed to get a full picture of how gene expression is regulated. For example, in a 
lymphoblastic cell line study of nearly 15,000 traits, the average heritability was larger than 
0.3 (DIXON et al. 2007). eQTL with heritability>0.8 have mapped to more than one 
chromosome position. This again indicates that genetic background impactes a large number 
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of gene expression traits. Moreover, these genetic factors, including cis and trans regulatory 
elements, were widespread across the whole genome.  
Another reason to study eQTL is the special intermediate role that gene expression 
serves between genotypic and phenotypic variation. Phenotypic QTL makes a connection 
between DNA sequence and regular trait phenotypes. eQTL further provides complementary 
information on an mRNA level about how the relevant gene expression is regulated by the 
genome. The collocation of eQTL and phenotypic QTL provides much stronger evidence of 
causal mutation.  
2) Important approaches used in eQTL study 
(1) eQTL mapping method and FDR control 
The standard QTL mapping methods discussed above are used for eQTL mapping as 
well. Therefore, these approaches will not be discussed in this section. An important question 
that is addressed by eQTL mapping, and also regular QTL mapping, is the multiple-
comparison problem. This is not surprising when we consider the statistical approaches and 
problems in microarray experiments. Historically, some methods have been developed to 
control FDR (false discovery rate) for multiple testing problems. For example, q-value 
measures the proportion of false positives incurred when the result of the test is significant 
(GRUNENFELDER and WINZELER 2002; HUBNER et al. 2005; STOREY and TIBSHIRANI 2003). 
In other words, q-value can be viewed as a transformed form of p-value. According to the q-
value, significance cut-offs can be made similar to a p-value. This method has been used to 
solve many genomic problems. Another option to solve multiple-comparison problems is the 
permutation method (BREM and KRUGLYAK 2005). This method can be used to control FDR 
for a single location. Moreover, an empirical Bayesian approach discussed by Kendziorski 
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(KENDZIORSKI et al. 2006) is also applicable to control FDR for multiple locations. The 
Bayesian approach adjusts for multiple tests across both traits (mRNA transcripts) and 
markers used in the analysis. This Bayesian approach is more accurate when multiple eQTL 
are detected for one transcript. 
(2) Cis- vs. trans- eQTL 
From the eQTL mapping result, cis-acting modulators or local modulators and trans-
acting modulators or distant modulators can be distinguished by comparing the transcript 
location and the eQTL location (ROCKMAN and KRUGLYAK 2006).  
i. Cis- eQTL 
Usually, SNPs within 100 kb upstream and downstream of the target gene can be 
viewed as cis-acting eQTL (COOKSON et al. 2009). It is suggested that cis- regulation is more 
often caused by genetic variation in the gene itself. This is supported by evidence that eQTL 
are more densely dispersed within the 250 bp around the transcription initiation sites 
(VEYRIERAS et al. 2008).  
ii. Tran-s eQTL 
Trans- regulation is caused by polymorphism of other regions across the genome. It 
has been found in eQTL studies that the frequency of a long-distance regulatory element is 
much less than that of a short-distance regulatory element (DIXON et al. 2007; STRANGER et 
al. 2007), especially in rats (MORLEY et al. 2004; SCHADT et al. 2003) and humans (HUBNER 
et al. 2005). The trans-eQTL might be candidate genes for transcription factors. Therefore, it 
is expected that some trans-eQTL might have multiple effects on a number of transcripts at 
the same time. The trans-eQTL are sometime also defined as ‘master regulators’ and have 
been identified in many different species, e.g Drosophila (DIXON et al. 2007; EMILSSON et al. 
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2008), rat (HUBNER et al. 2005) and humans (MORLEY et al. 2004). But trans-regulation can 
also be caused by other indirect regulations, e.g non-cell-autonomous effects and (ROCKMAN 
and KRUGLYAK 2006), interchromosomal interactions (SPILIANAKIS et al. 2005).  
(3) eQTL hot spots 
Master regulator is a special case of eQTL hot spots. eQTL hot spots are genomic 
regions where multiple transcripts have been mapped  (KENDZIORSKI and WANG 2006). 
Kendziorski and Wang (2006) provided a criterion? to identify eQTL hot spots by. For 
example, the number of mapping transcripts and the sum of LOD scores need to be 
considered. In addition, statistical tests have been considered to determine which spots are 
truly hot. A Poisson-based test was proposed by Brem et al. (2002) to test if particular 
chromosomal regions are “ghost” hot spots. This test was also been discussed by another 
researcher (PEREZ-ENCISO 2004). Other statistical approaches for detection of eQTL hot 
spots have been developed (BARRY et al. 2005; SUBRAMANIAN et al. 2005).  
(4) eQTL and GWA study 
Another important application of eQTL study is to combine it with a genome-wide 
association (GWA) study to identify candidate genes for disease study. A GWA study builds 
a connection between genetic variation through the whole genome and disease. With the aid 
of eQTL, GWA can be used to identify genetic markers that affect both the disease and the 
gene expression profiles at the same time (COOKSON et al. 2009). This approach is especially 
useful when a GWA study alone is not powerful enough to target a candidate gene. There are 
two common examples. First, the genome regions identified by a GWA study covers a couple 
of genes and no gene is an obvious candidate gene for the disease. An eQTL study can be 
used to find transcripts that co-localize in this region. If the transcripts and a certain gene 
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from the GWA study list overlap, it is very possible that this gene is highly associated with 
the disease. Therefore, this gene can be chosen as a candidate gene. Success stories using this 
application comes from a GWA study of asthma (DIXON et al. 2007; MOFFATT et al. 2007). 
Another situation where these two tools can be applied is when the genome regions 
suggested by the GWA study does not provide any candidate gene list. Sometimes, the gene 
that causes the disease phenotype is not located in the GWA polymorphism region. It is 
indirectly influenced by another long distance cis- or trans- regulator factor, and this 
regulator is located in the GWA polymorphism region. An eQTL study provides additional 
evidence for the association between GWA polymorphism and the candidate gene expression. 
One example is the PTGER4 gene that impacts Crohn’s disease (CD) in a mouse study 
(KABASHIMA et al. 2002; LIBIOULLE et al. 2007). The direct region identified by GWA in this 
study was in a gene desert. However, through another eQTL study, a connection was built 
between GWA polymorphism and the PTGER4 transcripts. 
(5) Pathway and integration of other –nomics 
eQTL hot spots that influence many transcripts at the same time are likely to be the 
hub of a regulatory pathway. The mapping transcripts from an eQTL study give a list of 
candidates that connect to the hub (KENDZIORSKI and WANG 2006). The first procedures to 
fit the pieces from this biological jigsaw together were proposed in 1998 (EISEN et al. 1998). 
In Jansen and Nap (2001), they expressed the similar ideas more formally. After 
summarizing the information gained from eQTL study, a putative pathway could be 
reconstituted (JANSEN and NAP 2001; SERVIN and STEPHENS 2007).  
One method used in a neural synapse function study (CHESLER et al. 2005) was to 
calculate pair-wise correlations among the mapping transcripts. The extent of correlation 
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could be used to identify cliques. The relationship between any two transcripts among cliques 
could be studied by their correlation. It has also suggested to narrow down the transcripts 
lists in the network by including only highly correlated eQTL candidates and transcripts 
(BING and HOESCHELE 2005). One potential problem is a risk to falsely place closely linked 
loci from different networks together.  
It has been proposed that information from an eQTL mapping study can be used to 
find the best network model (ZHU et al. 2004). The number of hubs in the network and the 
complexity of the network could be reduced. Moreover, after calculating the correlation 
between transcript abundance and phenotype values, an indirect association is made between 
eQTL and phenotypes.  
However, pathway assembly is a demanding job because a regulatory factor is plastic 
and susceptible to special and temporal change (LI et al. 2006; PETRETTO et al. 2006; SERVIN 
and STEPHENS 2007; STERN et al. 2007; VAN SWINDEREN and GREENSPAN 2005). 
Nevertheless, a combination of genomics, transcriptomics, proteomics and metabolomics is 
expected to elucidate the genetic architecture and molecular mechanism of complex traits in 
the future (DITTRICH et al. 2008; MELZER et al. 2008). 
Epistasis 
1) Introduction 
Genetic modifiers are genes that alter the expression of another gene (BRIDGES 1919; 
GRUNEBERG 1950). Epistasis is one special form of genetic modification (PHILLIPS 1998). 
Approximately 100 years ago, the word ‘epistasis’ was invented by William Bateson to 
explain the difference between the predicated Mendelian segregation ratio and the actual 
outcome of the flower color in sweet pea (BATESON 1909). In his paper, this kind of epistatic 
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interaction was caused by one gene masking the effect of other gene. An additional statistical 
meaning of this term was defined by R. A. Fisher, as any statistical deviation from the 
additive combination of two loci in their effects on a phenotype. This is defined as ‘epistacy’ 
by him (FISHER 1918). This statistical definition of epistasis is widely used in population and 
quantitative genetics. The original definition from Bateson is more often used by geneticist 
for segregation in a specific cross (PHILLIPS 2008). These two definitions are not equal. A 
lack of statistical evidence for epistasis does not mean a lack of genetic interaction (CORDELL 
2002; MOORE and WILLIAMS 2005).  
There are currently three main categories of epistasis (PHILLIPS 2008). The first 
category of epistasis is ‘functional epistasis’. This kind of interaction can also be viewed as 
protein-protein interaction. Proteins in the same pathway or same complex interact with each 
other (BOONE et al. 2007). The evidence of functional epistasis comes from biochemistry 
experiments. The second category of epistasis is ‘compositional epistasis’. This kind of 
epistasis is the same as the one defined by Bateson (BATESON 1909). To study compositional 
epistasis, only the loci of interest are altered while the other genetic loci throughout the 
genome are kept the same. Both quantitative and qualitative phenotypes can be measured for 
compositional epistasis. The third category of epistasis is ‘statistical epistasis’, which is the 
same as the one proposed by Fisher. Statistical epistasis measures the phenotypes of samples 
from a population while compositional epistasis ‘intentionally constructs’ the phenotype 
(PHILLIPS 2008). A very detailed example of mouse coat color was given by Philips (2008) to 
illustrate the difference between these three categories of epistasis. The interaction between 
the two loci that were involved in this coat color study could be viewed as an example of 
compositional epistasis. A further dissection of proteins that participated in this pathway was 
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an example of functional epistasis. A quantitative genetics way to look at the coat color was 
used to combine marker genotypes, phenotypic values and give an estimate of genetic 
estimate of these loci. This is a statistical epistasis way to look at coat color. 
The concept of epistasis is also emphasized by systems biology (MOORE and 
WILLIAMS 2005). In systems biology, results from genomics, transcriptomics, proteomics and 
metabolomics are integrated to explore molecular mechanisms behind variation. This kind of 
multifactorial analysis increases the power to find gene interactions. 
2) How to measure epistasis 
Epistasis is the deviation of phenotype from what is expected. It is very important to 
find the proper way to measure this “expected” phenotypic value. Different mathematical 
models have been used to measure the phenotype. The most common model for epistasis is 
derived from Fisher’s definition of epistasis (FISHER 1918). This model includes the additive 
and dominance effects of two loci and four epistasis terms (additive by additive, additive by 
dominance, dominance by additive, dominance by dominance). If epistasis does not exist, 
then the coefficients for the four epistasis terms are defined to be zero. Both a haploid and 
diploid model can be derived from it. This linear model is easy to analyze with statistical 
methods. The problem with Fisher’s definition is that the scale of measurement can be 
affected if the phenotype is additive and epistatic. After some transformation, an additive 
phenotype may show epistasis (FRANKEL and SCHORK 1996; GREENLAND and ROTHMAN 
1998). In addition, population geneticists use multiplicative (HODGE 1981; RISCH 1990) and 
heterogeneity (NEUMAN and RICE 1992; RISCH 1990) models to define epistasis. These two 
models will not be discussed in detail here.  
3) Epistasis in QTL mapping 
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Epistasis also plays an important role in complex traits. Historically, it has not been 
elucidated or even neglected in complex trait studies (BARTON and KEIGHTLEY 2002; 
CARLBORG and HALEY 2004; DOERGE 2002; FLINT and MOTT 2001; HOH and OTT 2003; 
JANSEN 2003). This might be one the reasons why it is difficult to repeat human association 
studies (HIRSCHHORN et al. 2002). In addition, it might also lead to the disappearance of an 
identified QTL effect after these QTL are isolated (CARLBORG and HALEY 2004).  
In some QTL mapping studies, epistasis is detected between loci, in which one or 
both have significant effects on the phenotype (FIJNEMAN et al. 1996; LI et al. 1997; LONG et 
al. 1996). Recent studies also identified epistasis between loci that had no individual effects 
(CARLBORG and ANDERSSON 2002; SEN and CHURCHILL 2001). Empirical and theoretical 
results support the conclusion that inclusion of epistasis into QTL mapping analyses could 
improve the statistical power to identify QTL (GAUDERMAN and THOMAS 2001; KAO and 
ZENG 2002).  
4) Methods used to identify epistatic QTL 
In the previous QTL mapping section, several common QTL mapping methods were 
discussed. The principle of these methods can alos be used to map epistatic QTL. Epistatic 
QTL mapping requires use of a multi-QTL model instead of a single QTL model. Marginal 
QTL effects and the epistatic effects associated with pairs of loci are considered 
simultaneously. This is the main difference from traditional QTL mapping. Several methods 
have been used to search for epistatic QTL. One method is to first conduct a single QTL 
scanning. Following the scan, epistatic interaction is tested between QTL with significant 
marginal effects. This method is discussed in detail in (CULVERHOUSE et al. 2002). The 
second method is to perform a two dimensional QTL scan across the genome (HALEY and 
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KNOTT 1992; WANG 1999). This method does not require significant main effects of QTL for 
the epistatic interaction to be detected. In addition, stepwise selection has been applied to 
find the best genetic model by fitting additive, dominance and epistatic effects into the model. 
This approach was applied in the multiple interval mapping (MIM) (KAO et al. 1999; ZENG 
et al. 1999) in backcross experiments to identify epstatic QTL. Similar to QTL mapping, 
Bayesian methods have been studied and applied in epistatic QTL mapping (SEN and 
CHURCHILL 2001). After the reversible jump Markov Chain Monte Carlo (MCMC) algorithm 
was proposed (GREEN 1995), it was applied to QTL mapping to estimate epistatic 
interactions (YI and XU 2002; YI et al. 2003). 
5) Epistasis studies in livestock animals 
Many important traits in livestock animals are complex traits. Elucidating more detail 
about the role of epistasis in livestock animals will help to better understand the molecular 
mechanism that controls these traits. However, very few epistatic QTL have been identified 
in livestock animals. The reason is that only interactions with an effect greater than 0.4 
standard deviations can be detected. The same power problem also happens in swine studies 
(VARONA et al. 2002). Nevertheless, several epistatic QTL were successfully identified in 
livestock animals. For example, two QTL were identified in beef cattle for significant 
interaction on backfat thickness and meat tenderness (CASAS et al. 2000). Another cattle 
study of the calpain gene family identified epistatic interactions between a QTL at calpain 1 
(CAPN1), located on chromosome 29, with a QTL at calpastatin (CAST), located on 
chromosome 7 (BARENDSE et al. 2007). A more successful story of epistatic QTL mapping 
was performed in chicken (CARLBORG et al. 2003). With a large population size, epistatic 
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interactions were observed to contribute a large amount of variation in early growth traits, 
while later growth was mostly regulated by additive effects. 
6) Epistasis studies in mice and humans 
In mammals, gene interaction impacts coat color (SILVERS 1979). In this book, he 
discussed the loci and the interactions between these loci that control coat color in mice in 
detail. It has been estimated that epistasis could explain about 30% of phenotypic variation in 
body weight and fat accumulation (BROCKMANN et al. 2000). They also estimated that about 
20-33% of phenotypic variation in muscle weight and hormone concentration in serum was 
from epistatic interactions. Therefore, epistasis is an important factor of phenotypic variation 
in mice. Other studies in mice reached the same conclusion (KIM et al. 2001; SHIMOMURA et 
al. 2001; SUGIYAMA et al. 2001). Carlborg and Haley pointed out that the estimation of 
epistasis in mice might be overestimated because of small population sizes (CARLBORG and 
HALEY 2004). Relatively speaking, studies with a larger sample size provide more accurate 
estimations. 
As expected, epistasis also plays an important role in human health. This is not 
surprising because most of human diseases are complex traits (MOORE 2003; SUGIYAMA et al. 
2001). For example, coronary heart disease (CHD) is a complex disease affected by many 
traditional risk factors such as age, smoking, and body mass index (KARDIA et al. 2003). 
Studies found that epistasis and gene-environment interactions play an important role in 
disease susceptibility (REA et al. 2006; SING et al. 2003). Moreover, gene interactions were 
identified in other human diseases, e.g coronary artery disease (KARDIA et al. 2006; 
MENDONCA et al. 2009), diabetes (PHILLIPS et al. 2008; WU et al.; ZUNIGA et al. 2006), 
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bipolar effective disorder and autism (ABOU JAMRA et al. 2007; TSAI et al. 2007; WILTSHIRE 
et al. 2006).  
7) Challenges faced in epistasis studies 
Despite increasing recognition in genetic studies, epistasis analysis faces some 
practical challenges as well. One potential problem that an epistasis study encounters is the 
huge dimension of data that needs to be manipulated. With the increasing number of genes 
considered, the number of pair-wise interactions is boosted rapidly. If three-way or even 
higher interactions need to be explored, some special approaches must be applied. Logistic 
regression (MILLSTEIN et al. 2005), machine learning and data mining methods (MCKINNEY 
et al. 2006) and multifactor dimensionality reduction (MDR) (HAHN and MOORE 2004; 
MOORE 2004; MOORE et al. 2006; MOORE and WILLIAMS 2002; RITCHIE et al. 2003; RITCHIE 
et al. 2001) were developed for this purpose.  
The second problem facing an epistasis analysis is to set a reasonable significance 
threshold. In multiple testing, the threshold can be obtained by randomization tests 
(CHURCHILL and DOERGE 1994; KAO et al. 1999; SEN and CHURCHILL 2001). However, the 
randomization test sets a very stringent threshold when a large number of gene interactions 
are tested. As a result, only large epistatic effects will be identified. New approaches are 
needed to solve this problem.  
The sample size for epistasis study is another challenge. When the number of 
interacting loci increases, the number of individuals in each genotype combination decreases. 
Consequently, this requires a large sample size so that a moderate epistatic effect can be 
detected (DEMUTH and WADE 2006).  
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CHAPTER 2. MAPPING GENETIC LOCI THAT INTERACT WITH MYOSTATIN 
TO AFFECT GROWTH TRAITS 
A paper to be summited to the Heredity Journal 
Ye Cheng, Satyanarayana Rachigani, Jack C Dekkers,  
Mary Sue Mayes, Richard Tait, James M Reecy 
Abstract 
Myostatin, or GDF8, is an inhibitor of muscle growth. A non-functional myostatin 
mutation leads to a double muscling phenotype in some animals. Previous studies have 
indicated that there are loci in the genome that interact with myostatin to control backfat 
depth and other complex traits. We now report a QTL (quantitative trait loci) mapping study 
designed to identify loci that interact with myostatin to impact growth traits in mice. Body 
weight and average daily gain traits were collected on F2 progeny derived from a myostatin-
null C57BL/6 strain by M16i cross. Forty-four main effect QTL were detected above a 5% 
genome-wide significance threshold when an interval mapping method was used. In addition, 
we identified 37 QTL that significantly interacted with myostatin, sex, or reciprocal cross. 
Twelve of these QTL interacted with myostatin genotype. These results provide a foundation 
for the further fine mapping of genome regions that harbor loci that interact with myostatin.  
Conflict of interest 
The authors declare no conflict of interest. 
Introduction 
Growth traits are complex traits of economic importance to animal agriculture. A good 
understanding of mechanisms that control growth will benefit both meat production and 
human health. Therefore, growth traits have been widely studied in animal models (Corva 
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and Medrano, 2001). Heritability studies of growth-related traits (Eisen, 1974; McCarthy, 
1982) indicate that there are genetic mechanisms that control these traits. Previous 
publications have estimated the amount of phenotypic variation in growth traits that can be 
explained by different types of genetic effects (Brockmann et al., 2000; Carlborg et al., 2003). 
It has been demonstrated that, among these genetic effects, epistasis explains a large amount 
of phenotypic variation, as compared to additive and dominance effects. For example, 
Brockmann (2000) estimated that about 33% of the phenotypic variation of body weight in 
mice could be attributed to epistasis. Another study indicated that there might be a time 
dependent pattern for these genetic effects and epistasis might be more important for early 
growth traits (Carlborg et al., 2003).  
Identification of key genes that control growth traits has shed light on the molecular 
mechanisms that regulate growth. For example, myostatin has been shown to inhibit muscle 
growth in cattle, dogs, mice, and humans (Grobet et al., 1997; McPherron et al., 1997; 
McPherron and Lee, 1997; Schuelke et al., 2004; Mosher et al., 2007). As a member of the 
transforming growth factor beta family, myostatin was first identified in mice for its 
significant effect on skeletal muscle growth (McPherron et al., 1997). Interestingly, not all 
myostatin-null animals show an obvious difference in their muscle mass. For example, some 
South Devon cattle that are homozygous for myostatin-null mutations do not exhibit the 
double-muscling phenotype (Smith et al., 2000). In addition, Grobet (1998) showed that 
Limousin and Blonde dAquitaine, which both posess wild-type myostatin alleles, exhibited a 
double muscling phenotype.  
Other loci might epistatically interact with myostatin to control skeletal muscle growth. 
To date, only loci that interact with myostatin to control backfat depth and meat tenderness 
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have been identified and mapped in cattle (Casas et al., 2000; Casas et al., 2001). Since the 
main function of myostatin is to control skeletal muscle growth, it will be critical to map 
these loci. Furthermore, the knowledge gained will help elucidate the molecular details 
behind the genetic architecture of growth traits.  
Here, we developed an F2 population from myostatin-null C57BL/6 mice by M16i 
obese mice. A whole genome scan was performed to identify main effect QTL. Subsequently, 
a model comparison approach was applied to search for potential epistatic QTL. We further 
investigated the phenotypic and genetic variation that could be accounted for by these QTL.  
Methods   
Mapping population  
An F2 cross design was used for this study. We first derived the mapping population 
from reciprocal crosses between the two founder strains, myostatin-null C57BL/6 
(McPherron et al., 1997) and M16i high body weight mice (Hanrahan et al., 1973). Four 
myostatin-null male mice were mated with eight M16i females to produce 35 male and 37 
female F1 offspring. In addition, two M16i males and seven myostatin-null females were 
crossed to generate 31 male and 55 female F1 offspring. Within each of these two crosses, F1 
mice were intercrossed to produce the F2 mapping population.   
Phenotyping and genotyping procedure 
Each F2 litter was standardized to 9 pups one day after birth. At 1 week of age, mice 
were individually identified. Mice were weaned when they were three weeks old. Isolated 
DNA was used to determine the myostatin genotype by a standard PCR reaction. A total of 
1000 F2 generation progeny that were either homozygous myostatin wild-type or 
homozygous myostatin-null were collected for genotype and phenotype information. Among 
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these 1000 F2 mice, 552 mice were from the myostatin-null male by M16i female cross 
while 448 mice were from the reciprocal cross. Each of the F2 individuals had its body 
weight recorded at 7, 14, 21, 28, 35 and 42 days of age. Based on the measurements of body 
weights, growth rate was calculated for different growth periods. For the pre-weaning period, 
average daily gain was calculated for the 2nd week and 3rd week, along with the 1st to 3rd 
week interval. During the post-weaning period, average daily gain was calculated for the 4th 
week, 5th week, 6th week, and the 4th to 6th week interval. Furthermore, average daily gain for 
the 1st to 6th week interval was calculated and included as a measurement of overall growth 
rate. Genomic DNA from each of the F0, F1 and F2 generation mice was purified by a 
phenol chloroform method. All animal procedures were approved by the Iowa State 
University Animal Care and Use Committee prior to this study. 
Linkage map  
We genotyped 242 SNPs on the Sequenom® platform at GeneSeek® (Lincoln, 
Nebraska).  These SNPs were evenly distributed on 19 autosomes and the X chromosome. 
First, genotyping data were checked for genotyping errors on the basis of Mendelian 
inheritance and pedigree information. SNPs with low call rates (less than 80%) and 
genotyping errors were discarded. After this first selection, 152 SNPs were left and they were 
distributed on 17 autosomes (no informative SNPs were present on chromosome 15 and 
chromosome 16) and the X chromosome. Second, a Chi-square test was used to evaluate the 
extent of segregation distortion in the F2 population. Most markers did not significantly 
deviate from the expected Mendelian segregation ratios, except for SNPs close to the 
myostatin locus, which was expected because only homozygotes at the myostatin locus were 
included. Therefore, the remaining 152 SNPs were used for our statistical analysis. Finally, a 
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linkage map was constructed in Kosambi centimorgans with Cri-map (Green, et al., 1990). 
Marker order and position in this map (Supplemental Table 1) was in reasonable agreement 
with those from the Wellcome-CTC Mouse Strain SNP Genotype Set 
(http://www.well.ox.au.uk/mouse/INBREDS). Thus, we performed the following QTL 
mapping analysis based on our linkage map. 
General statistical analysis  
The SAS 9.2 (SAS Institute, Inc., Cary, NC) was used to explore the data structure of 
the F2 phenotypic data. First, simple statistics were calculated on the fourteen growth traits.  
Second, Q-Q plot and normality tests were used to verify that each trait was normally 
distributed. Third, the Proc GLM procedure was applied to each trait to identify significant 
factors that need to be accounted for in the QTL mapping model.  Specifically, effects of 
myostatin genotype, coat color, sex, reciprocal cross and interactions among these factors 
were evaluated. All these factors have been previously shown to impact growth traits. Finally, 
after removing fixed effects that were identified in the previous step, residual correlations 
were calculated and tested between each pair of traits by the Proc CORR procedure. 
Main effect QTL analysis  
GridQTL (Seaton, et al., 2006), a web-based QTL analysis program, was used to 
identify QTL associated with the 14 growth traits by interval mapping. The QTL model 
included the main effects of myostatin genotype, coat color, sex, and reciprocal cross, and the 
interaction effects of sex × myostatin genotype, sex × reciprocal cross, myostatin genotype × 
reciprocal cross, sex × coat color and sex × myostatin genotype × reciprocal cross along with 
the additive and dominance effect at the single QTL position. For each trait, both F-values 
and LOD-values were provided by GridQTL. Genome-wide significance levels (1% and 5%) 
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were determined by the genome-wide permutation procedure (Churchill and Doerge, 1994) 
implemented in GridQTL, using 1000 permutations. Additive and dominance effects, along 
with the corresponding standard errors, were estimated for each significant QTL peaks. The 
percentage of phenotypic variation accounted for by a QTL position was computed as the 
percentage of residual sum of squares explained by the additive and dominance effects at the 
QTL.  For each trait, the total phenotypic variation of all QTL was calculated by summing 
the percentage of phenotypic variation together.  
QTL interaction with myostatin genotype, sex and reciprocal cross effect  
To test the potential interaction between a QTL and myostatin genotype, we first 
applied a forward QTL selection strategy. In this step, the dataset was split into two subsets 
by myostatin genotype.  Interval mapping analysis was completed using the main effect QTL 
model without myostatin genotype effect within each subset.  All positions that reached a 5% 
genome-wide significance level were identified. In the second step, the interaction between 
each of these positions and myostatin genotype was tested by comparing four models in the 
full data. Fixed effects in the following effect were same as before. 
Model 1:  
ε+×+×
+++=
position) (QTL effect dominance   Myostatinposition) (QTL effect additive  Myostatin
 position) (QTL effect dominanceposition) (QTL effect additive  effects fixedvalue Phenotypic  
Model 2: 
ε position) (QTL effect additive  Myostatin
 position) (QTL effect dominance position) (QTL effect additive  effects fixedvalue Phenotypic
+×
+++=  
Model 3: 
ε position) (QTL effect dominance  Myostatin
 position) (QTL effect dominance position) (QTL effect additive  effects fixedvalue Phenotypic
+×
+++=  
61 
 
Model 4:  
ε+++= position) (QTL effect dominanceposition) (QTL effect additive  effects fixedvalue Phenotypic  
The F-value was computed with the following formula: 
To test overall interaction: 
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The corresponding p-value was calculated from the F-distribution. A comparison-wise 
P-value less than 0.05 was considered significant.  
To analyze the interaction effect between QTL and sex, the full dataset was split into two 
subsets according to gender: female F2 mice and male F2 mice data. A similar approach to 
the one described above was used by substituting the myostatin ×additive effect with the Sex 
×additive effect and the myostatin ×dominance effect with the Sex ×dominance effect.  
To analyze the interaction effect between QTL and reciprocal cross, the full mouse 
dataset was again split into two subsets according to reciprocal cross information: the M16i 
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female × myostatin male cross and the M16i male × myostatin female cross data.  Again, a 
similar approach as described above was used by substituting the myostatin ×additive effect 
with the Cross ×additive effect and the myostatin ×dominance effect with the Cross 
×dominance effect.  
For each of the detected QTL, the additive and dominance effects were estimated.  The 
amount of phenotypic variation accounted for by each was calculated using the percentage of 
sum of squares explained as described above for main effect QTL. For each trait, the total 
variation explained by QTL was calculated as the sum of phenotypic variation from all main 
effect QTL and interaction QTL that were identified for the trait. 
Results   
General statistics 
Our initial statistical analyses indicated that all 14 phenotype traits were normally 
distributed (supplemental Figure 1). The histograms in supplemental Figure 1 illustrate that 
the effect of myostatin-null genotype and male sex increased with age from 1st to 6th week of 
age. The general statistics of these 14 traits are presented in Table 1. Most of the body weight 
and average daily gain traits had significant correlations with one another (Table 2).  Early 
body weights (1st to 3rd week) were negatively correlated with body weights during the post-
weaning growth period (4th to 6th week). In addition, the 14 body weight traits were identified 
for significant main effects of myostatin genotype, sex, and reciprocal cross. Interactions 
between main effects were significant for some traits (unpublished results).   
Main effect QTL 
Based on the genome wide scan in the whole F2 population with the additive and 
dominance QTL model specified in the method section, we observed 26 and 44 QTL that 
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were associated with these 14 growth traits at a 1% and 5% genome-wide significance level, 
respectively (Table 3). These 44 QTL were distributed on 10 autosomes (chromosome 1, 2, 3, 
4, 5, 6, 10, 11, 12 and 18; Figure 1). Chromosome 2 harbored the greatest number of QTL, 
while chromosome 12 contained the least number of QTL. We identified four pre-weaning 
body weight QTL, 14 post-weaning body weight QTL, eight pre-weaning growth rate QTL, 
12 post-weaning growth rate QTL, and six overall growth rate QTL (Figure 1). The total 
phenotypic variation explained by these QTL was summed for each trait in Table 4, along 
with the number of QTL. The average phenotypic variation accounted for by each of the 44 
QTL was about 2.5%. Average daily gain for the 1st to 6th week period (Figure 2) had the 
most QTL identified and these QTL also explained the largest amount, about 15.6%, of the 
phenotypic variance (Table 4).  
Epistasis and interaction effect 
We identified 12 epistatic QTL that significantly interacted (p-value<0.05) with 
myostatin genotype (Table 5). Similarly, 11 and 14 QTL were detected with a significant 
interaction with reciprocal cross and sex, respectively (Table 6 and 7). These 37 QTL were 
distributed on chromosomes 1, 3, 4, 6, 7, 8, 10, 11, 12, 14 and X chromosome (Figure 3). 
Twenty-one of these QTL were also detected for their significant additive and dominance 
QTL effect when the whole genome scan was performed on the full data. However, the other 
16 QTL did not have a significant QTL effect when the whole F2 population was analyzed. 
The phenotypic variation accounted for by these additive and dominance interaction effects 
are summarized in Table 5, 6 and 7, along with the corresponding F and p-values. The 
amount of total phenotypic variation of each trait that was explained by these interaction 
effects ranged from 1.18% to 6.36% (Table 8). Epistatic interaction effects accounted for the 
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greatest amount of phenotypic variation for 3rd week average daily gain. Sex × QTL 
interactions were detected during both the pre-weaning and post-weaning periods. However, 
no myostatin × QTL or cross × QTL interaction effects were detected for pre-weaning body 
growth traits (Table 9).  
Partitioning the total genetic variation 
The total genetic variation accounted for by QTL was partitioned into four genetic 
components, e.g. additive, dominance, additive interaction, and dominance interaction. The 
phenotypic variation explained by these four types of effects was summarized in Figure 4. 
About 30% of the genetic variation could be attributed to an interaction effect for the 1st 
week body weight. Additive and dominance effects accounted for more genetic variation in 
body weights as age increased. No interaction effects were detected for 2nd week body weight 
and average daily gain traits.  For most of the growth traits, dominance interactions explained 
more of the variation than did additive interactions. 
Discussion  
Comparison with other growth trait QTL studies 
In this study, we analyzed 14 highly correlated growth traits in an F2 population 
derived from a myostatin-null C57BL/6 by M16i high body weight mouse line cross. 
Compared with previous QTL mapping studies in the mouse, some of the 44 main effect 
QTL were coincident to QTL positions that had been previously discovered (supplemental 
Table 2). In particular, the QTL with the largest F value detected in our study, which was 
associated with ADG3 on chromosome 2, was very close to the largest QTL identified by 
Rocha et al. (2004). Although it was shown to be associated with week 10 body weight, it 
was very possible that these two QTL came from one common QTL with pleitropic effect. In 
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addition, no body weight QTL have been reported on chromosomes 1, 14 and X. For 
example, we detected main effect QTL associated with ADG5, ADG6 and ADG64 on 
chromosome 1 in our F2 population. In addition to these four chromosomes, we also detected 
QTL in several regions on chromosomes 3, 6, 10 and 18, which had never been shown to be 
associated with body weight traits. Interestingly, these regions were not detected in the 
Rocha et al. growth study either (Rocha et al., 2004). Similar to our study, their study also 
used M16i as one of the founders for its mapping population. This indicated that the unique 
QTL we identified was most likely from the C57BL/6 genetic background and these loci 
might not be polymorphic in other mouse strains, which made the F2 progenies derived from 
C57BL/6 and M16i a valuable mapping population. Moreover, some of the QTL that had 
been identified in previous studies were associated with different traits in our studies. Since 
the traits names and their definition are not very consistent between studies, this makes it 
difficult to conclude whether or not these QTL really control the same traits. Even for our 
own study, many of the QTL that we detected for different traits were localized to the same 
chromosomal region. One reason might be that some traits were highly correlated. Moreover, 
this might indicate the presence of pleitropic QTL. Without testing for pleiotropy, we cannot 
tell whether this is caused by pleitropic QTL or multiple QTL that are tightly linked. Further 
investigation, e.g. fine mapping, can help to increase the mapping resolution and provide 
more information.    
Epistatic QTL interactions with myostatin gene 
Myostatin protein binds the activin type II receptor (ActRIIB) (Lee and McPherron, 
2001). Previous research found that transgenic mice that over express follistatin, a myostatin 
antagonist, exhibit more muscle mass than myostatin knockout mice (McPherron et al., 
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1997). This indicates that other molecular signals might be involved in this growth-related 
pathway through multi-level interactions. This information was consistent with the fact that 
significant myostatin × QTL interactions were detected in our study. A study of mapping 
myostatin modifiers that impact muscle growth in the Compact mouse line was previously 
reported (Varga et al., 2003). However, only a Chi-square test was used to identify 
chromosomal regions linked to the putative myostatin modifiers. Compared to their study, 
our results were based on a more quantitative analysis. Therefore, our study was the first to 
successfully identify QTL that interacted with myostatin to control growth traits. Most of the 
QTL that were detected in this study were associated with post-weaning (3-6 week after birth) 
traits, which corresponds with the onset of puberty. This indicates that these QTL might 
interact with sex hormones. Moreover, it has been suggested that myostatin effects might be 
time-dependent (Lee, 2004). Therefore, these QTL regions could provide more information 
about how this kind of time-dependent mechanism is regulated. On the other hand, body 
weight is composed of multiple organ weights. Therefore, it will be of further interest to 
dissect whole body weight gain into single organ weights, e.g. adipose, muscle and etc. It has 
been shown that myostatin is also expressed in adipose tissue of the adult mouse (McPherron 
et al., 1997). Other studies have indicated that QTL by myostatin interactions can influence 
some adipose traits in cattle (Casas et al., 2000).  
Gene interaction with sex effect and cross effect 
Sexual dimorphism in QTL mapping has been studied previously (Kenney-Hunt et al., 
2006; Fawcett et al., 2008). These QTL that significantly interact with sex might truly 
function differently between male and female. However, they can be a false positive result in 
QTL analysis. In our study, we identified 14 QTL that had a significant sex × QTL 
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interaction. Compared with QTL that exhibited a myostatin × QTL interaction, we did not 
observe a clear time-dependent trend in sex × QTL interactions (Table 9). We found that 
among these 14 QTL, four were located on chromosome X. These QTL associations can be a 
result of X chromosome dosage compensation or sex-specific genes. In mammals, X 
chromosome dosage compensation results in equal gene expression between different sexes. 
Further investigation could be performed to narrow these regions and identify causal 
mutations. The most significant sex × QTL interaction controlled growth traits during the 
pre-weaning period. Functional studies of genes that underlie these QTL could be important 
to elucidate the role that sex plays in growth.  
Among the 11 QTL that had a significant reciprocal cross × QTL interaction, six were 
located on chromosome 4. This type of interaction indicated a strain-dependent gene 
expression pattern. There are several possible ways to explain this kind of reciprocal cross 
interaction. First, there might be an interaction between the mitochondrial and nuclear 
genome, as F2 individuals only inherited mitochondrial DNA from one of the F0 founder 
lines. Different alleles of these QTL might interact directly with mitochondrial DNA or its 
protein product to affect body growth. Given the importance of mitochondria in energy and 
metabolism processes, it was not surprising that such interactions were observed. Similarly, 
differential reciprocal cross effects have been documented in other QTL mapping studies 
(Smith Richards et al., 2002; Lagerholm et al., 2009). Another explanation of this reciprocal 
cross effect could be a result of some effects from the Y chromosome. Since F2 mice within 
each cross only inherited their Y chromosome from either M16i or C57BL/6 founders. These 
QTL loci might interact with genes on the Y chromosome to affect growth. Statistically 
speaking, any effect resulting from the Y chromosome was confounded with the effect of 
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mitochondrial DNA. Therefore, further investigation is needed to identify the real reason 
behind this cross × QTL interaction. 
Variation explained by epistatic interactions 
In spite of the fact that we identified 37 QTL with significant interactions with 
myostatin, sex or reciprocal cross effect, the total phenotypic variation accounted for by these 
QTL was not very large (Table 8). The QTL with the largest effect accounted for only about 
6.36% of the phenotypic variance of ADG3 trait. This is much smaller than that estimated by 
Brockmann et al. and Carlborg et al. (Brockmann et al., 2000; Carlborg et al., 2003). They 
reported that epistasis could account for approximately 33-36% of the phenotypic variance 
observed in body weight and fat accumulation in mice. However, both these studies and our 
study show that there might be a time-dependent trend for epistatic or interaction effects. 
Gene interactions seem to be more important for early growth (Table 9). In addition, 
dominance QTL interactions with myostatin genotype explained more phenotypic variation 
than did additive QTL interactions. Dominance interaction effects might be a preferred 
mechanism for the myostatin associated growth pathway. There are several possible 
explanations for the difference between Carlborg’s (Carlborg et al., 2003) and our estimates 
of genetic variation. One obvious reason could be that we only considered the interactions 
between the myostatin locus and QTL. This is a small proportion of overall pair-wise gene 
interactions that might be involved in the control of body weight. A further analysis of the 
interaction between these QTL and interaction between non-significant genome locations 
could possibly explain more phenotypic variance. In addition, Carlborg et al. used a 20% 
genome wide significant threshold to identify epistatic QTL while we used a 5% level. The 
difference of significance threshold might lead to a difference in the total number of QTL 
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detected. Furthermore, the allele segregation status in M16i and C57BL/6 genome can also 
be a reason for this. Some QTL that associate with body weight traits might not be 
segregating in the F2 population derived from these two strains and this limits the number of 
QTL that can be detected. One possible way to solve this problem is to use a mapping 
population that has more genetic variation. For example, the collaborative cross is a good 
candidate (Threadgill et al., 2002). By an 8-way intercross, a collaborative cross represents 
more abundant genetic variation than any single mouse strains, because a large number of 
recombination events occurred in the genome during the development of the collaborative 
cross. QTL mapping studies in these mice will provide a higher statistical power and better 
resolution. 
Conclusions 
We identified a substantial number of QTL that control body weight and growth rate 
traits. In addition, we also detected QTL that significantly interact with myostatin genotype, 
sex and reciprocal cross. Further investigation of individual tissues will help to elucidate 
more details on how myostatin regulates growth. In future studies, these QTL regions could 
be used to search for candidate genes that affect the myostatin signaling pathway. 
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Tables and Figures   
Tables 
Table 1. Summary statistics for growth traits in this study 
Traits Average S.D Min Max 
BW1 5.42 1.00 2.14 8.91 
BW2 9.28 1.46 4.53 14.19 
BW3 12.10 2.47 4.29 21.82 
BW4 19.77 4.06 5.75 33.89 
BW5 26.41 5.04 8.89 44.87 
BW6 30.29 6.10 15.35 52.08 
ADG2 0.55 0.13 0.02 0.99 
ADG3 0.40 0.20 -0.19 1.09 
ADG4 1.10 0.33 -0.01 2.56 
ADG5 0.95 0.37 -0.68 2.38 
ADG6 0.55 0.36 -1.15 2.21 
ADG31 0.48 0.13 0.06 0.92 
ADG64 0.75 0.32 -0.17 1.72 
ADG61 0.71 0.17 0.33 1.30 
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Table 2. Phenotypic correlations among growth traits 
Traits BW1 BW2 BW3 BW4 BW5 BW6 ADG2 ADG3 ADG4 ADG5 ADG6 ADG31 ADG64 ADG61
BW1 1.00 0.78 0.81 0.68 0.48 0.31 0.15 0.62 0.33 -0.14 -0.20 0.56 -0.20 0.16 
BW2  1.00 0.88 0.74 0.56 0.38 0.73 0.52 0.36 -0.07 -0.20 0.79 -0.15 0.26 
BW3   1.00 0.86 0.63 0.43 0.52 0.86 0.43 -0.11 -0.23 0.94 -0.19 0.31 
BW4    1.00 0.86 0.68 0.43 0.75 0.84 0.10 -0.06 0.81 0.02 0.59 
BW5     1.00 0.92 0.37 0.54 0.82 0.60 0.22 0.62 0.47 0.87 
BW6      1.00 0.26 0.36 0.74 0.71 0.59 0.42 0.75 0.99 
ADG2       1.00 0.15 0.20 0.04 -0.10 0.64 -0.03 0.25 
ADG3        1.00 0.40 -0.12 -0.21 0.86 -0.19 0.27 
ADG4         1.00 0.28 0.14 0.42 0.24 0.71 
ADG5          1.00 0.52 -0.07 0.88 0.76 
ADG6           1.00 -0.22 0.87 0.65 
ADG31            1.00 -0.16 0.34 
ADG64             1.00 0.81 
ADG61              1.00 
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Table 3. Statistics of main effect QTL detected in genome wide scan in the full data set 
Peak Flanking Markersc Estimate 
MMU Traitsa (cM)b Left Right F LOD a s.ea d s.ed %var
1 ADG6** 22 rs3696088 rs13472794 15.83 6.766 -0.107 0.020 -0.027 0.026 3.11
1 ADG64** 23 rs3696088 rs13472794 25.91 10.968 -0.108 0.015 -0.027 0.021 4.99
1 ADG5** 24 rs3696088 rs13472794 10.63 4.568 -0.110 0.024 -0.027 0.032 2.11
2 ADG3** 71 rs3144393 rs13476878 26.27 11.115 0.061 0.009 0.028 0.012 5.05
2 ADG31** 79 rs3144393 rs13476878 15.18 6.491 0.024 0.006 0.035 0.009 2.98
2 BW4** 79 rs3144393 rs13476878 11.88 5.096 0.548 0.187 1.082 0.276 2.35
2 BW3** 81 rs3144393 rs13476878 14.21 6.083 0.427 0.118 0.708 0.179 2.80
2 ADG2 96 rs13476878 rs3143843 8.13 3.500 -0.018 0.006 0.024 0.009 1.62
2 BW2** 101 rs13476878 rs3143843 10.27 4.414 -0.032 0.064 0.400 0.089 2.04
2 BW1** 103 rs3143843 rs6335805 10.46 4.497 0.077 0.044 0.269 0.063 2.08
3 ADG5** 25 rs3663409 rs13477132 13.32 5.708 0.040 0.013 0.075 0.019 2.63
3 ADG64 30 rs3663409 rs13477132 10.55 4.534 0.027 0.009 0.045 0.013 2.09
3 ADG61** 58 rs3663873 rs13477430 12.94 5.546 0.027 0.006 0.026 0.009 2.55
3 BW6** 61 rs3663873 rs13477430 10.78 4.632 0.988 0.239 1.011 0.405 2.14
3 BW5 64 rs3663873 rs13477430 8.95 3.851 0.999 0.246 0.713 0.438 1.78
3 ADG4 120 rs3724562 CEL-3_159340478 8.85 3.811 0.057 0.014 -0.011 0.027 1.76
4 ADG31** 63 rs6324470 rs3659226 10.15 4.363 -0.023 0.006 0.015 0.008 2.02
4 BW3 64 rs6324470 rs3659226 7.95 3.426 -0.400 0.110 0.262 0.169 1.59
4 BW4** 64 rs6324470 rs3659226 10.64 4.572 -0.738 0.175 0.486 0.269 2.11
4 BW5 67 rs6324470 rs3659226 8.08 3.480 -0.733 0.212 0.667 0.342 1.61
5 ADG61 76 rs3720626 rs3706737 8.52 3.669 0.020 0.005 -0.007 0.007 1.70
5 ADG64 78 rs3720626 rs3706737 8.94 3.850 0.029 0.008 -0.020 0.012 1.78
6 ADG31 23 rs13478727 rs13478839 8.11 3.495 0.019 0.006 0.021 0.009 1.62
6 BW4** 27 rs13478727 rs13478839 14.07 6.026 0.885 0.177 0.544 0.268 2.77
6 BW5** 27 rs13478727 rs13478839 16.54 7.064 1.157 0.203 0.316 0.307 3.24
6 BW6** 28 rs13478727 rs13478839 15.88 6.789 1.124 0.203 0.428 0.304 3.12
6 ADG61** 29 rs13478727 rs13478839 16.40 7.009 0.030 0.005 0.010 0.008 3.22
6 ADG4** 30 rs13478727 rs13478839 16.65 7.112 0.076 0.013 0.026 0.019 3.26
10 ADG2** 32 CEL-10_58149652 rs13480647 10.82 4.647 -0.026 0.006 -0.020 0.010 2.14
10 ADG64 32 CEL-10_58149653 rs13480648 10.65 4.578 0.038 0.008 -0.007 0.013 2.11
10 ADG5 36 CEL-10_58149654 rs13480649 8.77 3.777 0.056 0.013 -0.010 0.021 1.75
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Table 3. (continued) 
Peak Flanking Markersc Estimate 
MMU Traitsa (cM)b Left Right F LOD a s.ea d s.ed %var
10 BW6 37 CEL-10_58149655 rs13480650 9.08 3.907 0.864 0.207 -0.270 0.319 1.81
10 ADG4 44 rs3717445 rs13480707 8.39 3.611 0.053 0.013 -0.016 0.019 1.67
10 ADG61** 47 rs13480707 rs13480754 10.05 4.322 0.023 0.005 -0.008 0.008 2.00
11 ADG4** 26 rs6276300 rs6199956 17.78 7.584 0.073 0.014 0.053 0.022 3.48
11 ADG61** 28 rs6276300 rs6199956 20.51 8.726 0.034 0.006 0.012 0.009 3.99
11 BW6** 28 rs6276300 rs6199956 18.86 8.038 1.258 0.215 0.439 0.335 3.68
11 BW4** 29 rs6276300 rs6199956 13.66 5.851 0.873 0.187 0.563 0.291 2.69
11 BW5** 29 rs6276300 rs6199956 17.53 7.482 1.176 0.214 0.573 0.333 3.43
12 ADG2 61 rs6288403 rs6390948 8.91 3.836 -0.022 0.006 0.016 0.008 1.77
18 ADG61 8 rs13483233 rs3723947 8.53 3.673 0.021 0.005 0.002 0.007 1.70
18 BW5 8 rs13483233 rs3723947 9.15 3.938 0.819 0.192 0.042 0.272 1.82
18 BW6 8 rs13483233 rs3723947 8.61 3.707 0.802 0.193 0.043 0.275 1.71
18 ADG3 36 rs3670254 rs3718618 8.59 3.698 0.038 0.009 -0.001 0.014 1.71
 
Table 4. Total percentage of phenotypic variance accounted for by QTL detected 
Traits QTLa Total %varb 
BW1 1 2.08 
BW2 1 2.04 
BW3 2 4.39 
BW4 4 9.92 
BW5 5 11.88 
BW6 5 12.46 
ADG2 3 5.53 
ADG3 2 6.76 
ADG4 4 10.17 
ADG5 3 6.49 
ADG6 1 3.11 
ADG31 3 6.62 
ADG64 4 10.97 
ADG61 6 15.16 
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Table 5. Statistics of QTL with significant interactions with myostatin genotype 
  Position AI +DI AI DI 
MMU  Traitsa (cM)b %var P value %var P value %var P value 
1 ADG6 23 0.87 1.18E-02 0.21 1.81E-01 0.66  4.17E-03
1 ADG64 24 0.86 1.11E-02 0.37 6.16E-02 0.50  1.99E-02
3 ADG5 31 0.80 1.71E-02 0.63 9.10E-04 0.17  2.55E-01
3 BW6WK** 31 1.12 3.43E-03 0.75 1.22E-02 0.38  3.92E-03
3 ADG61** 32 1.15 2.93E-03 0.86 8.42E-03 0.29  1.04E-02
3 ADG64** 41 2.07 2.74E-05 1.41 7.93E-04 0.66  2.41E-03
6 ADG61 53 0.90 1.07E-02 0.30 9.89E-04 0.59  2.35E-02
6 BW6WK 54 0.83 1.52E-02 0.28 1.46E-03 0.55  4.07E-02
6 BW5WK 55 0.73 2.51E-02 0.15 7.76E-04 0.58  4.10E-02
7 ADG3** 12 1.25 1.92E-03 1.25 1.08E-03 0.01  1.45E-02
7 ADG5** 43 1.87 8.81E-05 1.59 7.17E-05 0.28  5.19E-02
7 ADG64** 43 2.29 1.07E-05 1.74 3.91E-05 0.56  1.39E-02
 
Table 6. Statistics of QTL that interacted with reciprocal cross  
  Position AI +DI AI DI 
MMU  Traitsa (cM)b %var P value %var P value %var P value 
3 ADG64 16 0.88 1.21E-02 0.33 1.89E-03 0.54  7.46E-03
4 ADG3 66 0.81 1.70E-02 0.00 4.46E-01 0.81  6.52E-03
4 ADG31 72 0.74 2.41E-02 0.02 1.94E-01 0.72  7.83E-03
4 BW4WK 72 0.66 3.66E-02 0.12 2.55E-01 0.54  2.99E-02
4 ADG61** 73 1.07 4.74E-03 0.52 3.74E-02 0.55  1.88E-02
4 BW6WK** 73 1.04 5.42E-03 0.50 4.84E-02 0.54  2.10E-02
4 BW5WK 74 0.74 2.48E-02 0.29 1.11E-01 0.45  4.46E-02
8 ADG4 17 0.84 1.46E-02 0.15 2.05E-01 0.70  7.69E-01
10 ADG4** 37 0.93 9.10E-03 0.79 9.11E-03 0.14  3.98E-01
11 ADG61 57 0.60 4.83E-02 0.56 3.81E-02 0.04  3.84E-01
12 ADG31 28 0.61 4.69E-02 0.56 1.51E-02 0.05  3.44E-01
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Table 7. Statistics of QTL interacted with sex 
  Position AI +DI AI DI 
MMU   Traitsa (cM)b %var P value %var P value %var P value 
4 ADG3** 57 0.99 7.21E-03 0.00 4.70E-01 0.99  1.27E-02 
6 ADG4 32 0.72 2.51E-02 0.04 5.35E-01 0.68  1.75E-02 
6 BW4WK 40 0.76 2.15E-02 0.03 7.96E-01 0.73  4.81E-02 
6 BW1WK** 50 1.18 2.85E-03 0.49 5.95E-02 0.69  9.38E-02 
6 ADG3 68 0.78 2.02E-02 0.35 8.76E-02 0.43  2.12E-02 
6 BW3WK** 68 1.00 6.54E-03 0.33 8.28E-02 0.67  8.03E-03 
11 ADG4 26 0.58 5.05E-02 0.03 4.88E-01 0.55  1.08E-01 
11 ADG61 28 0.69 2.93E-02 0.25 1.83E-01 0.44  4.96E-02 
11 BW6WK 28 0.73 2.33E-02 0.20 2.18E-01 0.53  4.49E-02 
14 BW3WK 7 0.63 4.25E-02 0.26 1.76E-01 0.37  1.82E-01 
X ADG3** 61 2.53 3.10E-06 0.13 6.57E-02 2.40  6.65E-06 
X ADG31** 61 1.81 1.15E-04 0.01 2.95E-01 1.79  1.49E-04 
X BW3WK** 61 1.80 1.21E-04 0.02 4.27E-01 1.78  1.03E-04 
X BW4WK** 61 1.70 2.02E-04 0.02 2.57E-01 1.68  2.16E-04 
 
Table 8. Total percentage of phenotypic variance accounted for by QTL interactions  
Traits QTLa Total %varb 
BW1 1 1.18 
BW3 3 3.34 
BW4 3 3.12 
BW5 2 1.47 
BW6 4 3.73 
ADG3 5 6.36 
ADG4 4 3.08 
ADG5 2 2.68 
ADG6 1 0.87 
ADG31 3 3.16 
ADG64 4 6.11 
ADG61 5 4.40 
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Table 9. Total percentage of phenotypic variance accounted for by QTL interactions  
Interactiona Growth periods QTLb Total %var 
Cross Pre-weaning BW - - 
 Post-weaning BW 3 2.44 
 Pre-weaning GR 3 2.16 
 Post-weaning GR 3 2.66 
 Overall GR 2 1.67 
Myostatin Pre-weaning BW - - 
 Post-weaning BW 3 2.68 
 Pre-weaning GR 1 1.25 
 Post-weaning GR 6 8.78 
 Overall GR 2 2.05 
Sex Pre-weaning BW 4 4.61 
 Post-weaning BW 3 3.19 
 Pre-weaning GR 4 6.10 
 Post-weaning GR 2 1.30 
  Overall GR 1 0.69 
 
Figures 
Figure 1 
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Figure 2 
 
 
Figure 3 
 
 
  
78
Figure 4 
 
 
Legends to Tables 
Table 1. Summary statistics for growth traits in this study 
Abbreviation: BW1, BW2, BW3, BW4, BW5 and BW6 are body weights (gram) measured 7, 
14, 21, 28, 35 and 42 days after mice were born. ADG2, ADG3, ADG4, ADG5, ADG6, 
ADG31, ADG64 and ADG61 are average daily gain calculated for the 1st - 2nd, 2nd - 3rd, 3rd - 
4th, 4th -5th, 5th - 6th, 1st – 3rd, 4th – 6th and 1st – 6th week growth periods. S.D: standard 
deviation.     
Table 2. Phenotypic correlation among growth traits 
Phenotypic correlation coefficients have p-value less between 0.01 and 0.05 are in italic.  
Phenotypic correlation coefficients have p-value larger than 0.05 are in bold.  
All other phenotypic correlation coefficients have p-value less than 0.01. 
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Table 3. Statistics of growth trait QTL detected in genome wide scan 
aQTL with an F value that exceeded the 1% genome-wide permutation threshold are denoted 
by **; other QTL exceeded the 5% threshold.  
bPeak position of QTL detected in Kosambi centimorgans. cFlanking markers (left and right) 
of the QTL peak.  
Abbreviation: a: additive effect; d: dominance effect; A positive estimate indicates that the 
effect of the recurrent QTL genotype is larger than the effect of the heterozygous genotype. 
s.ea: standard error of additive effect; s.ed: standard error of dominance effect. %var: 
percentage of phenotypic variance accounted for by QTL.  
Table 4. Total percentage of phenotypic variance accounted for by QTL detected 
aTotal number of QTL that were associated with each trait.  
bTotal percentage of phenotypic variance accounted for by QTL for each trait.   
Table 5. Statistics of QTL interacted with myostatin effect 
aTrait name of QTL with significant interaction. Interactions with p-value less than 0.01 are 
denoted by **; others have p-value less than 0.05.  
bPeak position of QTL with significant interaction in Kosambi centimorgans.  
Abbreviation: AI: additive interaction; DI: dominance interaction. %var: percentage of 
phenotypic variance accounted for by QTL. 
Table 6. Statistics of QTL interacted with reciprocal cross effect  
aInteraction with p-value less than 0.01 is denoted by **; others have p-value less than 0.05.   
bPeak position of QTL with significant interaction in Kosambi centimorgans.  
Abbreviation: AI: additive interaction; DI: dominance interaction. %var: percentage of 
phenotypic variance accounted for by QTL. 
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Table 7. Statistics of QTL interacted with sex effect 
aTrait name of QTL with significant interaction. Interaction with p-value less than 0.01 is 
denoted by **; others have p-value less than 0.05.  
bPeak position of QTL with significant interaction in Kosambi centimorgans.  
Abbreviation: AI: additive interaction; DI: dominance interaction. %var: percentage of 
phenotypic variance accounted for by QTL. 
Table 8. Total percentage of phenotypic variance accounted for by QTL interaction  
aTotal number of QTL that significantly interact with myostatin, sex or cross.  
bTotal percentage of phenotypic variance accounted for by QTL interaction.   
Table 9. Total percentage of phenotypic variance accounted for by QTL interaction  
aMain effect that QTL interact with. Cross: reciprocal cross; Myostatin: myostatin genotype; 
Sex: sex.  
bTotal number of QTL that significantly interact with cross or myostatin or sex. 
Abbreviation: Pre-weaning: 1st to 3rd week; Post-weaning: 4th to 6th week; BW: body weight; 
GR: growth rate, average daily gain. %var: Total percentage of phenotypic variance 
accounted for by QTL interaction.  
Legends to Figures 
Figure 1. Chromosomal distribution of QTL for different growth periods. 
Pre-weaning BW: pre-weaning body weight trait, include BW1, BW2 and BW3; Late BW: 
late body weight traits, include BW4, BW5 and BW6; Pre-weaning GR: pre-weaning growth 
rate traits, include ADG2, ADG3 and ADG31; Late GR: late growth rate traits, include 
ADG4, ADG5, ADG6 and ADG64; Overall GR: overall growth rate trait, includes ADG61.   
Figure 2. QTL scan for average daily gain of 1st week and 6th week by interval mapping. 
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Figure 3. Chromosomal distribution of QTL that interact with different main effect.   
Figure 4. Partitioning of the genetic variation explained by QTL mapped at a 5% 
genome-wide significance level. 
Abbreviation: A: additive effect; D: dominance effect; AI: additive interaction effect; DI: 
dominance interaction effect. 
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Supplementary information 
Supplemental Table 1. List of 152 SNPs used in the final QTL mapping 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13475701c 1 0.101 0.101 4486478
rs3696088 1 17.801 21.384 41127587
rs13472794 1 28.501 36.051 67523394
rs13475931 1 37.001 44.353 76665687
rs3670389 1 41.801 51.993 88560363
rs3667720 1 49.501 61.061 120679081
rs3703729 1 54.101 71.657 134380222
rs13476201 1 64.301 84.016 158969249
rs13476229 1 71.301 93.679 169239352
rs3658234 1 72.701 99.299 175004447
rs3666905 1 81.701 112.130 187551710
rs13476312 1 89.901 121.484 193706020
rs13476334c 2 3.176 3.176 7291472
gnf02.013.589 2 12.276 14.075 16612103
gnf02.035.469 2 22.776 27.077 33926782
rs6268714 2 30.676 35.464 57637194
rs13476554 2 39.076 43.046 67097663
rs6345656 2 46.476 48.890 74672761
rs13476636 2 52.076 56.122 91349993
rs3144393 2 68.676 70.425 118272621
rs13476878 2 92.976 91.035 160226215
rs3143843 2 101.676 98.041 169461615
rs6335805 2 112.076 110.897 178995956
rs13477019c 3 7.734 7.734 23242284
rs3663409 3 12.434 15.107 31989790
rs13477132 3 32.634 29.787 57754706
rs13477174 3 38.734 34.080 68244840
rs3670634 3 45.134 42.725 86937167
rs3663873 3 54.834 56.769 109985432
rs13477430 3 77.434 70.816 134895047
rs3724562 3 99.434 84.649 150313284
CEL-3_159340478 3 120.434 93.158 157721197
rs13477622c 4 16.514 16.514 28506701
rs6232550 4 26.414 26.916 41164426
rs3725792 4 30.214 30.376 44148723
rs3715031 4 36.214 37.502 54639377
rs13477745 4 42.114 46.233 64477730
rs3717837 4 50.114 54.794 85074942
mCV23905937 4 57.014 64.559 98478276
rs6324470 4 61.414 69.206 104937019
rs3659226 4 87.114 93.423 140587789
CEL-4_149694865 4 95.914 101.347 150301285
CEL-5_5867251c 5 2.208 2.208 5866538
UT_5_19.849706 5 11.308 9.503 20201136
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs6256504 5 45.708 24.714 38515920
CEL-5_52953963 5 55.108 33.321 53136372
rs3707918 5 64.808 43.343 72127548
rs3720626 5 67.908 50.292 76272435
rs3706737 5 80.308 64.852 96528453
rs13478466 5 86.608 73.634 111798781
CEL-5_117736621 5 92.908 80.048 119400029
gnf05.124.386 5 101.608 87.408 129543594
rs3721911 5 114.408 96.544 138881660
rs6284348 5 118.108 101.586 142681650
rs13478595 5 132.008 110.300 149284218
rs13478602c 6 0.001 0.001 3799841
petM-02094-1 6 6.601 7.058 17707097
rs3678887 6 12.701 13.010 32386962
rs13478727 6 19.001 23.577 43991377
rs13478839 6 32.001 39.724 78161749
rs4226048 6 34.201 45.897 84113292
mCV24115224 6 59.701 66.688 115076942
UT_6_123.37228 6 64.401 72.189 122110793
rs3688358 6 71.401 79.980 132429066
rs3725987 6 76.501 84.123 138352837
rs13479099 6 87.501 93.881 148127251
mCV22975338c 7 11.749 11.749 22376177
rs3719256 7 28.849 23.532 38614565
rs3717846 7 36.749 30.339 58400141
rs3676254 7 42.749 38.005 66569463
rs3656205 7 47.649 45.440 75343354
rs13479422 7 51.949 53.395 91892904
rs13479471 7 57.449 65.046 108991781
rs6275579 7 62.549 71.740 117862298
rs13479657c 8 14.694 14.694 24618506
rs13479757 8 46.894 29.437 50420731
rs13479844 8 56.094 38.394 75473491
rs3678433 8 60.394 45.510 83208899
rs6182338 8 77.894 60.514 106277983
rs13480071c 9 0.372 0.372 12385785
rs13480109 9 6.172 8.209 25783299
rs13480128 9 10.072 16.473 32666876
rs3719607 9 13.872 23.433 37141308
rs8259427 9 18.972 29.955 44998572
rs6213724 9 38.772 52.130 79802975
rs3712946 9 44.972 58.044 94386044
rs3657881 9 51.972 68.561 105214342
rs13480408 9 55.672 73.963 108844971
rs13480429 9 65.272 81.464 113641808
rs13480553c 10 10.818 10.818 25770673
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13480578 10 15.318 17.160 34640648
CEL-10_58149652 10 30.018 27.700 58359416
rs13480647 10 38.718 41.670 72833057
rs3717445 10 42.218 46.578 82879911
rs13480707 10 46.418 54.006 92301690
rs13480754 10 55.818 62.804 107371198
rs13480776 10 64.518 69.333 115607504
rs13480797 10 70.418 76.898 121584553
rs8259806 10 76.918 81.668 127093506
rs13480837c 11 0.201 0.201 3781731
rs6276300 11 11.701 15.322 27142847
rs6199956 11 37.201 30.082 50498109
rs13481054 11 41.701 36.195 59881071
rs3701609 11 49.801 46.592 72989283
rs8270290 11 64.701 64.638 97032985
rs3653651 11 67.601 74.951 101967778
rs13481216 11 71.901 82.153 107232603
rs6407460 11 78.501 90.804 113210907
CEL-11_118234030 11 84.801 96.663 118383994
rs3657682c 12 7.183 7.183 15091125
rs6225272 12 14.783 13.903 27459535
rs3725854 12 38.283 43.151 77999170
rs6288403 12 44.983 50.050 86374922
rs6390948 12 61.583 66.828 104149763
rs3713779 12 67.783 70.502 113105127
rs13481780c 13 17.399 17.399 40759094
rs3678784 13 46.999 32.379 61647402
rs13482096c 14 7.498 7.498 21085575
rs8251329 14 26.998 19.246 49481253
rs3712401 14 35.698 26.516 61778903
rs3709178 14 44.998 39.330 79100609
rs13482404 14 66.798 60.779 116103438
rs13482893c 17 11.306 11.306 13745716
rs3719497 17 19.706 16.339 23308349
rs3023442 17 25.306 22.288 31902550
rs6395919 17 44.706 35.586 48827083
rs6257479 17 64.606 50.679 68982152
rs3663966 17 71.606 57.945 76523597
rs13483140 17 78.506 64.412 82893669
rs3696168 17 83.806 69.866 88281513
rs13483233c 18 7.969 7.969 18327172
rs3723947 18 14.569 16.515 30680245
rs6313313 18 18.369 23.174 41881959
rs3722312 18 24.869 30.130 52561869
rs3670254 18 33.269 36.847 58103478
rs3718618 18 39.369 51.926 69446841
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13483438 18 47.969 59.023 74453057
rs6236348c 19 0.448 0.448 6000609
gnf19.017.711 19 12.148 13.059 19251882
rs13483569 19 18.748 20.231 23009796
rs6237466 19 29.148 29.105 31688846
rs3703185 19 34.548 36.175 38314921
rs8257588 19 40.448 42.991 47414608
mCV24736382 19 48.248 51.488 54414305
rs3718998 19 56.848 57.857 60090097
rs13483724c X 14.914 14.914 30628639
rs13483748 X 23.614 22.853 45251371
CEL-X_91222960 X 39.414 43.283 94420742
rs13483992 X 47.314 55.715 124104620
rs13484003 X 49.214 60.816 127148857
rs13484087 X 61.614 80.594 149574316
 aPosition of markers in Kosambi centimorgans. This column of linkage map is build using 
Cri-map (Green and Crooks, 1990).  
bPosition of markers in Kosambi centimorgans. This column of linkage map is from the 
Wellcome-CTC Mouse Strain SNP Genotype Set 
(http://www.well.ox.au.uk/mouse/INBREDS).  
cPositions of the first marker on each chromosome is from the Wellcome-CTC Mouse Strain 
SNP Genotype Set.   
 
  
89
Supplemental Table 2. Comparison with QTL detected for growth traits in other studies  
MMU Physical Positiona QTL identified in Rocha et al. studyb QTL identified in other studyc 
1 41127587 67523394   
2 118272621 160226215 W3g2, W6q2, Egq2, W10q1, Lgq2, Lgaq2 Gnf4, growth and fatness 49 
    Bwq5, body weight, QTL 512 
    Wg6, weight gain in high growth mice 65 
    Bglq2, body growth late QTL 24, 19 
    Pbwg11, postnatal body weight growth 118 
 160226215 169461615   
3 31989790 57754706 W10q3, Lgq3, Lgaq4  
 68244840 86937167 Egq3, Egaq-1  
 109985432 134895047   
 150313284 157721197   
4 85074942 98478276 W6q13, W10q10 Wght3, weight 32 
    Bgeq3, body growth Pre-weaning QTL 34 
    Bw8q2, body weight at 8 weeks QTL 221 
    Qbis1, QTL for body weight independent of sex 118 
5 76272435 96528453  Obwq2, obesity and body weight QTL 217 
6 43991377 78161749 Egq8, W6q4, W10q11 Wtlr1, weight loss response 113 
 84113292 115076942 W6q5, Egq11 Pbwg8, postnatal body weight growth 88 
    Egrm2, Pre-weaning growth rate, maternal effect 220
    Obwq3, obesity and body weight QTL 3116, 17 
    Cfbw2, cystic fibrosis body weight 26 
 122110793 132429066   
7 22376177 38614565 W6q17, W10q18, W3q10  
 66569463 75343354  Tabw, TallyHo associated body weight11 
8 24618506 50420731 Egq12, W10q14, W6q9, W3q5 Bdywt, body weight15 
10 58359416 72833057 W10q5 Pbwg16, postnatal body weight growth 167 
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Supplemental Table 2. (continued) 
MMU Physical Positiona QTL identified in Rocha et al. studyb QTL identified in other studyc 
 82879911 92301690   
 92301690 107371198 W10q8, Lgaq5, W6q8, Eqg9  
11 27142847 50498109 W3q4, Lgaq1, W10q2, Lgq1, W6q3, Egq4 W6q3, weight 6 weeks QTL 314 
 72989283 97032985  Bw4, body weight QTL 41, 3 
    Qbis3, QTL for body weight independent of sex 318 
    Wg7, weight gain in high growth mice 75 
12 27459535 77999170  Bwtn4, body weight at necropsy 410 
    Bglq9, body growth late QTL 94, 19 
 86374922 104149763 W6q10, Egq10  
14 0 21085575   
18 18327172 30680245   
 58103478 69446841 W3q16  
X 127148857 149574316     
aFlanking marker physical position of QTL identified in our study.  
bQTL names in Roach et al. growth traits study (Rocha et al., 2004). 
cQTL names and associated traits in other studies.    
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Supplemental Figure 1.  
  
Distribution of growth traits measured in this study. For each trait, the histogram is shown 
individually for all 4 subpopulations of different myostatin genotype and sex combination.   
Abbreviation: BW1, BW2, BW3, BW4, BW5 and BW6 are body weights (gram) measured 
on 7, 14, 21, 28, 35 and 42 days after mice were born. ADG2, ADG3, ADG4, ADG5, ADG6, 
ADG31, ADG64 and ADG61 are average daily gain calculated for the 1st - 2nd, 2nd - 3rd, 3rd - 
4th, 4th -5th, 5th - 6th, 1st – 3rd, 4th – 6th and 1st – 6th week growth periods.  
  
95
Supplemental Figure 1. (continued) 
  
  
96
Supplemental Figure 1. (continued) 
 
  
97
Supplemental Figure 1. (continued) 
 
  
98
Supplemental Figure 1. (continued) 
 
  
99
Supplemental Figure 1. (continued) 
 
  
100
Supplemental Figure 1. (continued) 
 
  
101
Supplemental Figure 1. (continued) 
 
102 
 
CHAPTER 3. IDENTIFICATION OF IMPRINTING AND MYOSTATIN 
INTERACTION EFFECTS ON  MUSCLE AND ADIPOSE MASS, OBESITY AND 
MORPHOMETRIC TRAITS IN MICE 
A paper to be summited to PloS Genetics 
Ye Cheng, Satyanarayana Rachigani, Jack C Dekkers,  
Mary Sue Mayes, Richard Tait, Daniel Nettleton, James M Reecy 
Abstract 
Obesity has a close relationship to many known chronic human diseases. Efforts have 
been made to investigate the genetic mechanisms behind obesity. Genome-wide association 
studies are widely performed to discover quantitative trait loci (QTL) and causal mutations 
that are associated with obesity-related traits. A number of obese mouse lines have been 
developed for this purpose. Although some obesity QTL regions have been identified in mice, 
limited research has been focused on the imprinting and interaction effects involved in 
obesity traits in mice. In preliminary studies, we found that myostatin genotype, reciprocal 
cross and sex effects interacted with numerous chromosomal regions to affect growth traits. 
Here, we used obese mouse line M16i and muscular mouse line C57BL/6 to identify muscle, 
adipose and morphometric phenotypic QTL (pQTL), translation and transcription QTL 
(tQTL) and expression QTL (eQTL) by applying a QTL model with additive, dominance, 
imprinting and interaction effects. Using an F2 population of 1000 mice, we identified a 
number of pQTL and eQTL that significantly impacted obesity traits. In addition, six 
imprinted pQTL were discovered on chromosomes 6, 9, 10, 11 and 18 that were associated 
with fat-related and body size traits. pQTL and eQTL that interacted with myostatin, 
reciprocal cross and sex effect were detected on some chromosomes. These interaction 
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effects accounted for a large amount of phenotypic variation in this study. Therefore, 
imprinting and interaction effects could be key players in the cause of obesity phenotypes. 
Author Summary 
Obesity genes have been widely identified in previous literature, however, the 
underlying genetic mechanism is still too complicated to be elucidated completely by 
candidate gene approach. Here, we applied QTL mapping methods to both phenotypic 
obesity-related traits and gene expression traits. Using F2 mice derived from a myostatin-null 
line and an obese line, we show that numerous genomic regions are associated with these 
traits. Some of them have significant interaction effects with myostatin genotype. Imprinting 
was also identified for several loci. Further study of these regions may provide novel genes 
that directly or indirectly regulate obesity. Our results also illustrate that gene expression 
profiles may be considered as a necessary part of QTL mapping to provide more information 
about regulating pathways. 
Introduction 
Obesity is an increasing problem faced globally. The World Health Organization 
estimated that around one billion adults in the world are overweight and more than 300 
million are obese. It has been pointed out that weight gain significantly increases the risk of 
diabetes [1]. In addition, excess weight has a close relationship with other severe chronic 
diseases, such as, cardiovascular disease, hypertension and stroke, certain forms of cancer, 
insulin resistance, and hyperinsulinemia [2].  
Environmental factors, such as consumption of sugars and less physical activity might 
also cause obesity [3,4]. In addition to this, genetics is another important cause of obesity. In 
human studies, several chromosomal regions that were associated with obesity-related traits 
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have been identified [5-7]. Novel genes involved in adipose accumulation might be harbored 
in these regions. Obesity loci have also been identified in pigs [8,9]. Unlike humans, it is 
easier to control environmental variation in model organisms, such as mice. Therefore, many 
QTL mapping studies have been conducted in mice to unravel loci that might play a role in 
obesity-related traits, e.g. fat depots, leptin, cholesterol, fatty acid, insulin and glucose levels 
[10-15].  
In this study, an M16i mouse line and C56BL/6 myostatin-null mouse line were 
crossed to obtain an F2 population for mapping obesity-related traits. The M16i is an obese 
mouse line derived from an ICR mouse line after selection for 3-6 weeks body weight gain 
[16]. M16i mice exhibit many typical obesity phenotypes [17-20]. On the other hand, the 
myostatin-null mouse displays a significant decrease in body fat accumulation with an 
increase in skeletal muscle mass [21]. Therefore, the F2 population developed from these two 
lines might contain segregating genetic loci that are involved in adipose and muscle 
development. These loci can be identified with the aid of QTL mapping. 
Here, we studied ten muscle, adipose and morphometric phenotypes, six transcription 
and translation traits  and nine gene expression traits in this F2 population. The nine genes 
were identified differentially expressed in myostatin-null and myostatin wild-type mice in a 
previous microarray experiment [22]. An imprinted QTL model was tested against an 
additive and dominance QTL model with the aim to identify potential imprinted QTL. 
Interaction effects between QTL and the myostatin genotype, reciprocal cross and sex were 
evaluated as well. Finally, the amount phenotypic variation accounted for by each QTL was 
computed. 
Results   
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Data evaluation 
Summary statistics for all phenotype measurements are presented in Table 1 and pair 
wise phenotypic correlations are in Table 2. Most traits were highly correlated with other 
traits (Table 2). In particular, the two adipose traits, BMI and fat pad weight had significant 
correlations (P<0.05) with all other traits.  
The significant main effects and interaction effects identified in Proc GLM were 
included as fixed effects in the QTL model. Polymorphism of SNPs within lines were 
detected for some SNPs, therefore, imprinted effects were also included in the QTL model 
for further testing. Details of these models are discussed in the method section and are not 
repeated here. 
Additive and dominance effect of pQTL 
We observed 21 and 38 non-imprinted pQTL at 1% and 5% genome-wide significance 
levels respectively, using the additive and dominance pQTL model (Table 3). We detected 
pQTL for all 10 traits measured in our study, except for the soleus muscle weight percentage. 
In particular, we detected the most number of pQTL for the gastrocnemius weight percentage 
(Table 3). Only one pQTL was detected for BMI and for tail length (Table 3). These two 
QTL were both located on chromosome 11. In addition, the 38 non-imprinted pQTL were 
distributed on 13 chromosomes. No pQTL were identified on chromosomes 4, 12, 13, 19 and 
X. Chromosome 1 harbored the greatest number of pQTL. The phenotypic variation 
accounted for by these 38 pQTL ranged from 0.86% to 9.88%. Interestingly, the pQTL that 
were associated with pectoralis and gastrocnemius on chromosome 1 had the two largest F-
values. These two pQTL also explained the largest amount of phenotypic variation (Table 3). 
The distribution of estimated additive, dominance effects are shown individually in Figures 
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1a and 1b. Most additive and dominance effects were small. Compared with the dominance 
effects, more pQTL had larger additive effects. 
Imprinting effect of pQTL 
We identified six imprinted pQTL with a comparison-wise P-value less than 0.05 
(Table 4). These pQTL were located on chromosomes 6, 9 10, 11 and 18. Of these pQTL, 
three were associated with nasal to anal length. The imprinted pQTL on chromosome 10 for 
nasal to anal length had the largest imprinting effect (Figure 2). The two imprinted pQTL on 
chromosome 18 shared the same peak position and both were associated with adipose traits. 
The variation accounted for by these pQTL was similar, about 2.2-2.4% of the total 
phenotypic variation. Although only six imprinted pQTL were detected, three had relatively 
large effects (Figure 1c). When compared to the P-values of additive, dominance and 
imprinting effects, the most significant effects came from the additive pQTL effects (Table 5). 
Summing additive, dominance and imprinting effects together, the total phenotypic variation 
accounted for by pQTL is presented in Figure 3. 
Interaction effect of pQTL with myostatin genotype, reciprocal cross and sex effect 
We identified 14 chromosomal positions that significantly interacted with myostatin 
genotype (comparison p-value<0.05) (Table 6). In addition, another nine and 18 positions 
were detected for their significant interaction with reciprocal cross and sex effect, 
respectively (Table 7, Table 8). Tables 6-8 include the P-values that were associated with 
three different tests for interaction. For example, in Table 6, the first test (am + dm + im) 
gives the P-value of the overall interaction, which includes interactions of additive, 
dominance, and imprinted pQTL effects by myostatin genotype interaction. The second test 
(am + dm) gave the P-value of the non-imprinted interaction, which includes interactions of 
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additive and dominance pQTL effect by myostatin genotype interaction. The third test (am) 
gave the P-value of the additive interaction, which includes interaction of additive by 
myostatin genotype interaction. More than half of the pQTL detected with myostatin 
genotype or sex interactions were associated with adipose traits (Table 6, Table 8). Most of 
the interaction effects were significant for either the non-imprinted interaction or the additive 
interaction. One exception is the BMI pQTL on chromosome 14 that interacted with sex. 
This pQTL had a significant overall pQTL by sex interaction but no significant non-
imprinted or additive pQTL by sex interaction. A pQTL with a similar interaction pQTL 
pattern was found for tail length on chromosome 7 for the cross interaction.  
Main effect eQTL and interaction with eQTL 
 We identified two main effect eQTL on chromosomes 1 and 4 (Table 9) by a 5% 
genome-wide significance level.  The eQTL on chromosome 1 was associated with  Tnni1 
expression level. The eQTL on chromosome 4 impacted Igf1 expression. Both eQTL 
explained about 2% of the phenotypic variation. In addition, two, four and one eQTL were 
detected with a significant interaction with reciprocal cross, myostatin genotype and sex 
effect (Table 10). These eQTL were located on chromosomes 1, 3, 6, 7, 8 and X. Similar to 
pQTL, the P-values from three interaction tests are presented in Table 10, along with the 
phenotypic variation that could be explained by these interactions. 
Main effect tQTL and interaction with tQTL 
  No significant main effect (additive, dominance or imprinted) QTL was identified for 
the six transcription and translation traits in our study by a 5% genome-wide significance 
level. Using a threshold of comparison-wise P-value less than 0.05, a total of seven tQTL 
were identified for their significant interaction with myostatin genotype, sex or reciprocal 
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cross effect (Table 11). Among these seven tQTL, five of them interacted with reciprocal 
cross, one of them interacted with myostatin genotype and one of them interacted with sex. 
After a testing of different interaction model, all of these seven QTL had signicant overall 
interaction, additive and dominance interaction (Table 11). The average variation accounted 
for by these QTL is about 2.5%. 
Genetic variation components from pQTL 
For each trait, the total amount of phenotypic variation accounted for by additive, 
dominance and imprinted pQTL is presented in Figure 3. pQTL that were associated with 
gastrocnemius muscle weight explained the largest amount of phenotypic variation. The 
phenotypic variation accounted for by interaction effects is summarized in Figure 4. For fat 
related traits, most of the variation was caused by pQTL interaction effects with myostatin 
genotype and sex. Compared with adipose traits, cross by pQTL interaction effects explained 
more phenotypic variation for muscle weight traits. We did not identify any phenotypic 
variation resulting from sex by pQTL interactions for body length traits. Summing all 
additive, dominance, imprinting and interaction effects, the variation explained by different 
components of total variation is presented in Figure 5. The largest proportion of phenotypic 
variation came from the additive and dominance QTL effects for most traits. Additive, 
dominance, and interaction QTL effects explained almost equal amounts of genotypic 
variation for BMI. Most of the genotypic variation for soleus weight came from interaction 
effects. The variation from imprinting effects varied from trait to trait and was relatively 
small for most traits.   
Discussion  
Imprinting effects 
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We identified six imprinted QTL in this study. The reason that we were able to detect 
these imprinting effects was that the two mouse lines used were not fully inbred. 
Polymorphisms of QTL were detected within the parental lines. This is shown in information 
content graph (Supplemental Figure 1). We also found that three of these six QTL were body 
length traits. 
In mice, imprinting effects have been studied by others. For example, a study by 
Leamy et al. [23] used used the post hoc t-test from regression analyses and discovered 
several QTL that displayed an imprinting pattern for mandible size and shape in mice. These 
QTL were located on chromosomes 2, 3, 6 and 12. Imprinted QTL have also been identified 
on mouse chromosome 8 for a mature body mass trait [24]. In addition, there was evidence to 
support that some genomic regions on mouse chromosomes 3, 4, 5, 6, 7, 12 and 18 had 
imprinting effects on adult body composition [25,26]. Compared with these previous 
mapping results, the QTL regions we discovered here on chromosomes 9, 10 and 11 had not 
been previously identified to affect body length traits. These regions might harbor unknown 
genes that regulate body size.  
The imprinted QTL we identified on chromosome 18 significantly impacted fat-related 
traits. This had not been described in other imprinted QTL studies. Limited research has been 
done in this area. In mice, imprinted obesity QTL were first identified  in LGXSM 
recombinant inbred strains [27]. Other studies of imprinted fat-related QTL support an 
association between fat pad weight and chromosome 2 and 7 in mice [28]. Imprinted obesity 
QTL are more widely identified in other species such as humans and pigs [29,30]. For 
example, the most famous study of fat-related imprinted QTL in pigs was the mapping of 
IGF2 locus [31]. This locus had a huge effect on muscle mass and fat deposition.  
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Additive and dominance effect of pQTL 
 Using interval mapping and the genome-wide permutation method, we identified 38 
pQTL with significant additive and dominance effects on the ten obesity traits. Most of the 
estimates of additive and dominance effect were very small. Six and one pQTL had relatively 
large additive and dominance effects, respectively (Figure 3). These results agree with the 
fact that quantitative traits are controlled by many genes of smaller effect and a few genes of 
larger effect. Furthermore, a large number of the identified additive and dominance pQTL in 
this study were associated with muscle weight or fat-related traits. This is understandable 
when considering the two mouse lines we used to set up the breeding. The biggest 
phenotypic difference between M16i and C57BL/6 myostatin-null lines are in skeletal 
muscle weight and fat accumulation. We expected that loci controlling these phenotypes 
were segregating in the F2 generation and could be identified through pQTL mapping.  
 The chromosomes we identified to be associated with significant pQTL effects 
contained some obvious candidate genes for muscle, adipose and body size development. For 
example, IGF-binding protein 2 on chromosome 1 modulated the activity of IGF1 to protect 
against obesity [32]. IGF-binding protein 5 on chromosome 1 was associated with whole-
body growth and muscle development [33]. The insulin-like growth factor 1 receptor gene on 
chromosome 7 and the growth hormone gene and signal transduction factor on chromosome 
11 were also located in our pQTL regions. Defects in these genes resulted in overgrowth [34], 
obesity [35] and insulin resistance [36].  However, QTL detected on chromosome 1 around 
the myostatin locus might be false positive due to segregation distortion.  
 Some of the pQTL that were associated with AI and fat weight overlapped. This agreed 
with the high positive correlation between these two traits. However, the pQTL identified on 
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chromosome 11 for BMI was not significant for either AI or fat weight. pQTL for fat-related 
traits, e.g. body fat mass and body mass, have been mapped to this region previously [37-39]. 
The fact that BMI, AI and fat weight pQTL were not totally identical supported the 
importance of using BMI as a measurement of obesity. BMI was first invented in the 19th 
century and after that it has been widely used in clinical obesity research. Studies found that 
the increase of body mass index in the United States during the 1980s coincided with an 
increase in the incidence of non-insulin-dependent diabetes [40]. Moreover, there has been 
tremendous interest in understanding the underlying genetic mechanism [41]. Genes have 
been identified for their significant impact on BMI at different growth periods [38,42,43]. 
BMI takes into account the body size information that might not be elucidated from AI and 
fat weight measurement alone.  
Interaction effect of pQTL 
 We tested the pQTL by myostatin genotype, pQTL by reciprocal cross and pQTL by 
sex interaction in this study. We also calculated the different components of the pQTL 
interaction effects, including additive, dominance and imprinting effects. Correspondingly, 
the interaction tests were also itemized to include three different types of interaction. The 
first test was an overall interaction test that considered the additive pQTL effect by myostatin 
genotype, reciprocal cross or sex interaction (am), the dominance QTL effect by myostatin 
genotype, reciprocal cross or sex interaction (dm) and the imprinted pQTL effect by 
myostatin genotype, reciprocal cross or sex interaction (im). The second test was an additive 
and dominance interaction test that only considered the am and dm. The third test was an 
additive interaction test that only considerer the am. The results from these tests gave an idea 
of what might be the most important interaction effect. For example, from our results (Table 
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6-8), the combination of additive and dominance interaction effects were significant for most 
of the traits tested. We also noticed that some these pQTL did not have a significant 
combination effect (am + dm) but actually had a significant additive interaction effect (am), 
e.g. pectoralis weight pQTL on chromosome 1 interacting with reciprocal cross effect. 
Meanwhile, there were other pQTL that did not have a significant additive interaction effect 
(am) but actually had a significant combination interaction effect (am + dm), e.g. 
gastrocnemius weight pQTL on chromosome 1 interacting with myostatin genotype effect. 
This second example might be an indication of important dominance interaction effect. Due 
to the limited functions provided by GridQTL, we did not test the dominance interaction 
effect directly.  
 In addition, we estimated the phenotypic variation accounted for by the interaction 
effect in our study. Compared with the additive and dominance effect, the phenotypic 
variation explained by the interaction effect was much smaller (<2% of the total phenotypic 
variation). In our previous pQTL mapping study of growth traits (unpublished work), we 
discovered a large number of interaction effects that also explained a small amount of 
phenotypic variation. These results suggest that for quantitative traits, gene-gene interaction 
effects are usually smaller than additive and dominance effect. However, when we take into 
account the total number of possible gene-gene interaction in a certain pathway, the total 
amount phenotypic variation that accounted for for these interaction effects may be a fairly 
large. 
tQTL, eQTL and pQTL 
 Two tQTL were identified on chromosomes 1 and 13. These two QTL significantly 
interact with cross to affect the total RNA amount and the RNA/DNA ratio in the F2 mice. 
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RNA/DNA ratio is a measurement of transcription rate. Therefore, these two QTL might be 
some cross-specific transcription factor that controls the RNA transcription rate from DNA. 
Another two tQTL that was associated with the total protein amount and the protein/DNA 
ratio were identified at close positions on chromosome 2. These two tQTL significantly 
interact with myostatin genotype and sex. Inactivation of myostatin post-natally can cause 
muscle hypertrophy [44] in mice. One important symptom of muscle hypertrophy is an 
increasing amount of protein or protein/DNA ratio in the cell. Therefore, these two QTL can 
be key mediators that are controlled by myostatin to affect protein synthesis and muscle 
hypertrophy. 
 It has been identified that Igf1 regulates skeletal muscle growth through promoting 
satellite cells and synthesizing muscle protein [45,46]. In our previous QTL study of growth 
traits in the same population, we discovered that the genomic region around 65 cM on 
chromosome 4 was significantly associated with average daily gain (from the 1st to 3rd week) 
and body weight (the 3rd, 4th and 5th week) traits. Here in this study, we identified an eQTL 
for Igf1 at 68cM on the same chromosome. Considering the fact that the Igf1 gene is on 
mouse chromosome 10, these results suggested that it is very possible that a trans-regulator 
element of Igf1 gene is on chromosome 4. This element might control the expression level of 
Igf1 gene to further regulate body growth. In addition, another Igf1 eQTL was identified on 
chromosome 7 for its significance interaction with reciprocal cross. We detected muscle 
pQTL with significant main and interaction effects with cross and sex near this position. Igf1 
seems to be a very active mediator factor between regulating elements and growth, and its 
expression level appears regulated by sex and genetic backgrounds. 
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We identified two eQTL that interacted with myostatin genotype to affect Atp2a2 
expression levels. These two eQTL did not locate on the same chromosome as Atp2a2 gene 
and might be long-distance regulating factors. Recently, it was shown that a change in 
Atp2a2 expression level represented a fiber-type transformation [47]. Another protein 
analysis of skeletal muscle in cattle demonstrated that myostatin impacted the number of 
different muscle fibers [48]. These pieces of information suggest that myostatin might 
interact with these two eQTL to regulate the Atp2a2 activity, and alter fiber type.  
The two examples of eQTL we discussed above prove the important role of eQTL 
mapping in quantitative trait analysis. It provides complementary details about genetic 
mechanism on an mRNA level. This is a key link between DNA and phenotypes and makes 
it much easy to identify candidate genes for regulators in a pathway. 
Conclusions 
Imprinted pQTL were identified on chromosomes 6, 9, 10, 11 and 18 to impact muscle 
weight, fat-related and body length traits. Furthermore, pQTL, tQTL and eQTL with 
significant interaction effects with myostatin genotype, reciprocal cross and sex effect were 
identified across the genome. These results will help to search for genes involved in obesity 
formation. Particularly, these QTL were evaluated for their additive, dominance and 
imprinting interaction effects. This knowledge is important to understand how obesity genes 
function to regulate adipose accumulation. 
Materials and Methods 
Mouse lines and breeding procedure  
Two founder mouse strains, myostatin-null C57BL/6 [49] and M16i high body weight 
[16], were reciprocally crossed to derive an  F2 mapping population. The Myostatin-null 
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C57BL/6 line contained non-functional Myostatin gene on both chromosomes. The M16i 
obese mouse line was derived and selected from an outbred population (ICR) for high weight 
gain before 6 weeks of age. To generate the F2 progenies, four myostatin-null male mice 
were crossed with eight M16i females. This generated 35 male and 37 female F1 mice. 
Meanwhile, two M16i males and seven myostatin-null females were mated in the reciprocal 
cross to produce 31 male and 55 female F1 offspring. The resulting F1 mice were 
intercrossed within each reciprocal cross to obtain the final mapping population.  
Traits collection procedure 
One day after birth, each F2 litter was standardized to nine pups. Mice were identified 
by toe clipping seven days after birth. At three weeks of age, mice were weaned and placed 
in separate cages. We obtained 552 mice from the myostatin-null male by M16i female cross 
and 448 mice from the reciprocal cross. These 1000 F2 mice were either homozygous 
myostatin wild-type or homozygous myostatin-null genotype. At 42 days of age, the body 
weight was recorded for each F2 individual. Subsequently, mice were sacrificed. Skeletal 
muscles (soleus, gastrocnemius, EDL and pectoralis) from both left and right sides of body 
and gonadal fat pad (epididymal for males and perimetrial for females) were collected and 
weighed. Body size (nasal-tail length, nasal-anal length and tail length) was also measured. 
Based on these measurements, body mass index (BMI) and adiposity index (AI) were 
calculated and included as measurements of obesity.  
A small cut of the right pectoralis muscle of each F2 mouse was first used for total 
RNA, DNA and protein isolation with standard protocol. The ratio of DNA/RNA, 
RNA/protein and DNA/protein were calculated based on these measurements. The rest of the 
muscle was then homogenized in liquid nitrogen. After homogenization, total RNA was 
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isolated using RNeasy (Qiagen). The resulting RNA was amplified and measured by a triplex 
qPCR using Quantitect (Qiagen). Three sets of triplex qPCR experiment were performed. 
The first set included beta-actin (Actb), adipophilin (Adfp) and ATPase2 (Atp2a2). The 
second set included epidermal growth factor (Egf), insulin-like growth factor 1 (Igf1) and 
insulin-like growth factor 2 (Igf2). The third set included myogenic factor 5 (Myf5), troponin 
I (Tnni1) and wingless-related MMTV integration site 4 (Wnt4). Each sample was measure 
twice and the averaged CT value was then normalized by the CT value of the Actb gene and 
by the plate efficiency. The adjusted CT values were then used as traits for eQTL mapping. 
All animal procedures were approved by the Iowa State University Animal Care and Use 
Committee prior to this study.  
Genotyping and linkage map  
Genomic DNA was isolated from toe clips and purified by a phenol chloroform method. 
A total of 242 SNPs evenly spanning 19 autosomes and X chromosome were genotyped, in 
addition to the myostatin locus on the 1000 F2 mice. The myostatin locus was genotyped by 
standard PCR and agarose gel electrophoresis protocols. The SNP genotyping procedure was 
performed on the Sequenom® platform at GeneSeek® (Lincoln, Nebraska). SNPs on 
chromosome 15 and chromosome 16 were discarded because no informative SNPs were 
present. Among the remaining SNPs, 152 SNPs with call rates greater than 80% and no 
observable genotyping errors were included in the analysis. These 152 SNPs were located on 
17 autosomes and the X chromosome. Marker segregation distortion was evaluated in the F2 
mice by a Chi-square test. Only SNPs close to the myostatin locus significantly deviated 
from the expected Mendelian segregation ratios. This was caused by the fact that only 
homozygotes at the myostatin locus were included. All 152 SNP markers were used to 
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generate a linkage map by Cri-map [50], with distances estimated in Kosambi centimorgans. 
The marker order and position in our map (Supplemental Table 1) were consistent with the 
map from the Wellcome-CTC Mouse Strain SNP Genotype Set. Therefore, we analyzed the 
data based on our linkage map. 
Data analyses  
Data exploration 
Simple statistics (mean, standard deviation, minimum and maximum) were calculated 
for each trait. In addition, all main factors (myostatin genotype, sex, reciprocal cross, coat 
color) and interaction terms (interactions between main effects) were tested for each trait by 
fitting a generalized linear model. Effects with P-value less than 0.1 were included in the 
QTL model (Supplemental Table 2). Finally, the significant factors were removed from the 
linear model to evaluate the residual correlations between each pair of trait values. All 
general statistical analyses in the F2 data were carried out using a SAS® software package. 
The corresponding procedures used were Proc MEANS, Proc GLM and Proc CORR.  
Additive, dominance and imprinting effects  
First, we analyzed each trait to identify imprinted QTL. To achieve this, two different 
models were used to perform a whole genome scan. The imprinted QTL model included 
significant main effects, interaction effects, along with additive, dominance and parent of 
origin (imprinting) effects at a single QTL position. The non-imprinted QTL model included 
all the terms in the first model except for the imprinting effect. Each QTL model was 
individually analyzed in GridQTL [51], a web-based QTL analysis program to identify QTL 
by interval mapping. A genome-wide permutation procedure [52] with 1000 repetitions was 
applied to each model to obtain 1% and 5% genome-wide significance levels. All QTL 
118 
 
positions above the 5% significance level under the imprinted QTL model and the non-
imprinted QTL model were used to evaluate the imprinting effect by calculating an F-value 
as follows: 
error of  squares sum:SSE
after) (same term error of freedom of degree :d.f.
model) QTL (imprintedSSEmodel) QTL imprinted-(nonSSESSE
model) QTL (imprintedfdmodel) QTL (imprintedSSE
SSEF
−=Δ
Δ=
../
 
The corresponding comparison-wise P-value was computed from a standard F-
distribution with the corresponding degrees of freedom. If the P-value was less than 0.05, the 
imprinted QTL model was assumed to be more suitable for this QTL position. Otherwise, the 
non-imprinted model was chosen. After the best model for each trait was determined, it was 
applied to each QTL position again to obtain F-values, LOD-values and estimates for QTL 
effects, along with the corresponding standard errors for each QTL peak.  
At each QTL position, a corresponding comparison-wise P-value was computed for the 
additive and dominance effect respectively as follows. 
Additive and dominance model (AD model): 
ε+++= position) (QTL effect dominanceposition) (QTL effect additive effects fixedvalue Phenotypic  
Additive model (A model): 
ε++= position) (QTL effect additive effects fixedvalue Phenotypic  
Full reduced model (R model): 
ε+=  effects fixedvalue Phenotypic  
For additive effect: 
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For dominance effect: 
model) (ADfdmodel) (ADSSE
model) (ADSSEmodel) (ASSEF
../
−=  
The corresponding comparison-wise P-values were computed from an F-distribution 
with the corresponding degrees of freedom. 
The phenotypic variance explained by the QTL was computed. For imprinted QTL, the 
percentage of phenotypic variation accounted for by a QTL position was computed as the 
percentage of residual sum of squares explained by the additive, dominance and imprinting 
effects at the QTL using the imprinted QTL model. For non-imprinted QTL, the percentage 
of phenotypic variation accounted for by a QTL position was computed as the percentage of 
residual sum of squares explained by the additive and dominance effec using the non-
imprinted QTL model. 
QTL interaction analysis  
We first analyzed the interaction between a QTL position and myostatin genotype. To 
accomplish this, we split the data into two subsets based on myostatin genotype. Within each 
myostatin genotype subset, both the imprinted QTL model and the non-imprinted QTL 
model were evaluated by interval mapping. All QTL positions identified at 5% genome-wide 
significance levels in either model were considered for analysis in the next step, in which the 
following six QTL models were fitted to these identified QTL positions in the full whole F2 
data.  
Model 1-1:  
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Model 1-2: 
εposition) (QTL effect imprinting
position) (QTL effect dominanceposition) (QTL effect additive  effects fixedvalue Phenotypic
++
++=  
Model 2-1:  
ε position) (QTL effect dominance  Myostatinposition) (QTL effect additive  Myostatin
position) (QTL effect dominance position) (QTL effect additive  effects fixedvalue Phenotypic
+×+×+
++=  
Model 2-2:  
ε+++= position) (QTL effect dominanceposition) (QTL effect additive  effects fixedvalue Phenotypic  
Model 3-1: 
ε+×+
+=
position) (QTL effect additive  Myostatin
position) (QTL effect additive effects fixedvalue Phenotypic  
Model 3.2: 
ε++= position) (QTL effect additive effects fixedvalue Phenotypic  
By comparing the above models, we determined the F-values for different interaction 
effects as follows: 
1) When considering the general interaction (additive, dominance and imprinting 
interaction): 
 
1)-1 (modelSSE2)-1 (modelSSESSE
1)-1 (modelfd1)-1 (modelSSE
SSEF
−=Δ
Δ=
../
3/
  
2) When considering the non-imprinting interaction (additive and dominance interaction): 
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3) When considering the additive interaction: 
1)-3 (modelSSE2)-3 (modelSSESSE
1)-3 (modelfd1)-3 (modelSSE
SSEF
−=Δ
Δ=
../  
Correspondingly, each F-value gave a comparison-wise P-value. Interactions with a P-
value less than 0.05 were considered significant.  
Using a similar approach, reciprocal cross × QTL interactions were analyzed.  Initially, 
the data was split into two subsets by reciprocal crosses and potential QTL positions for 
testing reciprocal cross interactions were identified within each cross subset. Then, 
interactions at each position were tested in the full data set, similar to the procedure used for 
myostatin interactions but with the myostatin effect replaced by the reciprocal cross effect in 
models 1-1 to 3-2.  
Finally, the same approach was applied to identify sex × QTL interactions. The data 
was split into two subsets by sex and potential testing QTL positions were identified within 
each sex subset. Myostatin effect in the QTL models were all replaced by sex effect and the 
corresponding interaction effects were switched as well.  
Estimates of additive and dominance effects and phenotypic variation accounted for by 
each identified QTL were estimated in the same way discussed above for main effect QTL. 
To calculate the total effect of pQTL, we summed the phenotypic variation explained by all 
main effect pQTL and interaction pQTL, for each trait respectively. 
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Figure legends 
Figure 1. Distribution of estimated additive effects (a), dominance effects (b) and 
imprinting effects (c) 
Figure 2. Genome scan of imprinted QTL on chromosome 10 at 58 cM to control 
lengthNA 
IMP: imprinted QTL model 
AD: additive and dominance QTL model 
Vertical line indicates the position of the imprinted QTL 
Figure 3. Phenotypic variation accounted for by QTL 
Trait abbreviations are the same as in Table 1. 
%var: phenotypic variation accounted for by QTL for each trait 
Figure 4. Phenotypic variation accounted for by QTL that interacted with myostatin 
genotype, reciprocal cross and sex effect 
Trait abbreviations are the same as in Table 1. 
Mstn: Myostatin genotype by QTL interaction 
Cross: Reciprocal cross by QTL interaction 
Sex: Sex by QTL interaction 
Figure 5. Partitioning of variation for different components  
interaction: the sum of myostatin genotype by QTL, reciprocal cross by QTL and sex by 
QTL effect 
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vi: imprinting QTL effect 
vd: dominance QTL effect 
va: additive QTL effect 
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Tables 
Table 1. Basic statistics for obesity traits in the F2 mapping population 
Traitsa Mean Std. Devb Rangec 
lengthNA 9.926 0.728 7.000-16.700
lengthNT 17.691 1.203 12.000-20.500
AI 0.470 0.250 0.041-1.743
BMI 30.598 4.312 10.517-45.793
Tail 7.764 0.784 2.100-10.000
Soleus 0.032 0.015 0.010-0.381
Gastro 0.592 0.113 0.367-1.013
Edl 0.358 0.080 0.193-1.649
Pec 0.636 0.245 0.277-1.310
Fat 0.470 0.250 0.041-1.743
a lengthNA: nasal to anal length (cm); lengthNT: nasal to tail length (cm); AI: adipose index; 
BMI: body mass index; Tail: tail length (cm); Soleus: soleus muscle weight percentage; 
Gastro: gastrocnemius muscle weight percentage; Edl: EDL muscle weight percentage; Pec:  
pectoralis muscle weight percentage; Fat: average gonadal fat pad weight percentage 
(epididymal for males and perimetrial for females).  
b standard deviation 
c minimum and maximum 
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Table 2. Phenotypic correlation among traits in this studya 
Traitsb lengthNA lengthNT AI BMI Tail Soleus Gastro Edl Pec Fat 
lengthNA 1.000 0.778** 0.308** 0.013* 0.264** -0.004* 0.112  -0.051* 0.097 0.309**
lengthNT  1.000 0.377** 0.158** 0.812** -0.043* 0.020* -0.111  -0.014* 0.377**
AI   1.000 0.008* 0.291** -0.016** -0.454** -0.439** -0.382** 1.000**
BMI    1.000 0.231** 0.110  0.550** 0.347** 0.676** 0.008* 
Tail     1.000 -0.063  -0.073  -0.123** -0.111 0.291**
Soleus      1.000 0.351** 0.301** 0.290** -0.164**
Gastro       1.000 0.668** 0.886** -0.454**
Edl        1.000 0.606** -0.439**
Pec         1.000 -0.382**
Fat          1.000 
a P-value for testing for significant correlation. **: P < 0.0001; *: 0.0001 < P < 0.05; otherwise, P > 0.05 
b Same abbreviations for traits as in Table 1 are used here. 
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Table 3. Statistics of non-imprinted QTL 
Peak Flanking Markersc Estimated 
MMU Traitsa 
(cM)b Left Right 
F-value LOD 
a s.ea d s.ed 
%vare
1 AI** 24 rs3696088 rs13472794 13.00 5.573 0.0813 0.0165 0.0332 0.0219 2.64
2 AI** 88 rs3144393 rs13476878 18.65 7.952 0.0519 0.0091 -0.0263 0.0138 3.65
6 AI** 27 rs13478727 rs13478839 10.27 4.413 0.0393 0.0090 -0.0121 0.0136 1.99
8 AI** 69 rs3678433 rs6182338 15.38 6.578 0.0546 0.0100 0.0032 0.0160 2.95
9 AI 23 rs8259427 rs6213724 8.94 3.849 0.0311 0.0091 0.0334 0.0139 1.79
17 AI** 17 rs13482893 rs3719497 11.20 4.809 0.0418 0.0091 -0.0079 0.0145 2.14
11 BMI 49 rs13481054 rs3701609 8.23 3.545 0.5312 0.1385 0.2684 0.1978 1.64
1 Edl** 25 rs3696088 rs13472794 7.19 3.100 -0.0327 0.0086 0.0010 0.0112 1.44
2 Edl 78 rs3144393 rs13476878 6.79 2.930 -0.0179 0.0052 0.0107 0.0082 1.36
3 Edl 64 rs3663873 rs13477430 5.45 2.353 0.0179 0.0058 0.0145 0.0103 1.10
17 Edl** 33 rs3023442 rs6395919 7.74 3.335 -0.0187 0.0049 0.0072 0.0079 1.55
1 Fat** 24 rs3696088 rs13472794 13.54 5.800 0.0817 0.0167 0.0367 0.0222 2.68
2 Fat** 88 rs3144393 rs13476878 19.62 8.353 0.0535 0.0092 -0.0279 0.0140 3.84
6 Fat** 28 rs13478727 rs13478839 9.97 4.286 0.0394 0.0091 -0.0122 0.0137 1.98
8 Fat** 68 rs3678433 rs6182338 15.00 6.415 0.0556 0.0102 0.0022 0.0163 2.96
9 Fat 23 rs8259427 rs6213724 9.18 3.952 0.0320 0.0091 0.0336 0.0140 1.83
17 Fat** 17 rs13482893 rs3719497 10.94 4.697 0.0415 0.0091 -0.0097 0.0144 2.14
1 Gastro** 23 rs3696088 rs13472794 35.40 14.844 -0.0417 0.0054 -0.0239 0.0073 6.73
2 Gastro** 80 rs3144393 rs13476878 9.40 4.044 -0.0117 0.0033 0.0124 0.0053 1.88
3 Gastro 56 rs3663873 rs13477430 6.51 2.807 0.0084 0.0032 0.0134 0.0050 1.31
5 Gastro 49 rs6256504 CEL-5_52953963 4.51 1.948 -0.0050 0.0030 0.0113 0.0048 0.91
6 Gastro 0 - rs13478602 6.64 2.864 -0.0058 0.0028 0.0125 0.0041 1.33
7 Gastro 47 rs3676254 rs3656205 5.65 2.438 0.0227 0.0068 -0.0170 0.0073 1.14
8 Gastro 37 rs13479657 rs13479757 7.22 3.111 0.0134 0.0036 -0.0032 0.0060 1.45
9 Gastro 0 - rs13480071 4.28 1.850 -0.0039 0.0029 -0.0100 0.0039 0.86
10 Gastro 30 rs13480579 CEL-10_58149653 4.50 1.944 -0.0082 0.0028 -0.0033 0.0041 0.91
11 Gastro 68 rs3653651 rs13481216 4.86 2.099 0.0086 0.0028 0.0026 0.0040 0.98
14 Gastro 34 rs8251329 rs3712401 7.77 3.348 0.0118 0.0030 0.0030 0.0042 1.56
17 Gastro** 68 rs6257479 rs3663966 9.62 4.136 -0.0128 0.0029 0.0024 0.0042 1.92
18 lengthNA 35 rs3670254 rs3718618 8.62 3.717 0.1345 0.0325 0.0149 0.0486 1.71
6 lengthNT** 45 rs3676254 rs3656205 13.45 5.762 0.2921 0.0578 0.1200 0.0975 2.58
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Table 3. (continued) 
Peak Flanking Markersc Estimated 
MMU Traitsa 
(cM)b Left Right 
F-value LOD 
a s.ea d s.ed 
%vare
10 lengthNT 26 rs13480578 CEL-10_58149652 7.96 3.427 0.1970 0.0519 -0.0946 0.0792 1.58
11 lengthNT** 26 rs6276300 rs6199956 21.55 9.163 0.3596 0.0556 0.0833 0.0892 4.15
18 lengthNT 34 rs3670254 rs3718618 8.39 3.615 0.2128 0.0522 0.0373 0.0780 1.67
1 Pec** 23 rs3696088 rs13472794 53.84 22.186 -0.0084 0.0089 -0.0503 0.0120 9.88
3 Pec 44 rs13477174 rs3670634 9.84 4.233 0.0143 0.0049 0.0243 0.0069 1.96
7 Pec** 47 rs3676254 rs3656205 10.54 4.528 0.0445 0.0113 -0.0169 0.0122 2.10
11 Tail** 25 rs6276300 rs6199956 16.87 7.205 0.2461 0.0425 0.0240 0.0682 3.29
a Trait abbreviations are the same as in Table 1. QTL with an F-value that exceeded 1% genome-wide permutation threshold are 
denoted by **; QTL without ** exceeded 5% genome-wide permutation threshold. 
b Peak position of QTL detected in Kosambi centimorgans.  
c Flanking markers (left and right) of the QTL peak. A “-“ notation denotes the end of the chromosome. See Supplemental Table 1 
for marker information. 
d a: additive effect; s.ea: standard error of additive effect; d: dominance effect; s.ed: standard error of dominance effect.  
e %var: percentage of phenotypic variance that a given QTL position could account for. 
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Table 4. Statisticsa of imprinted QTL 
Peakc Flanking Markersd Estimatee MMU Traitb 
(cM) Left Right a s.ea d s.ed i s.ei 
%varf
6 lengthNA 45  rs4226048 mCV24115224 0.1438  0.0361  0.0867  0.0609  -0.1492  0.0631  2.21  
9 Edl 1  rs13480071 rs13480109 -0.0008  0.0046  -0.0080  0.0064  0.0528  0.0114  2.27  
10 lengthNA 58  rs13480754 rs13480776 0.0679  0.0320  0.0693  0.0478  0.2329  0.0588  2.24  
11 lengthNA 23  rs6276300 rs6199956 0.1488  0.0350  0.0921  0.0561  -0.1188  0.0566  2.48  
18 AI 39  rs3670254 rs3718618 0.0406  0.0093  -0.0114  0.0141  0.0315  0.0156  2.42  
18 Fat 39  rs3670254 rs3718618 0.0411  0.0094  -0.0114  0.0142  0.0323  0.0157  2.36  
a Imprinted QTL with comparison-wise P-value <0.05.  
b Traits abbreviations are the same as in Table 1. 
c Peak position of QTL detected in Kosambi centimorgans.  
d Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
e a: additive effect; s.ea: standard error of additive effect; d: dominance effect; s.ed: standard error of dominance effect; i: 
imprinting effect; s.ei: standard error of imprinting effect.  
f %var: percentage of phenotypic variance that a given QTL position accounts for. 
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Table 5. Test statistics of additive, dominance and imprinting effects 
Peakb P-valuec MMU Traita 
(cM) i a d 
1 Gastro 23  - 2.839E-14 1.163E-03 
1 Pec 23  - 3.215E-20 3.095E-05 
1 AI 24  - 8.787E-07 1.303E-01 
1 Fat 24  - 1.009E-06 9.831E-02 
1 Edl 25  - 1.581E-04 9.176E-01 
2 Edl 78  - 5.918E-04 1.938E-01 
2 Gastro 80  - 3.047E-04 1.818E-02 
2 AI 88  - 8.358E-09 5.794E-02 
2 Fat 88  - 4.246E-09 4.612E-02 
3 Pec 44  - 7.396E-03 4.479E-04 
3 Gastro 56  - 1.648E-02 7.392E-03 
3 Edl 64  - 2.955E-03 1.570E-01 
5 Gastro 49  - 6.298E-02 1.875E-02 
6 Gastro 0  - 5.719E-02 1.972E-03 
6 AI 27  - 1.211E-05 3.764E-01 
6 Fat 28  - 1.403E-05 3.723E-01 
6 lengthNA 45  1.830E-02 1.292E-04 1.761E-01 
6 lengthNT 45  - 8.074E-07 2.189E-01 
7 Gastro 47  - 1.528E-02 2.072E-02 
7 Pec 47  - 1.338E-05 1.671E-01 
8 Gastro 37  - 1.767E-04 6.040E-01 
8 Fat 68  - 5.471E-08 8.935E-01 
8 AI 69  - 5.283E-08 8.433E-01 
9 Gastro 0  - 1.499E-01 1.108E-02 
9 Edl 1  4.151E-06 9.182E-01 2.469E-01 
9 AI 23  - 4.997E-04 1.663E-02 
9 Fat 23  - 8.658E-04 7.905E-03 
10 lengthNT 26  - 1.506E-04 2.325E-01 
10 Gastro 30  - 3.926E-03 4.230E-01 
10 lengthNA 58  7.994E-05 3.132E-02 1.405E-01 
11 lengthNA 23  3.309E-02 2.907E-05 9.537E-02 
11 Tail 25  - 9.287E-09 7.246E-01 
11 lengthNT 26  - 1.533E-10 3.507E-01 
11 BMI 49  - 1.408E-04 1.751E-01 
11 Gastro 68  - 2.348E-03 5.128E-01 
14 Gastro 34  - 1.118E-04 4.744E-01 
17 AI 17  - 4.198E-06 5.851E-01 
17 Fat 17  - 4.993E-06 4.979E-01 
17 Edl 33  - 1.371E-04 3.638E-01 
17 Gastro 68  - 1.503E-05 5.690E-01 
18 lengthNT 34  - 3.849E-05 7.595E-01 
18 lengthNA 35  - 5.058E-05 6.329E-01 
18 AI 39  4.448E-02 1.355E-05 3.992E-01 
18 Fat 39  4.002E-02 1.214E-05 4.023E-01 
a Traits abbreviations are the same as in Table 1. 
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b Peak position of QTL detected in Kosambi centimorgans.  
c Comparison P-value for testing QTL effect. i: imprinting effect; a: additive effect; d: 
dominance effect. Only imprinted QTL (Table 3) were estimated for the imprinting effect. 
A “-“ notation indicates that the effect was not estimated. P-value< 0.01 is shown in bold 
type. 
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Table 6. Statistics of QTL interacting with myostatin genotype effect 
Position Flanking markersc am + dm + imd am + dme amf MMU Traitsa 
(cM)b Left Right P-value %var P-value %var P-value %var 
1 BMI 22  rs3696088 rs13472794 7.35E-02 0.70  3.85E-02 0.65  8.48E-03 0.69  
1 Gastro 24  rs3696088 rs13472794 2.45E-08 3.58  1.77E-08 3.34  1.49E-01 0.20  
1 Pec 25  rs3696088 rs13472794 3.95E-12 5.06  1.08E-11 4.56  3.52E-03 0.80  
3 Pec 43  rs13477174 rs3670634 2.31E-02 0.95  1.02E-02 0.91  8.95E-02 0.29  
6 Fat 27  rs13478727 rs13478839 4.24E-03 1.31  1.36E-03 1.31  2.74E-04 1.31  
6 lengthNT 69  UT_6_123.37228 rs3688358 1.34E-01 0.55  7.28E-02 0.52  3.65E-02 0.43  
8 AI 20  rs13479657 rs13479757 1.42E-02 1.04  5.09E-03 1.04  1.14E-03 1.04  
8 Fat 20  rs13479657 rs13479757 1.15E-02 1.10  4.13E-03 1.09  9.01E-04 1.09  
14 BMI 63  rs3709178 rs13482404 9.57E-02 0.63  4.50E-02 0.62  1.23E-01 0.24  
17 Fat 15  rs13482893 rs3719497 4.84E-02 0.74  3.38E-02 0.65  1.44E-02 0.64  
17 AI 28  rs3023442 rs6395919 3.76E-02 0.83  2.68E-02 0.71  7.06E-03 0.71  
17 Soleus 69  rs6257479 rs3663966 3.77E-02 0.86  1.82E-02 0.81  3.49E-02 0.45  
18 AI 42  rs3718618 rs13483438 3.92E-02 0.82  2.97E-02 0.69  4.65E-02 0.39  
18 Fat 42  rs3718618 rs13483438 3.27E-02 0.87  2.78E-02 0.71  4.88E-02 0.39  
a Traits abbreviations are the same as in Table 1. 
b Peak position of QTL detected in Kosambi centimorgans.  
c Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
d am + dm + im testes the overall interaction, which includes interactions of additive, dominance, and imprinted pQTL effects by 
myostatin genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at 
QTL position. 
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e am + dm tests the non-imprinted interaction, which includes interactions of additive and dominance pQTL effect by myostatin 
genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
f am tests the additive interaction, which includes interaction of additive by myostatin genotype interaction. P-value< 0.05 is 
shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
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Table 7. Statistics of QTL interacting with cross effect 
Position Flanking markersc am + dm + imd am + dme amf MMU Traitsa 
(cM)b Left Right P-value %var P-value %var P-value %var 
1 Gastro 23  rs3696088 rs13472794 2.85E-06 2.68  4.41E-06 2.32  3.14E-06 2.06  
1 Pec 23  rs3696088 rs13472794 1.62E-02 0.94  7.04E-02 0.49  5.78E-03 0.71  
1 Edl 25  rs3696088 rs13472794 4.02E-04 1.81  8.59E-03 0.95  4.14E-03 0.82  
6 lengthNA 63  mCV24115224 UT_6_123.37228 3.24E-02 0.87  5.46E-02 0.58  2.81E-02 0.48  
7 Pec 47  rs3676254 rs3656205 3.82E-02 0.84  1.64E-02 0.82  1.25E-01 0.24  
7 Tail 61  rs13479471 rs6275579 3.45E-02 0.86  5.23E-01 0.13  6.42E-01 0.02  
11 Fat 57  rs3701609 rs8270290 5.27E-02 0.77  1.76E-02 0.81  8.18E-02 0.31  
11 AI 57  rs3701609 rs8270290 6.46E-02 0.72  2.18E-02 0.76  1.06E-01 0.26  
17 Edl 31  rs3023442 rs6395919 2.00E-01 0.47  9.81E-02 0.47  3.46E-02 0.45  
a Trait abbreviations are the same as in Table 1. 
b Peak position of QTL detected in Kosambi centimorgans.  
c Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
d am + dm + im testes the overall interaction, which includes interactions of additive, dominance, and imprinted pQTL effects by 
myostatin genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at 
QTL position. 
e am + dm tests the non-imprinted interaction, which includes interactions of additive and dominance pQTL effect by myostatin 
genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position.
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f am tests the additive interaction, which includes interaction of additive by myostatin genotype interaction. P-value< 0.05 is 
shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
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Table 8. Statistics of QTL interacting with sex effect 
Flanking markersc am + dm + imd am + dme amf MMU Traitsa Position 
(cM)b Left Right P-value %var P-value %var P-value %var 
1 Soleus 19  rs3696088 rs13472794 1.57E-06 2.94  3.28E-01 0.23  5.05E-01 0.05  
1 Pec 23  rs3696088 rs13472794 1.23E-03 1.45  5.64E-03 0.95  7.01E-04 1.07  
1 Edl 89  rs3666905 rs13476312 1.65E-02 1.03  3.48E-01 0.21  1.68E-01 0.19  
3 Pec 36  rs13477132 rs13477174 1.90E-02 0.99  8.37E-02 0.50  2.39E-02 0.51  
3 Edl 64  rs3663873 rs13477430 4.79E-02 0.80  2.09E-02 0.78  4.70E-01 0.05  
6 Fat 10  petM-02094-1 rs3678887 3.61E-02 0.86  2.06E-02 0.78  3.46E-01 0.09  
6 AI 11  petM-02094-1 rs3678887 6.05E-02 0.73  3.85E-02 0.65  5.31E-01 0.04  
7 Pec 47  rs3676254 rs3656205 5.61E-03 1.25  2.84E-03 1.16  3.39E-03 0.85  
9 Fat 15  rs3719607 rs8259427 2.31E-02 0.95  1.02E-02 0.92  4.53E-01 0.06  
9 AI 15  rs3719607 rs8259427 3.50E-02 0.85  1.61E-02 0.82  5.38E-01 0.04  
11 AI 14  rs6276300 rs6199956 3.29E-02 0.87  4.53E-02 0.62  4.35E-02 0.41  
11 Fat 15  rs6276300 rs6199956 3.75E-02 0.85  4.80E-02 0.61  3.65E-02 0.44  
11 Gastro 24  rs6276300 rs6199956 3.00E-04 1.90  1.77E-04 1.74  3.23E-05 1.74  
11 BMI 49  rs13481054 rs3701609 1.44E-01 0.54  6.64E-02 0.54  2.85E-02 0.48  
14 BMI 65  rs3709178 rs13482404 1.54E-02 1.03  1.16E-01 0.43  5.64E-01 0.03  
17 Gastro 11  rs13482893 rs3719497 1.15E-01 0.59  5.29E-02 0.59  1.67E-02 0.57  
17 AI 13  rs13482893 rs3719497 5.86E-02 0.73  2.56E-02 0.72  4.15E-02 0.41  
17 Fat 13  rs13482893 rs3719498 4.83E-02 0.78  2.11E-02 0.77  4.19E-02 0.41  
a Trait abbreviations are the same as in Table 1. 
b Peak position of QTL detected in Kosambi centimorgans.  
e Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
  
136
d am + dm + im testes the overall interaction, which includes interactions of additive, dominance, and imprinted pQTL effects by 
myostatin genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at 
QTL position. 
e am + dm tests the non-imprinted interaction, which includes interactions of additive and dominance pQTL effect by myostatin 
genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
f am tests the additive interaction, which includes interaction of additive by myostatin genotype interaction. P-value< 0.05 is 
shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
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Table 9. Results for genome-wide scan of eQTL 
Peak Flanking Markersb MMU Gene 
(cM)a Left Right 
F LOD Var%c 
1 Tnni1 23 rs3696088 rs13472794 8.73 3.747 2.23 
4 Igf1 68 rs6324470 rs3659226 8.46 3.633 2.17 
a Peak position of eQTL detected in Kosambi centimorgans.  
b Flanking markers (left and right) of the QTL peak.  
c %var: percentage of phenotypic variance that a given QTL position could account for. 
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Table 10. Statistics of eQTL interacting with myostatin, cross and sex effect 
Position Flanking markersb am + dm + imc am + dme ame Factor Gene MMU 
(cM)a Left Right P-value %var P-value %var P-value %var
Cross Tnni1 1 24 rs3696088 rs13472794 3.03E-02 1.14 1.25E-02 1.12 4.84E-03 1.02
Cross Igf1 7 53 rs13479422 rs13479471 1.62E-02 1.33 6.47E-03 1.31 5.18E-03 1.02
Mstn Atp2a2 3 120 rs3724562 CEL-3_159340478 8.87E-03 1.57 7.31E-03 1.34 3.72E-03 1.14
Mstn Igf2 8 33 rs13479657 rs13479757 6.63E-02 1.10 3.30E-02 1.05 8.20E-01 0.01
Mstn Atp2a2 X 54 rs13484003 rs13484087 1.74E-04 2.69 1.11E-04 2.46 1.96E-03 1.30
Mstn Egf X 56 rs13484003 rs13484087 3.34E-02 1.18 1.75E-02 1.10 1.33E-02 0.83
Sex EGF 6 32 rs13478839 rs4226048 4.18E-03 1.79 2.08E-03 1.67 4.85E-04 1.64
a Peak position of QTL detected in Kosambi centimorgans.  
b Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
e am + dm + im testes the overall interaction, which includes interactions of additive, dominance, and imprinted pQTL effects by 
myostatin genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at 
QTL position. 
d am + dm tests the non-imprinted interaction, which includes interactions of additive and dominance pQTL effect by myostatin 
genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
e am tests the additive interaction, which includes interaction of additive by myostatin genotype interaction. P-value< 0.05 is 
shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
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Table 11. Statistics of QTL that interact with myostatin, cross and sex effect to affect muscle hypertrophy 
Position Flanking markersc am + dm + imd am + dme amf Factor Traitsa MMU 
(cM)b Left Right P-value %var P-value %var P-value %var
Cross R 1 29 rs13472794 rs13475931 1.09E-05 3.50 2.03E-02 1.09 1.10E-01 0.36 
Cross R/D 1 29 rs13472794 rs13475931 1.39E-04 2.82 1.81E-02 1.12 1.65E-01 0.27 
Cross R 13 25 rs13481780 rs3678784 1.08E-03 2.21 2.08E-04 2.34 1.26E-03 1.44 
Cross R/D 13 25 rs13481780 rs3678784 2.05E-03 2.02 4.71E-04 2.12 4.36E-03 1.13 
Cross R/D 14 18 rs13482096 rs8251329 3.64E-04 2.56 6.77E-04 2.03 1.05E-03 1.50 
Mstn P/D 2 61 rs13476636 rs3144393 2.66E-04 2.64 1.56E-04 2.43 1.52E-04 2.00 
Sex P 2 34 rs6268714 rs13476554 1.18E-02 1.53 3.73E-03 1.55 2.04E-01 0.23 
a R: total RNA (µg/mg sample); R/D: RNA/DNA ratio (µg/µg); P/D: protein/DNA ratio (µg/mg); P: Total protein (mg/mg sample). 
b Peak position of QTL detected in Kosambi centimorgans.  
c Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
d am + dm + im testes the overall interaction, which includes interactions of additive, dominance, and imprinted pQTL effects by 
myostatin genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at 
QTL position. 
e am + dm tests the non-imprinted interaction, which includes interactions of additive and dominance pQTL effect by myostatin 
genotype interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
f am tests the additive interaction, which includes interaction of additive by myostatin genotype interaction. P-value< 0.05 is 
shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
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Figure 1. (continued) 
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Supplementary information 
Supplemental Table 1. List of 152 SNPs used in the final QTL mapping 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13475701c 1 0.101 0.101 4486478
rs3696088 1 17.801 21.384 41127587
rs13472794 1 28.501 36.051 67523394
rs13475931 1 37.001 44.353 76665687
rs3670389 1 41.801 51.993 88560363
rs3667720 1 49.501 61.061 120679081
rs3703729 1 54.101 71.657 134380222
rs13476201 1 64.301 84.016 158969249
rs13476229 1 71.301 93.679 169239352
rs3658234 1 72.701 99.299 175004447
rs3666905 1 81.701 112.130 187551710
rs13476312 1 89.901 121.484 193706020
rs13476334c 2 3.176 3.176 7291472
gnf02.013.589 2 12.276 14.075 16612103
gnf02.035.469 2 22.776 27.077 33926782
rs6268714 2 30.676 35.464 57637194
rs13476554 2 39.076 43.046 67097663
rs6345656 2 46.476 48.890 74672761
rs13476636 2 52.076 56.122 91349993
rs3144393 2 68.676 70.425 118272621
rs13476878 2 92.976 91.035 160226215
rs3143843 2 101.676 98.041 169461615
rs6335805 2 112.076 110.897 178995956
rs13477019c 3 7.734 7.734 23242284
rs3663409 3 12.434 15.107 31989790
rs13477132 3 32.634 29.787 57754706
rs13477174 3 38.734 34.080 68244840
rs3670634 3 45.134 42.725 86937167
rs3663873 3 54.834 56.769 109985432
rs13477430 3 77.434 70.816 134895047
rs3724562 3 99.434 84.649 150313284
CEL-3_159340478 3 120.434 93.158 157721197
rs13477622c 4 16.514 16.514 28506701
rs6232550 4 26.414 26.916 41164426
rs3725792 4 30.214 30.376 44148723
rs3715031 4 36.214 37.502 54639377
rs13477745 4 42.114 46.233 64477730
rs3717837 4 50.114 54.794 85074942
mCV23905937 4 57.014 64.559 98478276
rs6324470 4 61.414 69.206 104937019
rs3659226 4 87.114 93.423 140587789
CEL-4_149694865 4 95.914 101.347 150301285
CEL-5_5867251c 5 2.208 2.208 5866538
UT_5_19.849706 5 11.308 9.503 20201136
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs6256504 5 45.708 24.714 38515920
CEL-5_52953963 5 55.108 33.321 53136372
rs3707918 5 64.808 43.343 72127548
rs3720626 5 67.908 50.292 76272435
rs3706737 5 80.308 64.852 96528453
rs13478466 5 86.608 73.634 111798781
CEL-5_117736621 5 92.908 80.048 119400029
gnf05.124.386 5 101.608 87.408 129543594
rs3721911 5 114.408 96.544 138881660
rs6284348 5 118.108 101.586 142681650
rs13478595 5 132.008 110.300 149284218
rs13478602c 6 0.001 0.001 3799841
petM-02094-1 6 6.601 7.058 17707097
rs3678887 6 12.701 13.010 32386962
rs13478727 6 19.001 23.577 43991377
rs13478839 6 32.001 39.724 78161749
rs4226048 6 34.201 45.897 84113292
mCV24115224 6 59.701 66.688 115076942
UT_6_123.37228 6 64.401 72.189 122110793
rs3688358 6 71.401 79.980 132429066
rs3725987 6 76.501 84.123 138352837
rs13479099 6 87.501 93.881 148127251
mCV22975338c 7 11.749 11.749 22376177
rs3719256 7 28.849 23.532 38614565
rs3717846 7 36.749 30.339 58400141
rs3676254 7 42.749 38.005 66569463
rs3656205 7 47.649 45.440 75343354
rs13479422 7 51.949 53.395 91892904
rs13479471 7 57.449 65.046 108991781
rs6275579 7 62.549 71.740 117862298
rs13479657c 8 14.694 14.694 24618506
rs13479757 8 46.894 29.437 50420731
rs13479844 8 56.094 38.394 75473491
rs3678433 8 60.394 45.510 83208899
rs6182338 8 77.894 60.514 106277983
rs13480071c 9 0.372 0.372 12385785
rs13480109 9 6.172 8.209 25783299
rs13480128 9 10.072 16.473 32666876
rs3719607 9 13.872 23.433 37141308
rs8259427 9 18.972 29.955 44998572
rs6213724 9 38.772 52.130 79802975
rs3712946 9 44.972 58.044 94386044
rs3657881 9 51.972 68.561 105214342
rs13480408 9 55.672 73.963 108844971
rs13480429 9 65.272 81.464 113641808
rs13480553c 10 10.818 10.818 25770673
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13480578 10 15.318 17.160 34640648
CEL-10_58149652 10 30.018 27.700 58359416
rs13480647 10 38.718 41.670 72833057
rs3717445 10 42.218 46.578 82879911
rs13480707 10 46.418 54.006 92301690
rs13480754 10 55.818 62.804 107371198
rs13480776 10 64.518 69.333 115607504
rs13480797 10 70.418 76.898 121584553
rs8259806 10 76.918 81.668 127093506
rs13480837c 11 0.201 0.201 3781731
rs6276300 11 11.701 15.322 27142847
rs6199956 11 37.201 30.082 50498109
rs13481054 11 41.701 36.195 59881071
rs3701609 11 49.801 46.592 72989283
rs8270290 11 64.701 64.638 97032985
rs3653651 11 67.601 74.951 101967778
rs13481216 11 71.901 82.153 107232603
rs6407460 11 78.501 90.804 113210907
CEL-11_118234030 11 84.801 96.663 118383994
rs3657682c 12 7.183 7.183 15091125
rs6225272 12 14.783 13.903 27459535
rs3725854 12 38.283 43.151 77999170
rs6288403 12 44.983 50.050 86374922
rs6390948 12 61.583 66.828 104149763
rs3713779 12 67.783 70.502 113105127
rs13481780c 13 17.399 17.399 40759094
rs3678784 13 46.999 32.379 61647402
rs13482096c 14 7.498 7.498 21085575
rs8251329 14 26.998 19.246 49481253
rs3712401 14 35.698 26.516 61778903
rs3709178 14 44.998 39.330 79100609
rs13482404 14 66.798 60.779 116103438
rs13482893c 17 11.306 11.306 13745716
rs3719497 17 19.706 16.339 23308349
rs3023442 17 25.306 22.288 31902550
rs6395919 17 44.706 35.586 48827083
rs6257479 17 64.606 50.679 68982152
rs3663966 17 71.606 57.945 76523597
rs13483140 17 78.506 64.412 82893669
rs3696168 17 83.806 69.866 88281513
rs13483233c 18 7.969 7.969 18327172
rs3723947 18 14.569 16.515 30680245
rs6313313 18 18.369 23.174 41881959
rs3722312 18 24.869 30.130 52561869
rs3670254 18 33.269 36.847 58103478
rs3718618 18 39.369 51.926 69446841
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13483438 18 47.969 59.023 74453057
rs6236348c 19 0.448 0.448 6000609
gnf19.017.711 19 12.148 13.059 19251882
rs13483569 19 18.748 20.231 23009796
rs6237466 19 29.148 29.105 31688846
rs3703185 19 34.548 36.175 38314921
rs8257588 19 40.448 42.991 47414608
mCV24736382 19 48.248 51.488 54414305
rs3718998 19 56.848 57.857 60090097
rs13483724c X 14.914 14.914 30628639
rs13483748 X 23.614 22.853 45251371
CEL-X_91222960 X 39.414 43.283 94420742
rs13483992 X 47.314 55.715 124104620
rs13484003 X 49.214 60.816 127148857
rs13484087 X 61.614 80.594 149574316
 aPosition of markers in Kosambi centimorgans. This column of linkage map is build using 
Cri-map (Green and Crooks, 1990).  
bPosition of markers in Kosambi centimorgans. This column of linkage map is from the 
Wellcome-CTC Mouse Strain SNP Genotype Set 
(http://www.well.ox.au.uk/mouse/INBREDS).  
cPositions of the first marker on each chromosome is from the Wellcome-CTC Mouse Strain 
SNP Genotype Set.   
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Supplemental Table 2. Effects included in the QTL model for traits in this studya 
Effects Muscle AI BMI Body length Transcription and translation Gene expression 
Myostatin genotype (M) * * * * * * 
Sex (S) * * * * * * 
Reciprocal cross (R) * * * * * * 
Coat color (C) * * * * * * 
M * S *    * * 
M * R *    * * 
M * C       
S * R *     * 
S * C *      
R * C *    * * 
M * S * R * * * *  * 
M * S * C * * * *   
M * R * C *    *  
S * R * C *     * 
M * S * R *C *     * 
Group     *  
Plate      * 
Replicate      * 
a A notation of “ *” indicates that the corresponding effect is included in the QTL model. Blank indicates that the corresponding 
effect is not included in the QTL model. 
b Effects in the QTL model. M: myostatin genotype; S: sex; R: reciprocal cross; C: coat color; Group: group effect in DNA, RNA 
and protein isolation; Plate: plate effect in real time PCR experiment; Replicate: replicate effect in real time PCR experiment. 
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Supplemental Figure 1. Information content values of imprinted effects 
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CHAPTER 4. QTL ANALYSIS OF INTERNAL ORGAN WEIGHT IN MICE 
REVEALS IMPRINTING AND INTERACTION EFFECTS 
A paper to be summited to Mammalian Genome 
Ye Cheng, Satyanarayana Rachigani, Jack C Dekkers,  
Mary Sue Mayes, Richard Tait, James M Reecy 
Abstract 
Myostatin is an important regulator of skeletal muscle mass. Our previous QTL 
mapping project utilized F2 mice derived from a myostatin-null C57BL/6 by M16i obese 
mice cross. The results from those studies indicated that a few regions in the mouse genome 
significantly interacted with myostatin genotype to affect growth, skeletal muscle and 
adipose traits. Here, we used the same F2 mapping population from our previous work to 
further explore the genome for loci that interacted with myostatin genotype to impact 
individual organ weights. We detected 18 main effect QTL on chromosomes 1, 2, 4, 5, 9, 10, 
11, 13, 14, 17 and X. Among these QTL, three appear to be imprinted with comparison P-
values less than 0.05. Moreover, six QTL on chromosomes 1, 4, 9 and 17 were identified for 
their significant interaction with myostatin genotype. Our analysis also indicated that seven 
and ten chromosomal positions interact with reciprocal cross and sex effect respectively. 
QTL interaction with myostatin genotype, sex and reciprocal cross could be an important 
contribution to the variation in body composition traits. 
Introduction 
Phenotypic variation in body weights is caused by both genetic and environmental 
factors. Many quantitative trait loci (QTL) that impact body weights have been successfully 
identified (Fisler and Warden 1997; Moody et al. 1999; Morris et al. 1999; Rocha et al. 
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2004a). However, it is still not clear how individual components of body weight are 
influenced by genetic factors due to the limited number of studies that have been conducted. 
The first published study of body composition discussed using genetic markers to predict 
adipose weight and bone size (Castle et al. 1936; Danforth and de Aberle 1927). Most 
research about body composition QTL mainly focused on fat, heart, kidney, liver and spleen 
(Brockmann et al. 1998; Brockmann et al. 2000; Kenney-Hunt et al. 2006; Leamy et al. 2002; 
Moody et al. 1999). It will also be interesting to identify QTL that impact other internal 
organ weights, e.g. lungs, intestines, stomach etc. In addition to the main effect QTL, 
epistatic QTL and sex specific QTL have been reported in mice, chicken and humans to 
affect organ weights (Carlborg et al. 2005; Eisen and Legates 1966; Segal et al. 2009; Wang 
et al. 2006; Weiss et al. 2006; Yi et al. 2006).  
 Myostatin, or GDF-8, was discovered as a new member of transforming growth factor-
beta (TGF-beta) superfamily (McPherron et al. 1997). Myostatin is mainly expressed in 
skeletal muscle as a major regulator of muscle mass. Previous studies on myostatin knockout 
mice demonstrated that a non-functional myostatin gene caused an increase in muscle weight 
and a decrease in fat accumulation (McPherron et al. 1997; McPherron and Lee 2002). 
However, it is unknown how myostatin affects individual organ weights. 
In our previous study, we developed a F2 mouse population to map QTL involved in a 
number of traits, e.g. body weight, fat pad weight and muscle weight etc. These F2 mice 
were derived from a myostatin null C57BL/6 line and M16i (Hanrahan et al. 1973), an obese 
mouse line that exhibits many obesity phenotypes. Our results identified many regions in the 
mouse genome that were associated with those growth and obesity related traits. In addition, 
a few QTL were detected for their significant interaction with myostatin genotype to affect 
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these traits. Since there is a close correlation between organ weights and those previously 
used traits in our study, we hypothesized that organ weight QTL might be also segregating in 
this F2 population.  
Here, we described a QTL study of organ weight traits using this F2 data. In each QTL 
position, we studied the QTL effect by comparing different QTL models including additive, 
dominance or imprinting effects. In addition, the interaction between QTL and myostatin 
genotype, QTL and sex, QTL and reciprocal cross was evaluated. 
Materials and methods 
The mouse lines used in this study included myostatin-null C57BL/6 (McPherron et al. 
1997) and M16i (Hanrahan et al. 1973) mice. Myostatin-null C57BL/6 mice carry non-
functional myostatin genes and as a result are hypermuscled. Detailed information about the 
breeding design, QTL mapping and interaction analysis have been presented in Cheng et al., 
(Ph.D dissertation Chapter 2 and 3).  F2 mice were sacrificed after having its body weight 
recorded at six weeks of age. Subsequently, internal organs (heart, kidney, large intestine, 
liver, pancreas, reproductive organ, small intestine, spleen, stomach, lungs and thymus) were 
collected and weighed. Based on this data, an internal organ weight percentage was 
calculated using the organ weight divided by the 6th week body weight. All animal 
procedures were approved by the Iowa State University Animal Care and Use Committee 
prior to this study. 
Results  and discussion 
Data summary 
 Traits used in the study are summarized in Table 1. Both the normality test and Q-Q 
plots supported that the traits were normally distributed (unpublished results). The 
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phenotypic correlations between traits are present in Table 2. Most traits had significant 
correlations (P-value < 0.05) with one another. Significant fixed effects for each trait were 
identified by Proc GLM and were included in the QTL model (discussed in methods).  
Main effect QTL 
We identified three imprinted (comparison-wise P-value < 0.05, Table 3) and 15 non-
imprinted QTL (5% genome-wide permutation level, Table 4).  
The three imprinted QTL were located on chromosomes 1, 2 and X. The comparison-
wise P-values for testing additive, dominance and imprinting effects are presented in Table 3. 
In particular, the imprinted heart QTL on chromosome 2 had significant additive, dominance 
and imprinting effects (P-value < 0.05).  
The 15 non-imprinted QTL were detected on nine chromosomes (chromosomes 1, 4, 5, 
9, 10, 11, 13, 14 and 17). Chromosome 1 and 17 harbored the greatest number of QTL. No 
genome positions were associated with either pancreas or lung weight. The largest number of 
QTL was associated with kidney weight. The largest two F-values were associated with the 
kidney QTL on chromosome 1 and the thymus QTL on chromosome 14. Except for the small 
intestine QTL on chromosome 9, all traits had comparison P-values less than 0.05 for 
additive QTL effects. The small intestine QTL on chromosome 9 exhibited only a significant 
dominance effect. In addition, the kidney QTL on chromosome 1 and chromosome 4, the 
liver QTL on chromosome 4 and the heart QTL on chromosome 5 had significant additive 
and dominance effects.  
QTL that interacted with myostatin genotype, reciprocal cross and sex  
We identified six, seven and ten chromosomal positions that significantly interacted 
with myostatin genotype, reciprocal cross and sex, respectively (comparison p-value < 0.05) 
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(Table 5). These 23 QTL were located on chromosomes 1, 4, 7, 9, 10, 11, 14, 17, 18 and X. 
In addition, chromosomes 1 and X had the largest number of QTL detected. The highest 
number of QTL was associated with stomach and large intestine weight traits.  
The P-values for three different interaction tests are presented in Table 5. For example, 
we did three different tests to identify QTL by myostatin genotype interactions. The first test 
(am + dm + im) tested the overall interaction, which was a combination of additive QTL by 
myostatin genotype, dominance QTL by myostatin genotype, and imprinted QTL by 
myostatin genotype. The second test (am + dm) tested the non-imprinted interactions, which 
included additive QTL by myostatin genotype and dominance QTL by myostatin genotype. 
The third test (am) tested for an additive QTL by myostatin genotype effect. Some of the 
identified QTL had P-values less than 0.05 for all three tests, e.g. the heart QTL on 
chromosome 9 that interacted with sex (Figure 1a). Other QTL had significant P-values for 
only one or two of these tests. For example, the stomach QTL on chromosome 4 was 
significant for the overall and non-imprinted interaction with myostatin genotype (Figure 1b). 
Whereas, the pancreas QTL on chromosome X was significant for the overall interaction 
with reciprocal cross effect only (Figure 1c).     
Phenotypic variation analyses 
 The amount of phenotypic variation accounted for by the imprinted QTL is presented 
in Table 3. At each QTL position, the amount of variation associated with additive, 
dominance or imprinted QTL  was also computed.  
 The amount of variation that could be explained by the additive and dominance effects 
of the non-imprinted QTL are presented in Table 4. Among all these QTL, the thymus QTL 
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on chromosome 14 accounted for the largest amount of phenotypic variation. Moreover, 
nearly all the explained variation at this position was attributed to the additive QTL effect. 
 In Table 5, we computed the phenotypic variation accounted for by QTL that interacted 
with myostatin genotype, reciprocal cross and sex. At each QTL position, this variation was 
computed as the variation caused by the overall interaction, the non-imprinting interaction 
and the additive interaction. The variation from overall interaction ranged from 0.45% to 
2.61%. Specifically, the overall QTL by sex interaction effect from the large intestine QTL 
on chromosome X explained the largest amount of overall phenotypic variation. 
 A stacked histogram was graphed to summarize the variation accounted for by different 
variation components (Figure 2). The amount of phenotypic variation explained by all 
identified QTL is shown for each trait. QTL that were associated with stomach weight 
accounted for the most amount of variation. However, the QTL we identified for Liver and 
small intestine weights could only explain a small proportion of the total variation in these 
traits.  
Discussion  
 We preformed a QTL scan to identify genomic regions that harbor genetic variants that 
influence internal organs weights in this study. Many of the traits we measured here had 
never been studied before. Previous studies of body composition traits mainly focused on the 
weight of heart, spleen, kidney, liver and fat pads due to their biological importance and 
relatively large weight proportion. Here we analyzed a large number of internal organs with 
the aim to identify genetic factors that controlled individual components of body weight.  
Imprinted QTL 
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We identified three imprinted QTL that had a comparison P-value less than 0.05. One 
of these QTL, heart QTL on chromosome 2, was previously discovered as a main effect QTL 
in a large sample QTL study (Rocha et al. 2004a). This study also used M16i as one of the 
founder stains to construct the mapping population. However, the QTL was associated with 
the direct heart weight in their study while the weight was normalized by the 6th week body 
weight in our study. The reason for normalizing the direct weight was that a small number of 
QTL could be identified if we used the direct weight. Normalizing the data by the body 
weight also helped to eliminate some of the noise in the data and thus increase the mapping 
power.  
In another study examining imprinting on body composition traits in mice (Cheverud et 
al. 2008), they discovered only one imprinted QTL over a genome-wide significance level. 
Another 13 imprinted QTL were significant at a chromosome-wide level. They suggested 
that the use of chromosome-wide significance level might help to avoid false positive 
according to the work done by (Chen and Storey 2006). It would be interesting to compare 
the results of mapping body composition traits by using different methods to set up the 
significance level. Unfortunately, Cheverud’s and our study performed the QTL mapping in 
different mapping populations. The traits we analyzed were different as well. We suggest that 
comparing the results in the same QTL mapping data by different significance levels might 
help to find a more appropriate significance level. Although we have not performed such a 
comparison, a comparison P-value might still be a good choice to set up the significance 
level according to the results in this study.  
Additive and dominance QTL 
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 We identified 15 non-imprinted QTL with 5% genome-wide significance level. Among 
these 15 QTL, several QTL were located in the same genomic regions as other body 
composition QTL that were previously discovered. For example, the positions of the kidney 
weight QTL on chromosome 4 and the spleen weight QTL on chromosome 9 were in 
agreement with QTL detected by (Rocha et al. 2004b). The kidney QTL on chromosome 1 
had been mapped to the same position in previous QTL studies (Brockmann et al. 2004; 
Leamy et al. 2002).  
 We estimated the additive and dominance effects associated with each QTL position. 
In our study, more than half of the QTL had a more statistically significant additive effect 
than a dominance effect. This was also reflected in the fact that the additive estimates were 
often larger than the dominance estimates. In contrast, Rocha et al. (2003) reported very 
similar additive and dominance estimates. In addition, their QTL were able to explain more 
phenotypic variation than our QTL. However, we used 6 week old mice as compared to 10 
week old mice in Rocha et al., (2003). The additive and dominance estimates of QTL 
identified in our study were almost the same order of magnitude as the body composition 
QTL estimates from (Rance et al. 2005). Moreover, the estimates of body composition QTL 
were much smaller in Leamy et al. (2002). Because each of the studies used different lines of 
mice, it was very possible that different QTL were segregating in the populations and each 
QTL had a different impact on the phenotypic values. Furthermore, as mentioned before, 
several traits used in this study, e.g. lungs, reproductive organs, have rarely been measured in 
previous QTL studies. Therefore, we could not compare the effect size of the QTL with other 
studies.  
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The most important point was that we did find a few regions within the genome that 
were associated with organ weights. This supported our hypothesis that there were indeed 
genetic factors that control these traits. Additional fine mapping in these regions will help to 
confirm these results and provide some knowledge to build a molecular connection between 
organ weights and body weights. 
Interactions with myostatin genotype, sex and reciprocal cross effect 
 We analyzed the interactions between QTL and myostatin genotype, sex or reciprocal 
cross in this study. These interaction effects were significant for many organ weight traits 
measured here. To the best of our knowledge, testing the interaction between QTL and 
myostatin genotype had not be been discussed in other body composition QTL studies. In 
addition to that, the way that interaction with myostatin genotype might affect organ weights 
has been seldom seen in the literature. Previous findings found that the myostatin gene was 
expressed in muscle and adipose tissue (Lee 2004). It is also known that liver is an important 
tissue for fatty acid synthesis and that the heart is mainly composed of muscle fiber. 
Therefore, it is expected that there might exist an interaction between the weights of these 
two organs and myostatin genotype. One finding that could support this hypothesis is from 
(Bunger et al. 2004). They noticed that myostatin null mice had reduced weights of liver, 
heart, kidney and digestive tract, but they did not look into the effect of myostatin gene on 
other internal organs. 
In this study, seven QTL were shown to have a significant interaction with myostatin 
genotype. The phenotypic variation accounted for by these QTL was similar to that from the 
main effect QTL identified. This could be evidence to support the importance of QTL by 
myostatin interaction in controlling organ weights. In addition, among these six QTL, one 
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affected liver weight, two affected kidney weight, one affected reproductive organ weight 
and the other two affected stomach and small intestine weight. Therefore, myostatin might 
still have an impact on other internal organs although a significant expression of myostatin in 
these organs could not be detected. This interaction could be realized though other mediator 
factors or circulating myostatin in the blood. If the causal mutation underlying these QTL 
could be identified, this would provide more detailed information for us to gain a more 
complete picture of the myostatin gene pathway. 
We identified ten and six QTL positions that had a significant interaction with sex and 
reciprocal cross, respectively. Sex and strain effects for spleen, liver, heart and kidney have 
been previously reported (Reed et al. 2008). Sex interaction might indicate sex-dependent 
gene expression. Reciprocal cross interactions could be caused by genetic variation in 
mitochondrial or Y chromosome DNA.  
We further tested three different interaction models (overall interaction model, non-
imprinted interaction model, and an additive interaction model) to each QTL position. 
Analysis of these three types of interactions gave more information about how these QTL 
interactions may function, e.g. additive vs. imprinted. Due to limited options provided in 
GridQTL, we did not directly test the interaction between imprinted QTL and fixed effects 
(myostatin, sex or reciprocal cross), or the interaction between dominance QTL effect and 
fixed effect. However, these results at least provide an estimate about genetic mechanism by 
which each interaction might operate. 
 In addition, we computed the phenotypic variation explained by QTL by myostatin 
genotype interaction, QTL by sex interaction and QTL by reciprocal cross interaction. The 
average amount of variation that these three different types of interactions could account for 
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were very similar, even though QTL by sex interactions accounted for a little bit more 
amount of variation. For some traits, e.g. large intestine, pancreas and reproductive organ 
weight, the sum of phenotypic variation from the different types of interactions was very 
close or even larger than the variation from the sum of additive, dominance and imprinting 
effects. This provided strong support for the importance of interaction between QTL and 
myostatin genotype, QTL and sex, QTL and reciprocal cross in body composition. 
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Tables  
Table 1. Summary statistics for phenotype traits in this study 
Traits Mean S.D Range 
Stomach 1.849 0.599 0.305-5.815 
Lintestine 3.244 0.784 0.084-7.697 
Sintestine 5.339 0.987 2.185-8.733 
Spleen 0.465 0.187 0.190-4.525 
Pancreas 0.799 0.360 0.212-4.585 
Liver 5.110 0.781 0.891-8.319 
Heart 0.638 0.118 0.368-1.083 
Lungs 0.844 0.181 0.389-2.462 
Thymus 0.326 0.119 0.074-0.800 
Kidney 0.664 0.113 0.331-1.084 
Ovary 0.697 0.307 0.134-2.674 
Testis 0.612 0.195 0.213-2.201 
a Lintestine (large intestine); Sintestine (small intestine). Phenotypic values used here were 
computed as the corresponding organ weights (gram) divided by the 6th week body weight 
(gram). 
b S.D: standard deviation 
c Range: minimum - maximum 
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Table 2. Pearson correlation coefficients among traits in this studya 
Traitsa Stomach Lintestine Sintestine Spleen Pancreas Liver Heart Lungs Thymus Kidney Ovary Testis 
Stomach 1.000 0.309** 0.32** 0.268 0.163** 0.198** 0.264** 0.093* 0.164** 0.148** 0.014 0.167* 
Lintestine  1.000  -0.031  -0.002 0.468** 0.061 0.334** 0.162** 0.269** 0.143** 0.054 0.258**
Sintestine   1.000  0.239** -0.269** 0.350** 0.133** 0.317** 0.396** 0.222* 0.162* 0.350**
Spleen    1.000 -0.08* 0.159** 0.056 0.141** 0.201** 0.063* 0.107* 0.002 
Pancreas     1.000  -0.013 0.374** 0.081* 0.134** 0.178** 0.103* 0.216**
Liver       1.000 0.238** 0.088* -0.042 0.673** 0.301** 0.504**
Heart       1.000 0.236** 0.176** 0.350** 0.166* 0.381**
Lungs        1.000  0.385** 0.076* 0.095* 0.263**
Thymus         1.000 -0.128** 0.228** -0.013 
Kidney          1.000  0.319** 0.632**
Ovary           1.000 - 
Testis                       1.000 
a P-value for testing for significant correlation. **: P < 0.0001; *: 0.0001 < P < 0.05; otherwise, P > 0.05. A “-“ notation denotes 
the correlation coefficient is not computed. 
b Same abbreviations for traits as in Table 1 are used here. 
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Table 3. Statistics of imprinted QTL 
Peak Flanking P-valued Estimatese %varf MMU Traitsa 
(cM)b 
F-value 
Markersc a d i a d i a d i 
1 Sintestine 25 7.32 rs3696088 4.75E-03 3.24E-01 3.62E-04 0.2008 0.1578 -0.5291 0.8151  0.0983 1.2772 
    rs13472794    (0.0740) (0.0980) (0.1478)    
2 Heart 53 9.74 rs13476636 1.05E-04 3.90E-02 8.12E-03 -0.0203 0.0156 0.0251 1.5188  0.4265 0.7025 
    rs3144393    (0.0051) (0.0071) (0.0094)    
X Stomach 15 12.61 rs13483724 7.96E-01 6.3E-07 5.36E-03 0.0778 0.3126 0.1703 0.0068  2.4966 0.7733 
       rs13483748    (0.0320) (0.0716) (0.0608)       
a Trait abbreviations are the same as in Table 1.  
b Peak position of QTL detected in Kosambi centimorgans.  
c Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
d P-value for testing additive, dominance and imprinting effects. a: additive effect; d: dominance effect; i: imprinting effect. 
e Estimates for additive effect, dominance and imprinting effects. The corresponding standard errors are in parenthesis.  
f %var: percentage of phenotypic variation accounted for by the additive, dominance and imprinting effects. 
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Table 4. Statistics of non-imprinted QTL 
Peak P-value %vard Estimatese MMU Traitsa 
(cM)b 
F-value Flanking Markersc
p (a) p (d) va vd a d 
1 Testis 25.101 13.54 rs3696088 6.10E-10 9.12E-01 7.3932 0.0023 0.0992 -0.0023
    rs13472794     (0.0157) (0.0217)
1 Kidney 22.101 16.68 rs3696088 1.02E-05 2.62E-04 1.9630 1.3220 0.0249 0.0282
    rs13472794     (0.0056) (0.0077)
1 Liver 27.101 6.26 rs3696088 2.65E-02 2.16E-04 0.4997 1.3780 0.1070 0.2173
    rs13472794     (0.0471) (0.0585)
4 Kidney 67.514 7.53 rs6324470 2.73E-05 3.46E-02 1.7753 0.4457 0.0140 0.0113
    rs3659226     (0.0033) (0.0054)
5 Heart 58.208 9.13 CEL-5_52953963 3.74E-02 2.09E-04 0.4400 1.3853 -0.0122 -0.0279
    rs3707918     (0.0050) (0.0075)
9 Sintestine 11.372 7.81 rs13480128 3.18E-01 2.48E-06 0.1013 2.2321 -0.0424 0.2614
    rs3719607     (0.0390) (0.0551)
9 Spleen 53.372 7.67 rs3657881 2.12E-04 2.20E-01 1.3870 0.1510 0.0317 -0.0149
    rs13480408     (0.0086) (0.0122)
10 Kidney 55.818 8.83 rs13480754 9.07E-05 1.40E-01 1.5474 0.2178 0.0199 0.0066
    rs13480776     (0.0030) (0.0044)
11 Liver 63.201 7.14 rs3701609 1.97E-05 8.48E-02 1.8371 0.2966 0.1157 -0.0678
    rs8270290     (0.0269) (0.0393)
13 Thymus 46.339 8.71 rs13481780 3.29E-05 8.40E-01 1.7396 0.0041 0.0168 0.0011
    rs3678784     (0.0040) (0.0057)
14 Lintestine 30.498 9.59 rs8251329 3.31E-05 1.83E-01 1.7386 0.1775 -0.1659 -0.0783
    rs3712401     (0.0391) (0.0587)
14 Thymus 39.498 14.37 rs3712401 8.89E-11 8.13E-01 4.1898 0.0055 -0.0278 0.0014
    rs3709178     (0.0042) (0.0061)
17 Stomach 11.306 10.52 rs13482893 4.97E-06 9.30E-01 2.0974 0.0008 0.1312 0.0347
    rs3719497     (0.0288) (0.0454)
17 Sintestine 38.306 6.28 rs3023442 1.57E-05 8.76E-01 1.8803 0.0024 0.1881 0.0111
    rs6395919     (0.0433) (0.0714)
17 Kidney 56.306 10.25 rs6395919 6.60E-06 1.00E+00 2.0457 0.0000 0.0151 0.0000
    rs6257479     (0.0033) (0.0054)
a Traits abbreviations are the same as in Table 1. 
b Peak position of QTL detected in Kosambi centimorgans.  
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c Flanking markers (left and right) of the QTL peak. See Supplemental Table 1 for marker information. 
d P-value for testing additive and dominance effects. a: additive effect; d: dominance effect. 
e Estimates for additive effect and dominance effects. The corresponding standard errors are in parenthesis.  
f %var: percentage of phenotypic variance accounted for by additive and dominance. 
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Table 5. Statistics of QTL that interacted with myostatin, reciprocal cross and sex 
Position Traitsb Factor Flanking markersc AM+DM+IM AM+DM AM MMU 
(cM)a     Left Right P Var% P Var% P Var%
1 20 Thymus Sex rs3696088 rs13472794 1.49E-02 1.05 6.44E-03 1.01 2.86E-02 0.49
1 22 Kidney Mstn rs3696088 rs13472794 9.83E-04 1.60 2.47E-01 0.28 2.26E-04 1.35
1 25 Liver Mstn rs3696088 rs13472794 1.17E-03 1.59 4.07E-04 1.55 1.09E-02 0.65
1 25 Testis Mstn rs3696088 rs13472794 5.78E-02 1.39 6.12E-01 1.44 2.03E-02 0.05
1 25 Sintestine Cross rs3696088 rs13472794 1.60E-02 1.03 1.39E-02 0.86 2.99E-01 0.11
1 27 Liver Cross rs3696088 rs13472794 7.00E-02 0.71 3.98E-02 0.64 3.65E-03 0.85
4 52 Stomach Mstn rs3717837 mCV23905937 1.07E-02 1.12 4.50E-02 0.63 2.13E-01 0.16
6 0 Testis Mstn rs13478602 petM-02094-1 9.79E-03 2.27 1.72E-02 2.24 3.51E-03 1.13
7 46 Stomach Sex rs3676254 rs3656205 4.63E-02 0.80 2.15E-02 0.77 7.79E-03 0.71
9 10 Sintestine Mstn rs13480128 rs3719607 6.15E-02 0.73 4.11E-02 0.63 1.17E-01 0.25
9 13 Sintestine Sex rs13480128 rs3719607 8.95E-02 0.65 3.90E-02 0.65 2.75E-02 0.49
9 51 Heart Sex rs3712946 rs3657881 1.78E-05 2.47 4.93E-06 2.45 1.47E-05 1.89
10 56 Kidney Cross rs13480707 rs13480754 3.47E-02 0.87 9.63E-01 0.01 1.00E+00 0.00
11 51 Stomach Sex rs3701609 rs8270290 1.02E-02 1.13 3.86E-03 1.11 1.27E-01 0.23
14 27 Lintestine Sex rs8251329 rs3712401 4.55E-02 0.80 2.47E-02 0.74 9.98E-03 0.66
17 57 Kidney Mstn rs6395919 rs6257479 6.69E-02 0.71 6.08E-02 0.56 2.22E-02 0.52
18 25 Lintestine Cross rs3722312 rs3670254 1.61E-01 0.52 8.15E-02 0.50 4.03E-02 0.42
X 15 Stomach Sex - rs13483724 2.04E-01 0.45 3.34E-02 0.67 1.02E-05 1.96
X 41 Liver Sex CEL-X_91222960 rs13483992 6.22E-03 1.24 1.51E-03 1.31 7.31E-01 0.01
X 47 Lintestine Cross CEL-X_91222960 rs13483992 1.21E-02 1.10 4.51E-01 0.16 5.37E-01 0.04
X 57 Lintestine Sex rs13484003 rs13484087 8.95E-06 2.61 4.75E-04 1.54 2.87E-02 0.49
X 60 Pancreas Sex rs13484003 rs13484087 3.61E-05 2.33 4.79E-03 1.08 5.65E-02 0.37
X 61 Pancreas Cross rs13484003 rs13484087 2.77E-02 0.92 2.59E-01 0.27 2.43E-01 0.14
a Traits abbreviations are the same as in Table 1.  
b Peak position of QTL detected in Kosambi centimorgans.  
c Interaction factors: Mstn (myostatin genotype); Cross (reciprocal cross); Sex (sex).  
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d Flanking markers (left and right) of the QTL peak. A “-“ notation denotes the end of the chromosome. See Supplemental Table 1 
for marker information. 
e Comparison P-value for testing interaction effect. am: additive QTL interaction; dm: dominance QTL interaction; im: imprinting 
QTL interaction. P-value< 0.05 is shown in bold type. %var: percentage of phenotypic variance accounted for at QTL position. 
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Figure Captions 
Figure 1. QTL that interacted with (a) sex , (b) myostatin genotype and (c) reciprocal 
cross 
(a) QTL on chromosome 9  at 51cM that interacted with sex to control heart weight. 
(b) QTL on chromosome 4 at 52cM that interacted myostatin genotype to control stomach 
weight. 
(c) QTL on chromosome X at 46cM that interacted with reciprocal cross to control 
pancreas weight. 
Figure 2. Phenotypic variation components 
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Figures 
Figure 1. QTL that interacted with (a) sex , (b) myostatin genotype and (c) reciprocal 
cross 
(a) QTL on chromosome 9  at 51cM that interacted with sex to control heart weight. 
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Figure 1. (continued) 
(b) QTL on chromosome 4 at 52cM that interacted myostatin genotype to control stomach 
weight. 
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Figure 1. (continued) 
(c) QTL on chromosome X at 46cM that interacted with reciprocal cross to control pancreas 
weight. 
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IMP: imprinting QTL model 
AD: additive and dominance QTL model 
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Figure 2. Phenotypic variation components 
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Traits abbreviations are the same as in Table 1.  
%var: percentage of phenotypic variance accounted for by additive (A), dominance (D), 
imprinting (I), interaction with reciprocal cross (cross), sex (sex) and myostatin genotype 
(mstn) effects. 
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Supplementary information 
Supplemental Table 1. List of 152 SNPs used in the final QTL mapping 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13475701c 1 0.101 0.101 4486478
rs3696088 1 17.801 21.384 41127587
rs13472794 1 28.501 36.051 67523394
rs13475931 1 37.001 44.353 76665687
rs3670389 1 41.801 51.993 88560363
rs3667720 1 49.501 61.061 120679081
rs3703729 1 54.101 71.657 134380222
rs13476201 1 64.301 84.016 158969249
rs13476229 1 71.301 93.679 169239352
rs3658234 1 72.701 99.299 175004447
rs3666905 1 81.701 112.130 187551710
rs13476312 1 89.901 121.484 193706020
rs13476334c 2 3.176 3.176 7291472
gnf02.013.589 2 12.276 14.075 16612103
gnf02.035.469 2 22.776 27.077 33926782
rs6268714 2 30.676 35.464 57637194
rs13476554 2 39.076 43.046 67097663
rs6345656 2 46.476 48.890 74672761
rs13476636 2 52.076 56.122 91349993
rs3144393 2 68.676 70.425 118272621
rs13476878 2 92.976 91.035 160226215
rs3143843 2 101.676 98.041 169461615
rs6335805 2 112.076 110.897 178995956
rs13477019c 3 7.734 7.734 23242284
rs3663409 3 12.434 15.107 31989790
rs13477132 3 32.634 29.787 57754706
rs13477174 3 38.734 34.080 68244840
rs3670634 3 45.134 42.725 86937167
rs3663873 3 54.834 56.769 109985432
rs13477430 3 77.434 70.816 134895047
rs3724562 3 99.434 84.649 150313284
CEL-3_159340478 3 120.434 93.158 157721197
rs13477622c 4 16.514 16.514 28506701
rs6232550 4 26.414 26.916 41164426
rs3725792 4 30.214 30.376 44148723
rs3715031 4 36.214 37.502 54639377
rs13477745 4 42.114 46.233 64477730
rs3717837 4 50.114 54.794 85074942
mCV23905937 4 57.014 64.559 98478276
rs6324470 4 61.414 69.206 104937019
rs3659226 4 87.114 93.423 140587789
CEL-4_149694865 4 95.914 101.347 150301285
CEL-5_5867251c 5 2.208 2.208 5866538
UT_5_19.849706 5 11.308 9.503 20201136
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs6256504 5 45.708 24.714 38515920
CEL-5_52953963 5 55.108 33.321 53136372
rs3707918 5 64.808 43.343 72127548
rs3720626 5 67.908 50.292 76272435
rs3706737 5 80.308 64.852 96528453
rs13478466 5 86.608 73.634 111798781
CEL-5_117736621 5 92.908 80.048 119400029
gnf05.124.386 5 101.608 87.408 129543594
rs3721911 5 114.408 96.544 138881660
rs6284348 5 118.108 101.586 142681650
rs13478595 5 132.008 110.300 149284218
rs13478602c 6 0.001 0.001 3799841
petM-02094-1 6 6.601 7.058 17707097
rs3678887 6 12.701 13.010 32386962
rs13478727 6 19.001 23.577 43991377
rs13478839 6 32.001 39.724 78161749
rs4226048 6 34.201 45.897 84113292
mCV24115224 6 59.701 66.688 115076942
UT_6_123.37228 6 64.401 72.189 122110793
rs3688358 6 71.401 79.980 132429066
rs3725987 6 76.501 84.123 138352837
rs13479099 6 87.501 93.881 148127251
mCV22975338c 7 11.749 11.749 22376177
rs3719256 7 28.849 23.532 38614565
rs3717846 7 36.749 30.339 58400141
rs3676254 7 42.749 38.005 66569463
rs3656205 7 47.649 45.440 75343354
rs13479422 7 51.949 53.395 91892904
rs13479471 7 57.449 65.046 108991781
rs6275579 7 62.549 71.740 117862298
rs13479657c 8 14.694 14.694 24618506
rs13479757 8 46.894 29.437 50420731
rs13479844 8 56.094 38.394 75473491
rs3678433 8 60.394 45.510 83208899
rs6182338 8 77.894 60.514 106277983
rs13480071c 9 0.372 0.372 12385785
rs13480109 9 6.172 8.209 25783299
rs13480128 9 10.072 16.473 32666876
rs3719607 9 13.872 23.433 37141308
rs8259427 9 18.972 29.955 44998572
rs6213724 9 38.772 52.130 79802975
rs3712946 9 44.972 58.044 94386044
rs3657881 9 51.972 68.561 105214342
rs13480408 9 55.672 73.963 108844971
rs13480429 9 65.272 81.464 113641808
rs13480553c 10 10.818 10.818 25770673
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13480578 10 15.318 17.160 34640648
CEL-10_58149652 10 30.018 27.700 58359416
rs13480647 10 38.718 41.670 72833057
rs3717445 10 42.218 46.578 82879911
rs13480707 10 46.418 54.006 92301690
rs13480754 10 55.818 62.804 107371198
rs13480776 10 64.518 69.333 115607504
rs13480797 10 70.418 76.898 121584553
rs8259806 10 76.918 81.668 127093506
rs13480837c 11 0.201 0.201 3781731
rs6276300 11 11.701 15.322 27142847
rs6199956 11 37.201 30.082 50498109
rs13481054 11 41.701 36.195 59881071
rs3701609 11 49.801 46.592 72989283
rs8270290 11 64.701 64.638 97032985
rs3653651 11 67.601 74.951 101967778
rs13481216 11 71.901 82.153 107232603
rs6407460 11 78.501 90.804 113210907
CEL-11_118234030 11 84.801 96.663 118383994
rs3657682c 12 7.183 7.183 15091125
rs6225272 12 14.783 13.903 27459535
rs3725854 12 38.283 43.151 77999170
rs6288403 12 44.983 50.050 86374922
rs6390948 12 61.583 66.828 104149763
rs3713779 12 67.783 70.502 113105127
rs13481780c 13 17.399 17.399 40759094
rs3678784 13 46.999 32.379 61647402
rs13482096c 14 7.498 7.498 21085575
rs8251329 14 26.998 19.246 49481253
rs3712401 14 35.698 26.516 61778903
rs3709178 14 44.998 39.330 79100609
rs13482404 14 66.798 60.779 116103438
rs13482893c 17 11.306 11.306 13745716
rs3719497 17 19.706 16.339 23308349
rs3023442 17 25.306 22.288 31902550
rs6395919 17 44.706 35.586 48827083
rs6257479 17 64.606 50.679 68982152
rs3663966 17 71.606 57.945 76523597
rs13483140 17 78.506 64.412 82893669
rs3696168 17 83.806 69.866 88281513
rs13483233c 18 7.969 7.969 18327172
rs3723947 18 14.569 16.515 30680245
rs6313313 18 18.369 23.174 41881959
rs3722312 18 24.869 30.130 52561869
rs3670254 18 33.269 36.847 58103478
rs3718618 18 39.369 51.926 69446841
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Supplemental Table 1. (continued) 
SNP name MMU cM (Crimap)a cMb Map Locationc
rs13483438 18 47.969 59.023 74453057
rs6236348c 19 0.448 0.448 6000609
gnf19.017.711 19 12.148 13.059 19251882
rs13483569 19 18.748 20.231 23009796
rs6237466 19 29.148 29.105 31688846
rs3703185 19 34.548 36.175 38314921
rs8257588 19 40.448 42.991 47414608
mCV24736382 19 48.248 51.488 54414305
rs3718998 19 56.848 57.857 60090097
rs13483724c X 14.914 14.914 30628639
rs13483748 X 23.614 22.853 45251371
CEL-X_91222960 X 39.414 43.283 94420742
rs13483992 X 47.314 55.715 124104620
rs13484003 X 49.214 60.816 127148857
rs13484087 X 61.614 80.594 149574316
 aPosition of markers in Kosambi centimorgans. This column of linkage map is build using 
Cri-map (Green and Crooks, 1990).  
bPosition of markers in Kosambi centimorgans. This column of linkage map is from the 
Wellcome-CTC Mouse Strain SNP Genotype Set 
(http://www.well.ox.au.uk/mouse/INBREDS).  
cPositions of the first marker on each chromosome is from the Wellcome-CTC Mouse Strain 
SNP Genotype Set.   
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CHAPTER 5. IDENTIFICATION OF INTERACTING QTL THAT CONTROL 
BONE STRENGTH TRAITS IN MICE 
A paper to be summited to Genetics Notes 
Ye Cheng, Satyanarayana Rachigani, Jack C Dekkers,  
Mary Sue Mayes, Richard Tait, James M Reecy 
Abstract 
 In this study, quantitative trait loci (QTL) for bone strength were mapped in 1000 F2 
mice, which were derived by crossing C57BL/6 myostatin-null by M16i polygenic obese 
mice. Six main effect QTL, including one imprinted QTL, were identified at a 5% 
genome-wise significance level. Numerous QTL that interacted with sex, cross or myostatin 
genotype were also detected. It appears that epistatic interaction controls bone strength traits 
in mice. 
Introduction 
Bone strength measures bone resistance to the exerted force. It has been estimated that 
bone mineral density (BMD) could explain about 60% of the variation in bone compression 
strength (WEINSTEIN 2000). Other studies also indicate that BMD is associated with bone 
fracture risk (CUMMINGS et al. 1985; MELTON et al. 1989). Therefore, QTL research about 
bone strength has focused on BMD (BEAMER et al. 1999; BENES et al. 2000; KLEIN et al. 
1998; KOLLER et al. 2000; SHIMIZU et al. 1999).  
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In addition to BMD, another important measurement of bone strength is femur breaking 
strength (FBS). FBS measures the maximum force that a bone can bear before it breaks. 
Studies of mapping QTL on FBS in mice indicate that these QTL might account for part of 
the variation in bone strength (LI et al. 2002; YU et al. 2009). The remaining proportion of 
the phenotypic variation in bone strength might be explained by factors besides single gene 
effects or undetected QTL. For example, epistatic and sex-specific QTL have been identified 
for bone strength traits (LI et al. 2002; ORWOLL et al. 2001).  
Previous literature demonstrates that muscle mass imposes a large amount of force on 
bones (BURR 1997). GDF-8, also known as myostatin, regulates the growth of skeletal 
muscle growth. To investigate the potential role of myostatin on bones, the bone mass was 
measured in myostatin null mice (HAMRICK et al. 2003). They found that myostatin null 
animals had an increase in bone mass. Moreover, another study indicated that myostatin 
deficient mice had an increase in bone strength (HAMRICK et al. 2006). However, it is still 
unknown whether there is any epistatic interaction with myostatin to regulate bone strength.   
The objective of this study was to identify bone strength QTL in the F2 mice derived 
from myostatin null C57BL/6 and M16i polygenic obese mice. More importantly, we 
investigated the presence of interactions between bone strength QTL and myostatin genotype, 
with the aim to provide candidate regions for fine mapping these epistatic QTL. Interactions 
of QTL by sex and by reciprocal cross, and QTL imprinting effects were also analyzed. 
Results and Discussion 
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After fitting a linear model to the full F2 phenotype data, we found the most appropriate 
statistical model, which included the fixed effects of myostatin genotype, sex, reciprocal 
cross, color, sex by myostatin genotype interaction, myostatin genotype by color interaction, 
myostatin by reciprocal cross interaction, sex by myostatin genotype by cross interaction, and 
myostatin by color by reciprocal cross interaction. 
We identified six main effect QTL using a whole genome scan that utilized the full data 
set (Table 1). Among these six QTL, five had a significant impact on the maximum tolerated 
force (AvgForce2). Except for the two QTL on chromosome 11 and 18, all QTL were 
significant at the 1% genome-wise significance threshold. Compared with previous studies of 
bone strength QTL, the position of the QTL on chromosome 2 was close to the femur 
breaking strength QTL 1 (Fembrs1) that was reported by Li et al. 2002. Despite the QTL 
name difference, these QTL actually measured the same phenotype. The QTL on 
chromosome 11 overlapped with a previously discovered femur mechanical trait QTL 14 
(Fmtq14) (WERGEDAL et al. 2006). The average phenotypic variation accounted for by these 
six QTL was about 2.28%, with a minimum of 1.75% and a maximum of 2.84%. 
The QTL on chromosome 11 that affected AvgForce 2 exhibited an imprinting effect 
with a comparison-wise P-value of 0.022. Further testing of this QTL indicated that it also 
had significant additive and dominance effects, with comparison P-values of 0.022 and 0.012, 
respectively. This QTL had been previously identified (WERGEDAL et al. 2006) for its 
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significant additive and dominance effect. To the best of our knowledge, this might be the 
first imprinted QLT for bone strength to be documented in the mouse. 
In this study, significant interactions of QTL with myostatin genotype, reciprocal cross, 
sex effects were detected (Table 2). For example, one QTL on chromosome 4 significantly 
interacted with myostatin genotype to control AvgForce1, a measure of bone elasticity. 
However, no QTL by myostatin genotype interaction was detected on this chromosome that 
affected body weight or muscle mass traits. Bone elasticity and muscle mass were two key 
factors that impacted bone strength. Therefore, the results here suggested that this QTL by 
myostatin interaction could affect bone strength only via its influence on bone elasticity. 
Some independent regulation pathway might exist for bone elasticity. 
In addition, three QTL on chromosomes 4, 6 and 8 significantly interacted with 
reciprocal cross to control bone stiffness (AvgGrad) and AvgForce2. The phenotypic 
variation accounted for by these QTL ranged from 1% to 1.25%. The most significant 
P-value was from the QTL on chromosome 6 that was associated with sex interaction on 
AvgForce2. Sex-specific bone strength QTL have been reported in other studies in mice. For 
example, five female-specific and six male-specific BMD QTL were identified by Orwoll et 
al. 2001. Furthermore, other studies support the existence of sex-specific QTL on mouse 
chromosomes 1 and 11 (TURNER et al. 2003). In humans, there is a known difference of 
osteoporosis rates between males and females, but the genetic mechanism underlying it is not 
clear. Therefore, the knowledge gained from the sex interaction in mice study will be useful 
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to elucidate this. 
In conclusion, this study identified five additive and dominance QTL, and one imprinted 
QTL for bone strength traits. Significant interactions were detected between QTL and the 
myostatin genotype, which affect bone elasticity. In addition, interactions of QTL with sex 
and reciprocal cross explained some of the phenotypic variation in these traits. Some of these 
QTL were novel and the results indicated that some regions in the genome might interact 
with myostatin to affect bone strength.  
We would like to thank Dr. Daniel Pomp for providing the M16i mice used in our 
study and technical insights. This research was supported by grants from the USDA CSREES 
2006-35205-16696. 
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Table 1. Statistics of main effect bone strength QTL 
Traitsa MMU Position F LOD Flanking markersc %vard 
  (cM)b   Left Right  
AvgForce2  2 75 11.95 5.12 rs3144393 rs13476878 2.540 
AvgForce2  6 69 10.52 4.52 UT_6_123.37228 rs3688358 2.242 
AvgForce2  8 71 13.40 5.73 rs3678433 rs6182338 2.839 
AvgForce2 11 27 7.04 4.53 rs6276300 rs6199956 2.252 
AvgForce2 18 9 8.16 3.51 rs13483233 rs3723947 1.748 
AvgForce1 X 40 9.74 4.19 CEL-X_91222960 rs13483992 2.080 
a AvgGrad: stifness (Newton/second); AvgForce1: stress at maximum load (Newton); AvgForce2: maximum tolerated force 
(Newton). The imprinted QTL was in bold type. 
b Chr: mouse chromosome.  
c Peak position of QTL detected in Kosambi centimorgans. d Flanking markers (left and right) of the QTL peak.  
e Flanking markers (left and right) of the QTL peak.  
Materials and Methods: The mapping population consisted of F2 mice derived from the crossing of myostatin null C57BL/6 line 
(MCPHERRON et al. 1997) and M16i obese mouse line (HANRAHAN et al. 1973). Detailed information about the breeding design 
and the QTL mapping and interaction analysis are in Cheng et al., (Ph.D dissertation Chapters 2 and 3). F2 homozygotes were 
raised until six weeks of age. The mice were sacrificed and femurs were collected from both the left and right side. Bone strength 
of each femur was measured by three-point bending using a TA-XT2i Texture Analyzer system (Texture Technologies Corp., 
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Searsdale, New York) after it was chilled at 4°C overnight. The bone was placed horizontally on supports that were separated by a 
distance of 9 mm. The crosshead speed was 0.4 mm/min with a sampling speed of 100 samples per second. Stiffness, stress at 
maximum load and maximum tolerated force were determined by Stable Micro Systems Texture Expert Exceed version 2.6 
(Stable Micro Systems). Stiffness measured the resistance of bone to the breaking force, and was calculated as the slope of the 
linear portion of the load displacement curve from 0.30 to 0.60 seconds (WERGEDAL et al. 2005). The stress at maximum load was 
measured at exactly 0.30 seconds. The maximum tolerated force was also called maximum force or femur breaking strength, and 
measured the maximum force that the femur could bear before it was broken. The average bone strength from both sides of each 
mouse was used as phenotypic values. 
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Table 2. Statistics of QTL interacting with myostatin, reciprocal cross and sex effect 
Factora Traitsb Chrc Position Flanking markerse P-valuef %varg 
    (cM)d Left Right   
Mstn AvgForce1 4 23  rs13477622c rs6232550 0.026 0.999 
Cross AvgForce2 4 62  rs6324470 rs3659226 0.025 1.014 
Cross AvgForce2 8 78  rs3678433 rs6182338 0.010 1.190 
Cross AvgGrad 6 28  rs13478727 rs13478839 0.021 1.046 
Sex AvgForce2 6 71  UT_6_123.37228 rs3688358 0.008 1.245 
a Interaction factors: Mstn (myostatin genotype); Cross (reciprocal cross); Sex (sex).  
b Traits abbreviations are the same as in Table 1. 
c Chr: mouse chromosome.  
d Peak position of QTL detected in Kosambi centimorgans.  
e Flanking markers (left and right) of the QTL peak.  
f Comparison P-value for testing interaction effect. P-value< 0.01 is shown in bold type. 
g %var: percentage of phenotypic variance accounted for by the interaction effect at QTL 
position. 
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CHAPTER 6. GENERAL CONCLUSIONS 
General discussions 
The goal of this project was to identify loci that control muscle mass and fat 
accumulation in F2 mice generated from myostatin null C57BL/6 and M16i obese mouse 
lines. We measured 47 traits, including 14 body weight traits, ten obesity-related traits, 11 
body composition traits, three bone strength traits and nine gene expression traits. The QTL 
mapping results for 46 traits are presented here because the gene expression level of beta-
actin gene was used to normalize the other gene expression levels. Large phenotypic 
variation was observed in these 46 traits even before we began our statistical analysis. The 
linkage map that we constructed from our genotyping results was relatively consistent with 
the published mouse linkage map. In the previous chapters, we presented our work according 
to the different traits. Here we summarize the results of this dissertation work from a more 
general view. This is discussed from two main aspects, QTL that have additive, dominance 
and imprinting effects, and QTL that interact with myostatin genotype, sex or reciprocal 
cross effects. 
QTL that have additive, dominance and imprinting effects 
 QTL with significant main effects (additive, dominance and imprinting effects) were 
identified by interval mapping. The significance levels were set at 1% and 5% genome-wise 
significance, which was determined with a permutation method. The additive, dominance and 
imprinting effects were individually evaluated and the corresponding comparison-wise P-
values were provided. The variation explained by each QTL was computed as the percentage 
of the sum of squares that a given QTL could account for. 
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For the 46 traits we analyzed here, we identified a total of 115 main effect QTL at a 
5% genome-wide significance level. This number might seem to be large, however, the 
actual number of causal mutations might be much smaller. Some of these QTL overlapped 
and it is possible that a given QTL may control multiple phenotypes. A test of pleiotropy 
using multivariate analysis will help to solve this issue. Among these 115 QTL, ten had 
comparison-wise P-values that indicate that they may be imprinted. Of these ten imprinted 
QTL, six were associated with obesity-related traits, three with body composition and one 
with bone strength. For the remaining 105 main effect QTL, 44 were associated with body 
weight, 38 with obesity-related traits,15 with body composition, six with bone strength and 
two with gene expression levels. A few QTL with large effect were located close to the 
myostatin locus. These QTL need further study considering the fact that segregation 
distortion was detected for SNPs near the myostatin gene.  
The largest number of QTL detected in this study was associated with body weight, 
muscle and fat accumulation. This was as expected considering the two founder mouse lines 
we used, one heavily muscled line and one obese line. In previous publications, QTL that 
controlled individual organ weights were not extensively studied except for those associated 
with heart, kidney and livers. We measured a large number of different internal organs, 
including heart, kidney, large intestine, liver, pancreas, reproductive organ, small intestine, 
spleen, stomach, lungs and thymus. Our study successfully identified QTL for most of the 
traits, which indicates that genetic factors contribute to the phenotypic variation observed in 
these traits. A few QTL identified overlapped with QTL that had been previously discovered 
in other studies. Other QTL discovered were novel. This suggests that our F2 mapping 
population contained numbers of segregating alleles that affected the traits we studied. 
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Therefore, these mice could be used for future fine mapping study to identify the causal 
mutation underlying the phenotypes. 
We obtained some interesting results from the eQTL mapping portion of the study as 
well. For example, an eQTL for IGF1 was identified on chromosome 4 and several QTL for 
body weight traits were located very close to this eQTL. Combined with the fact that the 
IGF1 gene iss on mouse chromosome 10, this might indicate that chromosome 4 harbors a 
trans-regulatory element for the IGF1 gene. eQTL mapping provides us an alternative way to 
link gene expression to a certain phenotype. In addition, it also provides some indication 
whether a QTL could be a cis- or trans- regulator. If we could perform a large-scale gene 
expression QTL analysis (microarray or RNA-seq) with the samples collected here, it would 
offer more clues to build genetic networks that control these traits. This may provide us with 
a better picture of the genetic mechanisms underlying a certain phenotype.  
QTL that interact with myostatin genotype, sex or reciprocal cross effects 
The interaction effects were statistically identified by comparing a full model with 
reduced models. Both models had the same fixed effects, but the full model included an extra 
interaction term. The interaction effects we analyzed here were interactions of QTL with 
myostatin genotype, sex, and reciprocal cross. The sex-specific and cross-specific 
interactions have been widely discussed in previous studies. To the best of our knowledge, 
QTL that interact with myostatin genotype have not been studied for most of the traits we 
analyzed.  
We identified 38 QTL that interacted with myostatin genotype, 44 QTL that 
interacted with sex, and 31 QTL that interacted with reciprocal cross. Most of the 38 
myostatin interacting QTL were associated with body weight or obesity-related traits. In 
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particular, the body weight traits that were impacted the most were post-weaning traits. This 
result indicates that the myostatin gene effect was time-dependent and it was more important 
for postnatal growth. Another interesting finding from this study was that myostatin 
interactions were associated with some internal organ weight traits, although myostatin 
expression was not detectable in these tissues. One possible explanation was that there might 
be other mediators between myostatin and genes that regulated these organs. Alternatively, 
circulating myostatin may bind to a receptor on the surface of these tissues. Through the 
analysis of myostatin effect on bone strength traits, we found that myostatin could influence 
bone elasticity and that this effect was caused by an alternation of muscle mass. Therefore, 
myostatin might be a key regulator of whole body growth, as it appears to affect muscle, 
adipose, internal organs and bone strength. 
The phenotypic variation accounted for by the epistatic QTL effects that were 
identified in our study was relatively small compared to that reported by Brockmann et al. 
(BROCKMANN et al. 2000). One reason may be that we only investigated the interaction 
effects between QTL and myostatin, but they analyzed all genome-wide pairwise QTL 
interactions. This could also be caused by a difference in genetic background. Therefore, the 
difference in QTL identification leads to a difference in the variation explained by these 
QTL. 
Future Research 
The most obvious future work following this study is to fine map the QTL regions 
identified in this study. Many different approaches can be used to realize this. The key point 
here is to increase the number of recombination events and to shrink these regions. For 
example, an advanced intercross line (DARVASI and SOLLER 1995) provides an experimental 
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population for fine mapping. Advanced intercross lines may be used to fine map several QTL 
regions simultaneously. However, the cost for constructing advanced intercross lines might 
be high because it requires an effective number of 100 individuals for each of ten generations 
before it reaches the ideal mapping resolution. Recombinant inbred lines are another option 
for QTL fine mapping (TAYLOR 1978). These lines have very dense breaking points, which 
provide for a high mapping resolution. In addition, one strain just needs to be genotyped once 
and can be collected for multiple phenotypes to study environmental influence. Recently, a 
new project has been initiated to construct a large number of recombinant inbred lines from 
eight commercial mouse lines. This is named the Collaborative Cross (WILLIAM et al. 2002). 
With these eight carefully selected founder lines, the Collaborative Cross will provide better 
mapping resolution and greater statistical power to fine map any QTL. Moreover, speed 
congenic lines (HILL 1998) can be derived by intercrossing the myostatin null allele into the 
Collaborative Cross, which will only take five generations. Therefore, these mice can be used 
for fine mapping both the main effect QTL and epistatic QTL that interact with myostatin 
genotype. Although the construction of speed congenic lines itself does not require a huge 
number of mice, one congenic line needs to be developed for each QTL. Thus, the total 
number of mice is still large if we try to fine map several QTL.  
Once a narrow QTL region is obtained from the fine mapping step, candidate genes 
can be selected according to the phenotype of the QTL and the known functions of the genes 
in this region. Causal mutations can be located by other molecular biology approaches. If 
eQTL are fine mapped in the fine mapping population as well, a pathway or gene network 
might be constructed from the myostatin gene. 
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Other future work that might be done includes testing the pleiotropic effects of these 
QTL; testing the effects of additive QTL by myostatin genotype interaction, dominance QTL 
by myostatin genotype interaction and imprinting QTL by myostatin genotype interaction 
individually.  
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